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In response to external stimuli, many intracellular signaling proteins undergo 
dynamic changes in localization to the plasma membrane.  Using the 
Saccharomyces cerevisiae mating pathway as a model, I investigated the 
molecular interactions that govern plasma membrane localization of signaling 
proteins, and how the plasma membrane compartmentalization of a signaling 
complex influences the overall signaling behavior of the pathway.  
  
Signaling proteins often consist of multiple interaction domains that collectively 
dictate their localization and function.  Ste20 is a p21-activated kinase (PAK) that 
functions downstream of the Rho-type GTPase Cdc42 to activate several 
mitogen-activated protein (MAP) kinase pathways in budding yeast, including the 
mating pathway.  I identified a short domain in Ste20 that directly binds to 
membrane lipids via electrostatic interaction.  A mutation in this domain abolishes 
both the localization and function of Ste20.  Thus, the previously known Cdc42 
binding is necessary but not sufficient; instead, direct membrane binding by 
Ste20 is also critical.  By replacing this domain with heterologous membrane-
binding domains, I demonstrated that phospholipid specificity is not essential in 
vivo.  Functionally important short membrane-binding domains were also found in 
the Cdc42 effectors Gic1 and Gic2, indicating that generic membrane binding 
can work in concert with the CRIB domain to regulate activation of Cdc42 targets.  
vi
These results underscore the importance of cooperation between protein-protein 
and protein-membrane interaction in achieving proper localization of signaling 
proteins at the cell cortex. 
 
At the system level, MAP kinase cascades can be graded or switch-like.  The 
budding yeast mating pathway exhibits a graded response to increasing levels of 
pheromone.  Previously the scaffold protein Ste5 was hypothesized to contribute 
to this graded response.  To test this idea, I activated the pathway in a variety of 
ways and measured the response at the single cell level.  I found that the graded 
response is not perturbed by the deletion of negative regulators of the pathway 
whereas the response became switch-like when the pathway was activated by a 
crosstalk stimulus that bypasses the upstream components.  Interestingly, 
activation of the pathway in the cytoplasm using the graded expression of 
MAPKKK resulted in an ultrasensitive response.  In contrast, activation of the 
pathway at the plasma membrane using the graded expression of membrane-
targeted active pathway components remained graded.  In these settings, the 
scaffold protein Ste5 increased ultrasensitivity when limited to the cytosol; 
however, if Ste5 was allowed to function at the plasma membrane, signaling was 
graded.  The results suggest that, in the mating pathway, the inherently 
ultrasensitive MAPK cascade is converted to a graded system by the scaffold-
mediated assembly of signaling complexes at the plasma membrane.  Therefore, 
the plasma membrane localization of Ste5 helps shape the input-output 
vii
properties of the mating MAPK pathway in a manner that is suitable for the 
biology of mating. 
 
Taken together, this thesis underscores the importance of plasma membrane 
localization during mating pathway signaling in yeast.  The examples described 
here provide further appreciation of how multiple interaction domains can 
function together to achieve specific targeting of the signaling proteins, as well as 
advances in understanding the role of scaffold proteins in modulating signaling 
behavior to promote graded signaling at the plasma membrane.  
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  Chapter I 
 
General Introduction 
 
 
Cell signaling 
Every cell has the ability to alter its behavior in response to changes in the 
environment.  To do so, cells depend on a number of signal transduction 
pathways, in which the input from external signaling molecules is transmitted into 
the cell and converted to specific intracellular activities.  Cellular responses to 
external stimuli are mediated by intracellular signaling molecules that interact 
with each other to form signaling complexes that relay the signal to target 
molecules thereby bringing about changes in gene expression, cell shape or 
movement, or metabolism (Figure I-1A).  Signal transduction pathways consist of 
a variety of signaling proteins including cell surface receptors, intracellular 
signaling molecules such as kinases and phosphatases, and target proteins such 
as transcription factors.  They must physically interact with each other to carry 
out their functions and to transfer information throughout the cell.  
A simple example of a cell signaling is shown in Figure I-1B.  In this 
model, cell signaling is initiated when extracellular signaling molecules are 
detected by cell surface receptors.  Activation of the receptors leads to a dynamic 
and reversible recruitment of intracellular signaling proteins to the site of signal 
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 initiation (Cho, 2006; Teruel and Meyer, 2000).  This change in molecular 
interaction is crucial for conveying a signal from the cell surface to the cytoplasm.  
The signal is then transmitted to target proteins in the cytoplasm or nucleus, such 
as metabolic enzymes or transcription factors, which induce the various cellular 
changes.  The main topic of the present study is the plasma membrane 
localization of intracellular signaling proteins.  In particular, I focus on how a 
cytosolic signaling protein is localized to the plasma membrane and how 
assembly of a signaling complex at the plasma membrane influences the 
pathway behavior.  
 
Using budding yeast as a model 
Studies in model organisms have been successful in elucidating many 
important advances in the basic understanding of signal transduction, which 
helps untangle complex signaling behaviors in higher eukaryotes.  Budding yeast 
Saccharomyces cerevisiae is one of the most studied minimal model eukaryotes.  
Yeast is ideal for studies in signal transduction because many prototypical 
signaling pathways that mediate essential cellular processes, including cell cycle 
regulation, stress response and differentiation, operate in yeast (Bardwell, 2005; 
Hartwell, 1974; Hohmann et al., 2007; Schneper et al., 2004).  In addition, most 
of the pathway components have already been identified and this cumulative 
knowledge is advantageous in studying how the signaling response works at the 
systems level.  In this chapter, I will use the yeast mating pathway as an example 
2
 to discuss how signaling pathway components are assembled at the plasma 
membrane, how pathway activity and specificity are regulated by scaffold 
proteins, and how pathway behavior helps shape the biological response of the 
yeast cell. 
 
Yeast mating MAPK pathway  
One of the most studied signaling pathway systems is the three-
component mitogen-activated protein kinase (MAPK) cascade.  Since its 
discovery, the MAPK cascade has been found to regulate important cellular 
processes including cell proliferation, movement, and cell death in all eukaryotic 
cells (Avruch, 2007; Cowan and Storey, 2003).  The MAPK cascade consists of 
three kinases; the MAP kinase kinase kinase (MAPKKK), MAP kinase kinase 
(MAPKK), and MAP kinase (MAPK).  The sequential phosphorylation and 
activation of these kinases leads to the transmission of signal (Figure I-2A).  The 
MAPKKK are serine/threonine kinases which phosphorylate MAPKK, and the 
MAPKK are dual specificity kinases that phosphorylate MAPK at the T-X-Y motif 
in the activation loop (T-loop).  The MAPK can phosphorylate serine and 
threonine residues of their targets.  These components are highly conserved 
through evolution, as the yeast and mammalian MAPKs share nearly 50% 
identical primary sequences (Courchesne et al., 1989; Elion et al., 1990). 
In yeast, at least five MAPK pathways have been described to mediate a 
variety of cellular responses including mating, filamentous growth, stress 
3
 response, cell wall integrity, and sporulation (Chen and Thorner, 2007).  Of 
these, the mating pathway is the archetypal MAPK pathway and has been the 
most extensively studied (Bardwell, 2005; Dohlman and Thorner, 2001).  The 
mating pathway mediates the formation of a diploid zygote from two haploid 
yeast cells (Figure I-2B).  Yeast can reproduce by simple cell division or by 
mating, and haploid cells exist in two mating types, a and ?.  These cells secrete 
a cell-type specific mating pheromone (a-factor and ?-factor, respectively), which 
signals to cells of the opposite mating type to arrest growth and prepare to mate 
by the formation of a mating projection.  These projections grow towards each 
other until they meet and eventually fuse to form a diploid zygote.  The players in 
this mating pathway include a group of highly conserved signaling molecules; a 
G protein coupled receptor (GPCR) Ste2 (in a cells) or Ste3 (in ? cells), a 
heterotrimeric G protein (comprised of G? (Gpa1), G? (Ste4), and G? (Ste18)), a 
MAPK cascade (Ste11 (MAPKKK), Ste7 (MAPKK) and Fus3 or Kss1 (MAPKs)), 
and a scaffold protein Ste5.  The small G protein Cdc42 and its downstream 
effector kinase Ste20 also play an essential role in activating the mating pathway 
MAPK cascade (Figure I-2C).  Of these proteins, Ste5 and Ste20 are the two 
focuses of my study and will be discussed in more detail in later sections. 
The activation of the mating pathway by mating pheromone depends on 
proper molecular interactions among these pathway components.  Upon binding 
of the mating pheromone to the GPCR, the G? subunit of the heterotrimeric G 
protein exchanges GDP for GTP, undergoes a conformational change, and 
4
 dissociates from the G?? heterodimer (Dohlman, 2002; Sprang, 1997).  G?? in 
turn recruits the scaffold protein Ste5 to the plasma membrane with its 
associated MAP kinases (Pryciak and Huntress, 1998; Whiteway et al., 1995).  
This is thought to bring Ste11 into close proximity of Ste20, which phosphorylates 
and activates Ste11 and thus initiates sequential activation of the downstream 
kinases (Drogen et al., 2000; Wu et al., 1995).  In MAPK cascades, the adjacent 
downstream kinase is a substrate for the upstream kinase, and this kinase-
substrate interaction is important for the signaling through the cascade.  Ste11 
phosphorylates and activates Ste7, and Ste7 in turn phosphorylates and 
activates Fus3 or Kss1 (Errede et al., 1993; Neiman and Herskowitz, 1994; Zhou 
et al., 1993).  Once activated, the MAPKs translocate into the nucleus to 
phosphorylate downstream targets, resulting in cell cycle arrest, transcriptional 
activation of mating specific genes, and formation of a mating projection (Choi et 
al., 1999; Elion et al., 1993; van Drogen et al., 2001). 
 
Plasma membrane recruitment of signaling proteins  
It has been well established that many signaling proteins consist of 
multiple domains, which fold independently of each other to confer specific 
functions (Pawson and Nash, 2003).  Of these, molecular interaction domains 
are often key players in successful signaling events, as the formation of 
functional signaling complexes relies on specific and reversible interactions 
among signaling proteins.  In the yeast mating pathway, as in many other cases, 
5
 signaling complexes form at the cell cortex where external stimuli are detected by 
the cell surface receptors (Pierce et al., 2002).  In order for the receptor to 
convey the signal into the cytoplasm and nucleus, cytoplasmic signaling proteins 
must localize to the site of action using these interaction domains.   
Plasma membrane recruitment of cytoplasmic signaling proteins can be 
achieved in several ways.  These mechanisms include covalent modification of a 
protein with lipid anchors, protein-protein interactions, and lipid-protein 
interactions (Cho, 2006) (Figure I-3A).  Covalent attachment of isoprenoid groups 
and fatty acids acts as an anchor to localize modified proteins to a cellular 
membrane (Magee and Seabra, 2005).  For example, small GTPases are known 
to localize to cellular membranes by lipid modifications such as prenylation, 
myristoylation, and palmitoylation (Casey, 1995; Ross, 1995; Zhang and Casey, 
1996).  The Rho-type small GTPase Cdc42, an upstream component of the 
mating pathway, is prenylated at its C-terminus and localizes to the cortex at 
sites of polarized growth such as at the tip of the mating projection (Ziman et al., 
1993).  In addition, the heterotrimeric G protein in the yeast mating pathway is 
lipid modified on its alpha and gamma subunits; The G? subunit is both 
myristoylated and palmitoylated and G? subunit is both prenylated and 
palmitoylated (Hirschman and Jenness, 1999; Manahan et al., 2000).  These lipid 
modifications help these proteins to stably associate with the cellular 
membranes.  
6
 Protein-protein interaction domains can also mediate plasma membrane 
localization of a protein by directly binding to a membrane receptor or other 
cortical proteins (Pawson, 2004; Schlessinger and Lemmon, 2003).  This class of 
membrane localization mechanism was originally recognized in receptor tyrosine 
kinase signaling in mammalian cells, where the Src homology (SH) 2 domains of 
the Src-family of receptor-associated protein kinases localize to the plasma 
membrane by binding to a phosphorylated receptor (Pawson, 2004).  In the yeast 
mating pathway, the scaffold protein Ste5 uses a protein-protein interaction 
domain called the RING-H2 domain to interact with the G?? heterodimer at the 
plasma membrane (Figure I-3B) (Feng et al., 1998; Whiteway et al., 1995).   
Finally, various lipid-protein interaction domains are also found to mediate 
the direct binding of a protein with membrane lipids, thus localizing a signaling 
protein to cellular membranes.  At least 10 classes of such lipid-binding domains 
are reported to date, including pleckstrin homology (PH), Phox (PX), FYVE 
(Fab1/YOTB/Vac1/EEA1), and C1 (Protein kinase C conserved 1) to name a few 
(Cho and Stahelin, 2005; Hurley, 2006).  These conserved domains vary in their 
binding mechanisms; some are specific to certain membrane lipids, and others 
are more general membrane binders.  PH domains are the most abundant of 
these, and some of the well-understood examples of PH domains are found to 
localize to the plasma membrane in target-specific manner (Lemmon and 
Ferguson, 2000).  For example, PH domains can specifically bind 
phosphatidylinositol (PI) 3-kinase (PI3K) products such as PI(3,4,5)P3, and 
7
 signaling proteins in PI3K pathways such as protein kinase B (PKB, also known 
as AKT) are recruited to the membrane using their PH domains (Franke et al., 
1997).  This step is a critical for their activation at the plasma membrane 
(Cantrell, 2001; Leevers et al., 1999).  Also the PH domain from mammalian 
phospholipase C delta (PLC?) specifically binds to phosphatidylinositol (4,5)P2 
(PIP2), and the isolated domain can be fused to green fluorescent protein (GFP) 
and used as a marker for PIP2 levels in live cell analysis (Garcia et al., 1995; 
Lemmon et al., 1995; Varnai and Balla, 2006).  In the mating pathway, the 
scaffold Ste5 is reported to contain a PH domain that helps with membrane 
localization, and is important for signaling function (Figure I-3B) (Garrenton et al., 
2006).   
In addition to these well-characterized domains, a growing number of 
short polybasic motifs have been recently reported to play a role in lipid-protein 
interactions in many signaling proteins (Fivaz and Meyer, 2003; Heo et al., 2006; 
Loewen et al., 2004; Nakanishi et al., 2004; Winters et al., 2005).  These motifs 
contain multiple positively charged residues that interact with acidic lipids by 
nonspecific electrostatic interactions and also in some cases they have 
hydrophobic residues that help interact with the hydrophobic core of the lipid 
bilayer (Nakanishi et al., 2004; Winters et al., 2005).  Unlike the PH domains with 
phospholipid specificity, these short membrane-binding motifs interact with 
membrane in non-specific manner with low affinity.  Therefore, these motifs 
require additional mechanisms to promote temporal and spatial specificity in the 
8
 event of signaling (Lemmon, 2008).  One such mechanism is the cooperation 
among several domains.  For instance, many small G proteins contain polybasic 
motifs in addition to covalent lipid modifications (Heo et al., 2006).  Also, the 
mating scaffold Ste5 uses the short membrane-binding motif called the PM 
domain, which synergistically functions with the RING-H2 domain to localize to 
the plasma membrane in response to pheromone (Figure I-3B) (Winters et al., 
2005).  In fact, it has become increasingly clear that membrane targeting of a 
signaling protein is ultimately dictated by the interplay among modular domains 
and motifs that mediate binding between proteins and lipids (Pawson and Nash, 
2003).  By having multiple interaction domains functioning together, signaling 
proteins are able to integrate multiple inputs from each domain before achieving 
the localization event, thereby allowing additional levels of regulation (Strickfaden 
et al., 2007; Winters et al., 2005).  In Chapter II, I will discuss this class of short 
lipid-interaction domains in more detail and show results that Ste20 and other 
Cdc42 effectors use such a cooperative method to promote their localization and 
function.  
 
Cdc42 and its downstream effectors in yeast 
Among the most highly conserved signaling proteins is Cdc42, a member 
of the Rho-family of small GTPases.  Budding yeast Cdc42 has a high degree of 
similarity to mammalian counterparts (Shinjo et al., 1990).  As a G protein, Cdc42 
functions as a molecular switch; when bound to GTP it is active, and inactive 
9
 when bound to GDP (Sprang, 2000).  The activity of yeast Cdc42 is regulated by 
the guanine nucleotide exchange factor (GEF) Cdc24, and several GTPase 
activating proteins (GAPs) Bem3, Rga1 and Rga2 (Sloat et al., 1981; Stevenson 
et al., 1995; Zheng et al., 1994).  Cdc42 plays a central role in regulation of 
cellular polarity in all eukaryotic cells (Johnson, 1999).  In yeast, it has been 
shown to coordinate polarized cell growth by regulating actin and microtubule 
organization, septin organization, and directed membrane trafficking (Figure I-4) 
(Etienne-Manneville, 2004; Pruyne and Bretscher, 2000).  Consistent with its 
critical functions, Cdc42 is essential for cell viability in yeast.  Cdc42 temperature 
sensitive mutants cannot form buds and arrest as large, unbudded multinucleate 
cells (Adams et al., 1990).  Cdc42 is found at the cell cortex at sites of polarized 
growth.  This localization to the plasma membrane is ensured by C-terminal 
prenylation and by binding to proteins at the cell cortex such as Cdc24 and Bem1 
(Bender and Pringle, 1991; Ziman et al., 1993).  At the membrane, Cdc42 
interacts with a number of downstream effectors leading to the coordinated 
regulation of multiple signaling pathways that mediate cell polarity (Johnson, 
1999).  
One class of such downstream effectors of Cdc42 is the p21-activated 
kinase (PAK) family of serine/threonine protein kinases Ste20, Cla4, and Skm1 
(Dan et al., 2001; Hofmann et al., 2004).  Of these, Ste20 functions in multiple 
mitogen-activated protein kinase (MAPK) signaling pathways that regulate 
mating, filamentous growth, and osmotic stress response (Figure I-5) (Chen and 
10
 Thorner, 2007; Hohmann et al., 2007).  In addition, Ste20 is also involved in actin 
organization, polarized growth and cell cycle transitions (Cvrckova et al., 1995; 
Hofken and Schiebel, 2002; Holly and Blumer, 1999).  Another class of Cdc42 
effectors is GTPase interactive component (Gic) 1 and its related protein Gic2.  
Both Gic1 and Gic2 function in actin polarization and septin recruitment (Brown 
et al., 1997b; Chen et al., 1997).  The physiological roles of these proteins will be 
discussed in the following sections. 
 
Ste20 as an upstream regulator of multiple MAPK cascades 
As mentioned above, Ste20 is known to participate in three MAPK 
pathways in yeast; the mating pathway, the invasive growth pathway, and the 
high osmolarity glycerol (HOG) pathway (Leberer et al., 1992; Liu et al., 1993; 
Raitt et al., 2000).  Ste20 activates these three pathways by phosphorylating the 
single MAPKKK Ste11 that is common in all three pathways (Figure I-5).  
Therefore, specificity of each pathway activity is promoted by several 
mechanisms, which will be discussed in later sections.   
The invasive growth pathway mediates the filamentous differentiation of 
both haploid and diploid yeast cells in response to starvation (Cullen and 
Sprague, 2000; Gimeno et al., 1992).  When activated, ovoid yeast cells adopt an 
elongated cell morphology and change their budding pattern in such a way that 
they grow away from the mother cells, allowing them to search for a more 
nutrient-rich growth environment (Gancedo, 2001; Pan et al., 2000).  The 
11
 invasive growth pathway shares several components with the mating pathway, 
including Cdc42, Ste20, Ste11, Ste7, and Kss1 (Figure I-5).  The upstream 
components of the mating pathway including the GPCR, heterotrimeric G protein, 
and the scaffold Ste5 are not required for the invasive growth pathway.  In this 
pathway, Ste20 is thought to promote both MAPK-dependent and independent 
functions, which promote polarizing morphogenetic activity (Loeb et al., 1999). 
The HOG MAPK cascade mediates osmoadaptation response in which 
yeast cells regulate internal glycerol levels in response to changes in external 
osmolarity (Hohmann et al., 2007).  There are two upstream branches of this 
pathway called the Sho1 and Sln1 branches (Maeda et al., 1995; Posas and 
Saito, 1997).  The MAPKK Pbs2 acts as a scaffold that binds to Sho1, Ste11, 
and Hog1, thereby linking the upstream elements to the downstream MAPK 
Hog1 (Posas and Saito, 1997).  Activation of either branch leads to the activation 
of the MAPKK Pbs2 and the MAPK Hog1, but Ste20 participates only in the Sho1 
branch of the pathway (Figure I-5).  
 
MAPK-independent functions of Ste20 
In addition to activating multiple MAPK pathways, Ste20 also has MAPK-
independent functions.  Ste20 plays an essential role in vegetative growth with its 
related PAK, Cla4.  Cells lacking both Ste20 and Cla4 are inviable, and Cla4 
temperature-sensitive mutant cells in ste20? background at the restrictive 
temperature show defects in cytokinesis, proper bud formation and septin 
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 organization (Cvrckova et al., 1995; Eby et al., 1998).  Since Cla4 is not 
synthetically lethal with the MAPKKK Ste11, this essential role of Ste20 in the 
absence of Cla4 is not MAPK signaling dependent (Cvrckova et al., 1995).   
Ste20 also functions to promote exit from mitosis (Hofken and Schiebel, 
2002).  In S. cerevisiae, mitotic exit is triggered by a signaling pathway, which is 
initiated by the small G protein Tem1 (Hoyt, 2000; Shou et al., 1999).  Tem1 
activity is regulated by GEF Lte1; lte1? cells are viable at 30ºC but cannot exit 
mitosis at low temperature and arrest at the end of mitosis (Adams et al., 1990; 
Shirayama et al., 1994a; Shirayama et al., 1994b).  Deletion of Ste20 in lte1? 
background is lethal at 30ºC, suggesting that Ste20 plays a role in mitotic exit 
(Hofken and Schiebel, 2002).  Again, Ste11 is not synthetically lethal with Lte1, 
thus, the role of Ste20 in mitotic exit is not MAPK signaling dependent (Hofken 
and Schiebel, 2002).  Both the vegetative and mitotic exit functions of Ste20 
require Cdc42 binding. 
 
Polarity proteins Gic1 and Gic2 control actin polarization in yeast 
Polarity proteins Gic1 and Gic2 have been identified as factors that 
function downstream of Cdc42.  Gic1 and Gic2 regulate the actin cytoskeleton 
and they are redundantly required for polarized cell growth as the double mutant 
shows a large, unbudded multinucleate phenotype at high temperature (Brown et 
al., 1997b; Chen et al., 1997).  Gic1 and Gic2 are not required for MAPK 
signaling in the mating pathway; however, double mutants cannot form mating 
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 projections and are severely defective in producing diploid zygotes, suggesting 
that they are also required for establishing polarity during mating (Brown et al., 
1997b).  Gic2 is shown to genetically interact with a group of proteins that form 
the polarisome complex, which consists of several proteins that are required for 
normal actin cytoskeleton organization (see Appendix), thereby linking Cdc42 
and the polarisome (Jaquenoud and Peter, 2000).  Gic1 and Gic2 have also 
been shown to function in mitotic exit.  Gic1 inhibits interactions between the 
GAP Bub2 and its target the small G protein Tem1, which triggers the mitotic exit 
network (Hofken and Schiebel, 2004). 
 
Cdc42 controls localization and function of Ste20, Gic1 and Gic2 
Both the PAK family kinases and Gic proteins share a conserved Cdc42-
Rac-interactive binding (CRIB) domain that mediates Cdc42 binding and is 
essential for the function of these proteins (see Figure II-8A and below).  In the 
case of Ste20, its localization to the regions of polarized cell growth, such as bud 
tips (for growth) and shmoo tips (for mating), is controlled largely by Cdc42, 
which binds to the CRIB domain of Ste20.  Earlier studies used the deletion of 
the entire CRIB domain in Ste20 to analyze the importance of this interaction.  
Since the mating signaling function of Ste20 was not eliminated, the authors 
concluded that the Cdc42-Ste20 interaction is not essential for the activation of 
Ste20 (Leberer et al., 1997; Peter et al., 1996).  However, studies of both 
mammalian PAKs and Ste20 later showed that the CRIB domain also regulates 
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 kinase activity of these proteins by inhibiting their kinase domain (Hoffman and 
Cerione, 2000; Lamson et al., 2002; Lei et al., 2000).  Therefore, the CRIB 
domain in Ste20 has two functions: it mediates binding of Cdc42, and it 
participates in autoinhibitory interaction of the kinase domain.  This explains the 
previous observation of the functionality of the Ste20 ?CRIB mutant in the mating 
pathway, as the deletion of the entire CRIB domain eliminated both functions and 
resulted in a constitutively active kinase independent of Cdc42 regulation.   
Isolation of additional mutations within the Ste20 CRIB domain that 
separate these two functions led to a detailed activation model of Ste20 by 
Cdc42 (Figure I-6A) (Lamson et al., 2002).  Point mutations that disrupt Cdc42 
binding without affecting the autoinhibitory interaction (S338A, H345G) result in a 
nonfunctional kinase whereas mutations that disrupt the autoinhibitory interaction 
(L369G) result in constitutively active, Cdc42-independent kinase (Figure I-6B) 
(Lamson et al., 2002).  Interestingly, the hyperactive L369G mutant which still 
can bind Cdc42 had higher activity than other hyperactive mutants that cannot 
bind Cdc42 (?CRIB or S338A/H345G/L369G triple mutant) in both signaling and 
non-signaling functions of Ste20, suggesting that the binding of Cdc42 not only 
results in kinase activity but also has additional roles after Ste20 activation.  For 
instance, Cdc42 may provide proper localization information so that the activated 
kinase can efficiently interact with its substrates (Lamson et al., 2002).   
In addition, the fact that the ?CRIB and the S338A/H345G/L369G triple 
mutant are still functional in the mating signaling suggests that these mutants 
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 retain a residual localization capacity by binding to other targets at the 
membrane.  A later study showed that a proline-rich motif in Ste20 provides 
additional localization ability by binding to the SH3 domain of the cortical protein 
Bem1 (Winters and Pryciak, 2005).   
As in Ste20, both Gic1 and Gic2 contain a conserved Cdc42-binding CRIB 
domain, and binding to Cdc42 is essential for their function in vivo.  Furthermore, 
both Gic1 and Gic2 are shown to localize to the same sites of polarized growth 
as their regulator Cdc42 (Brown et al., 1997b; Chen et al., 1997).  Mutation in the 
CRIB domain disrupts the normal localization of Gic2; therefore, as in the case of 
Ste20, the localization and function of Gic1 and Gic2 are both regulated by 
Cdc42.   
In Chapter II of the present study, I will present evidence that the CRIB 
domain alone is not sufficient for the proper localization and function of Ste20, 
Gic1 and Gic2; an additional lipid-interaction domain termed the BR domain is 
required for all three cases, underscoring the importance of interplay among 
modular domains in proper targeting of signaling proteins.  
 
 
Regulation of MAPK signaling by the scaffold protein 
Scaffold proteins are organizing molecules that can bind to multiple 
proteins to help assemble multiprotein complexes (Bhattacharyya et al., 2006b; 
Dard and Peter, 2006).  The MAPK cascades often associate with scaffold 
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 proteins, and the yeast mating MAPK scaffold Ste5 was among the first to be 
identified (Choi et al., 1994; Marcus et al., 1994; Printen and Sprague, 1994).  In 
the mating pathway, Ste5 is essential for MAPK signaling as deletion of Ste5 
abolishes mating activity.  Since the discovery of Ste5, many mammalian MAPK 
scaffolds have also been found, establishing the concept of scaffolding as an 
essential modulator of MAPK signaling (Morrison and Davis, 2003).  A number of 
important functions of scaffold proteins have been described: they can promote 
kinase-substrate interactions, modulate the activity of bound pathway 
components, insulate pathways from each other by spatially restricting pathway 
activity, and integrate signal inputs, both from inside and outside of the pathway 
in which they participate (Figure I-7) (Bhattacharyya et al., 2006b).  Using the 
mating pathway scaffold Ste5 as an example, each of these functions of scaffold 
proteins will be discussed in more detail. 
 
Scaffold proteins promote pathway signaling  
As the name implies, scaffold proteins are thought to function as an 
organizing platform; they tether the pathway components and enhance the 
kinase-substrate interactions among the MAPKs (Morrison and Davis, 2003).  
The classic view of scaffold proteins involves binding of both kinase and 
substrate simultaneously in an ideal conformation and/or orientation for the 
reaction to proceed on the scaffold protein (Ferrell, 2000).  However, recent 
findings suggest this may not be the case.  Park et al. modified mating pathway 
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 signaling by artificially recruiting pathway components to a complex using well-
characterized heterodimerization PDZ domains from mammalian proteins (Park 
et al., 2003).  In these experiments, Ste5 mutants that cannot bind Ste11 or Ste7 
were used, and the recruitment of each kinase to the scaffold was mediated by 
the foreign PDZ domains fused to both the mutant Ste5 and the kinases 
(scaffold-kinase recruitment).  In another setting, the recruitment of each kinase 
to the Ste5 mutants is mediated by the interaction between the Ste11 and Ste7 
kinases with PDZ domains (kinase-kinase recruitment).  In both settings, artificial 
recruitment of the pathway kinases to the defective Ste5 allowed signaling to 
occur, indicating that specific conformation/orientation may not be required for 
the function of scaffold proteins (Park et al., 2003).  The kinase-kinase 
recruitment result also indicates that the enzymatic reaction between pathway 
kinases does not have to occur on scaffold proteins.  The authors concluded that 
simple tethering is sufficient to fulfill the function of scaffolding proteins to 
promote interactions between pathway kinases. 
 
Scaffold proteins modulate activities of bound pathway components 
Since signaling with the artificially recruited components used in the Park 
et al. study was not as efficient as with the wild-type Ste5, it is equally valid that 
the scaffold proteins do more than just passively bind to the MAPKs to facilitate 
signaling (Park et al., 2003).  In fact, several lines of evidence in both yeast and 
mammalian scaffold proteins suggest that the scaffold proteins may regulate the 
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 activity of their associated kinases (Bhattacharyya et al., 2006b).  In the yeast 
mating pathway, binding of the MAPK Fus3 to the scaffold Ste5 is shown to 
modulate the catalytic activity of Fus3 (Bhattacharyya et al., 2006a).  Specifically, 
Ste5 allosterically induced autophosphorylation of Fus3, which results in a 
partially active monophosphorylated form of the kinase that negatively regulates 
pathway activity.  In addition, the Drosophila phototransduction pathway scaffold 
protein called INAD has recently been reported to undergo an active 
conformational change, which influences the pathway downregulation kinetics 
(Mishra et al., 2007).  Therefore, the scaffold proteins in vivo may be more 
complex than simple platforms, directly influencing the signaling activity of the 
pathway in which they participate. 
 
Scaffold proteins ensure pathway specificity 
Scaffold proteins can also ensure pathway specificity by binding to a 
specific set of proteins thereby promoting a signaling through one pathway while 
restricting the activity of others by preventing shared pathway components from 
accessing inappropriate substrates.  As briefly mentioned previously, three yeast 
MAPK pathways (mating, invasive growth, and HOG pathways) share the same 
MAPKKK Ste11 (see Figure I-5).  However, the pathways operate independently 
of each other, and proper cellular changes occur that are specific to each 
response (McClean et al., 2007; Posas and Saito, 1997).  
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 The role of scaffold proteins in pathway insulation is demonstrated in the 
yeast mating pathway and the HOG pathway.  Harris et al. provided direct 
experimental evidence that the scaffold proteins in both the mating and the HOG 
pathways (Ste5 and Pbs2, respectively) direct the information flow from Ste11 to 
proper downstream substrates by selectively binding to pathway specific 
components (Harris et al., 2001).  In this study, Ste11 was physically fused to 
Ste5, Ste7 (MAPKK of the mating pathway), or Pbs2: when Ste11 was fused to 
mating pathway components (Ste5 and Ste7), it became mating-specific, 
whereas when fused to Pbs2, Ste11 became HOG-specific.  Therefore, both 
Ste5 and Pbs2 can direct information flow from active Ste11 to proper 
downstream pathway components, indicating the role scaffolds play in promoting 
pathway specificity.  Consistent with this model, an artificial Ste5-Pbs2 fusion 
scaffold that can bind Sho1, Ste11, and hog1 can induce HOG response by 
mating pheromone (Park et al., 2003). 
 It is worth mentioning that in addition to scaffolding, several other 
strategies are often used by MAPK pathways to prevent erroneous cross-
activation of pathways with shared components (Schwartz and Madhani, 2004).  
In the yeast mating and HOG pathways, mutual inhibition by the pathway-specific 
MAPKs Fus3 and Hog1 also plays an important role in preventing cross 
activation of inappropriate response.  In short, activation of Fus3 inhibits the 
HOG pathway signaling, and activation of Hog1 inhibits the mating pathway 
signaling (Hall et al., 1996; McClean et al., 2007; O'Rourke and Herskowitz, 
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 1998).  In fact, the crosstalk from the HOG pathway to the mating pathway can 
be observed in cells lacking the Hog1 MAPK or Pbs2 MAPKK/scaffold (see 
Figure III-3A) (O'Rourke and Herskowitz, 1998).  Since Ste5 is not required for 
the HOG to mating cross-talk to occur (O'Rourke and Herskowitz, 1998), this 
phenomenon is used to study the scaffold-independent signaling behavior of the 
mating pathway in Chapter III. 
 
Scaffold proteins as the site of pathway regulation 
 Finally, the scaffold proteins themselves are also regulated in a variety of 
ways, which in turn modulates the activity of the associated signaling pathways.  
The yeast scaffold protein Ste5 receives additional inputs from both inside and 
outside of the pathway; it has been shown to be phosphorylated by the mating 
pathway MAPK Fus3, which may attenuate the signaling activity of the pathway 
(Bhattacharyya et al., 2006a; Kranz et al., 1994).  It is also regulated by cell cycle 
machinery through multiple phosphorylation events, which influences the ability 
of the protein to be recruited to the plasma membrane (Strickfaden et al., 2007).  
In the case of mammalian scaffolds, multiple levels of regulation, from cell type 
specific expression and splicing variants to posttranslational modifications such 
as phosphorylation, alter scaffolding activities (Bhattacharyya et al., 2006b).  In 
short, scaffold proteins contribute in a variety of ways to help fine-tune pathway 
activity.  
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 Plasma membrane localization of the yeast mating MAPK pathway by the 
scaffold protein Ste5 
In the mating pathway, the plasma membrane recruitment of Ste5 is 
triggered in response to pheromone (Pryciak and Huntress, 1998).  The 
membrane localization of Ste5 is ensured by cooperation among multiple 
interaction domains such as the RING-H2, PH, and the short membrane-binding 
motif (PM domain) (see Figure I-3B) (Garrenton et al., 2006; Whiteway et al., 
1995; Winters et al., 2005).  Through these domains, Ste5 allows multiple levels 
of regulation that influence its own plasma membrane localization, which in turn 
regulates the assembly of the MAPK cascade (Pryciak and Huntress, 1998; 
Strickfaden et al., 2007).  In particular, the membrane localization of Ste5 
provides two critical functions; it allows activation of the MAPKKK Ste11 by 
Ste20, and enhances the signal from activated Ste11 to the rest of the cascade 
(see Figure III-6B) (Lamson et al., 2006).  The latter function was observed when 
a native level of activated Ste11 (Ste11-Asp3, which bypasses phosphorylation 
by Ste20) was expressed in yeast; mating pathway activity was mildly increased 
by low levels of Ste11-Asp3, but was dramatically enhanced by the addition of 
pheromone (Lamson et al., 2006).  This active Ste11-signaling enhancing effect 
(or “amplification”) was detected when Ste5 was targeted to the cellular 
membranes (plasma membrane, Golgi, and ER), and when Ste5 is dimerized by 
GST moiety, both of which commonly act to concentrate the pathway 
components (Kholodenko et al., 2000).  From the Lamson et al. study, it was 
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 proposed that the plasma membrane localization of Ste5 functions to increase 
the effective local concentrations of pathway kinases by confining the area of 
interaction to the close proximity of two-dimensional membrane surface instead 
of the three-dimensional cytoplasm.  Importantly for the present study, the 
plasma membrane localization of Ste5 may influence the overall signaling 
behavior of the pathway, as I will discuss in more detail in Chapter III. 
 
Understanding cell signaling at the systems level 
Recently, many studies have begun to address how a signaling pathway 
functions as a system.  The MAPK cascade is ideal for studying overall pathway 
behavior, because it allows the simultaneous observation of multiple pathway 
components by measuring the output at the bottom of the pathway (see Figure I-
2A).  Therefore, the input-output behavior of the MAPK cascade has been 
extensively studied.  The MAPK cascade uses three kinases instead of one, and 
it has been postulated that this is because having multiple kinases allows for 
signal amplification (Brown et al., 1997a).  Having multiple kinases also offers 
more sites of regulation that allow fine-tuning of pathway activity (Kolch et al., 
2005).  Recently, it has been suggested that having a multi-step cascade 
influences the dynamics of pathway signaling by generating ultrasensitivity 
(Ferrell and Bhatt, 1997; Huang and Ferrell, 1996).  By definition, an 
ultrasensitive system generates the same change in output level (i.e. 10% to 
90%) in response to a smaller change in input level than a system with Michaelis-
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 Menten sensitivity (Figure I-8A).  This kind of signaling behavior is important for 
the conversion of continuous input (analog) into binary output (digital) (Ferrell 
and Machleder, 1998). 
Huang and Ferrell showed both theoretically and experimentally that the 
MAPK cascade used in Xenopus oocyte maturation shows ultrasensitivity in 
response to increasing levels of stimulus and this ultrasensitivity increases as the 
reaction descends the cascade (i.e., more ultrasensitive at MAPK than MAPKK) 
(Huang and Ferrell, 1996).  They showed that the ultrasensitivity is generated by 
the non-processive multi-phosphorylation of MAPKs in the cascade (both the 
MAPKK and the MAPK need to be phosphorylated at two independent residues 
in order to achieve full activation, and these phosphorylation evens are 
independent of each other (hence the term “non-processive”)) (Ferrell and Bhatt, 
1997; Patwardhan and Miller, 2007).  Since MAPKK and MAPK are highly 
conserved and they all share the same two-collision reaction mechanism, all 
MAPK cascades can be inherently ultrasensitive.  
 
Graded vs. switch-like signaling of MAPK pathways 
An interesting implication of the Huang and Ferrell study is that the MAPK 
cascade may be suitable for mediating a biological process that requires a 
dramatic change in output levels in response to a relatively small change in the 
stimulus.  Based on this notion, Ferrell et al. elegantly showed that the Xenopus 
oocyte maturation MAPK pathway is highly ultrasensitive in vivo, such that the 
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 overall output is virtually all-or-none in response to an increasing amount of 
stimulus with no intermediate response (Ferrell and Machleder, 1998).  Thus, the 
authors called the system “switch-like.”  In this study, the authors were able to 
distinguish graded (Michaelian) vs. switch-like (ultrasensitive) behaviors by 
measuring the pathway response at the individual cell level; the two kinds of 
signaling behaviors may look identical at the population level, because the 
heterogeneity within the population of cells responding in switch-like manner 
could result in an apparently graded overall response.  Subsequently, another 
example of switch-like MAPK pathway is found in stress response Jun N-terminal 
kinase (JNK) pathway, indicating that the MAPK pathways can generate digital 
output in response to graded input (Bagowski and Ferrell, 2001).  
In contrast, the S. cerevisiae mating MAPK pathway has been reported to 
respond in a graded manner to increasing levels of pheromone (Poritz et al., 
2001) (see Figure III-1D).  Similarly, mammalian growth hormone MAPK 
signaling cascades such as ERK pathways have been shown to be graded as 
well (Mackeigan et al., 2005; Whitehurst et al., 2004).  Therefore, although they 
share the same type of signaling module, not all MAPK cascades behave the 
same at the systems level in different biological contexts.  These observations 
also suggest an additional level of regulation that modulates the inherently 
ultrasensitive behavior of the MAPK pathways. 
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 Mechanisms that modulate the MAPK signaling behavior 
One regulatory mechanism that modulates MAPK signaling behavior is 
positive feedback loops, in which pathway output amplifies signaling input earlier 
in the pathway (Figure I-8B).  It has been shown in the Xenopus oocyte MAPK 
response that inhibition of the positive feedback loop decreases the 
ultrasensitivity of the system and the extreme all-or-none behavior is attenuated 
(Ferrell and Machleder, 1998).  Similarly, artificial introduction of a positive 
feedback loop in the otherwise graded yeast mating MAPK pathway results in 
ultrasensitive response (Bashor et al., 2008; Ingolia and Murray, 2007).  Thus, 
the presence of a positive feedback loop within pathway circuitry predicts that the 
overall pathway behavior will be ultrasensitive. 
On the other hand, the mating MAPK Fus3 and Kss1 participate in a 
negative feedback loop, in which the activation of the MAPKs leads to 
downregulation of their upstream components (Figure I-9) (Gartner et al., 1992; 
Zhou et al., 1993).  The molecular mechanism of this negative feedback loop is 
not entirely clear; however, Fus3 phosphorylates upstream pathway components 
such as Ste5 and Ste7, which may alter their activity (Errede et al., 1993; Kranz 
et al., 1994).  Fus3 also promotes the ubiquitin-dependent degradation of Ste11 
(Esch and Errede, 2002).  In addition, the expression of negative components of 
the pathway is shown to be upregulated in response to pheromone (Dohlman et 
al., 1996; Manney, 1983).  Those include Bar1 and Sst2, which act at the top of 
the pathway to downregulate the pathway activity.  Bar1 is a protease for mating 
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 pheromones, and Sst2 is a GAP for the G? subunit of the heterotrimeric G 
protein.  Furthermore, the expression of the dual-specificity phosphatase Msg5 
that dephosphorylates Fus3 is also upregulated in response to pheromone (Doi 
et al., 1994).  Msg5, together with tyrosine-specific phosphatases Ptp2 and Ptp3, 
regulates the activity of mating pathway signaling by dephosphorylating Fus3 
(Zhan et al., 1997).  These negative regulators play important roles in 
determining the magnitude and duration of signaling (Bhalla et al., 2002; Martin 
et al., 2005).  Thus, it is possible that such a negative feedback loop influences 
the overall graded pathway behavior of the mating pathway. 
Another mechanism that may influence the pathway behavior is the 
presence of scaffold proteins.  As discussed earlier, scaffold proteins play a key 
role in the regulation of signal transduction.  Most importantly, it has been 
hypothesized that scaffold proteins might counteract the switch-like tendencies of 
MAPK cascades, because assembly of a multi-kinase complex could allow 
multiple phosphorylations to proceed processively, without intervening steps of 
dissociation (Ferrell, 2000; Levchenko et al., 2000).  Therefore, the graded 
signaling of the yeast mating pathway may result from the absence of a positive 
feedback pathway, the presence of the scaffold protein Ste5, or both.  However, 
no previous experimental evidence has addressed this question. 
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 Description of dissertation 
In the present study, the yeast mating pathway is used to investigate the 
plasma membrane localization of signaling proteins and how this localization 
affects the input-output properties of the overall pathway behavior.  In Chapter II, 
I will first describe the identification of a short membrane-binding domain, termed 
the BR domain, in the yeast Cdc42 effector Ste20.  Additional characterization of 
the BR domain led to the revised activation model of Ste20 in which the CRIB 
domain and the BR domain cooperatively functions to achieve plasma membrane 
localization of Ste20 and activation by Cdc42.  Subsequently, similar domains 
were also identified in Gic1 and Gic2, and were found to be functionally 
important.  Mutational analysis uncovered the detailed sequence requirements 
for the BR domains in these proteins, providing insights into how this class of 
short membrane-binding domains interacts with membranes.  These findings 
suggest a common activation mechanism for Cdc42 effectors that requires both 
membrane-binding and protein-binding activities, and provide additional 
examples in which multiple interaction domains in a signaling protein control 
specific subcellular targeting.  
In Chapter III, I will describe the body of work that investigates the 
molecular basis for the graded response in yeast mating pathway.  The yeast 
mating MAPK signaling was measured at the single cell level by flow cytometry 
and fluorescent microscopy.  Analysis of the input-output pathway behavior in 
mutants in negative regulators of the pathway revealed that the graded response 
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 persists in these settings, while in the HOG to mating crosstalk setting the 
pathway became switch-like.  Further analysis revealed that Ste5-independent 
signaling is mildly ultrasensitive but became more so in the presence of 
cytoplasmic Ste5.  In contrast, when Ste5 was used at the plasma membrane, 
the pathway behavior became graded.  These results suggest that Ste5 may 
promote graded response in the yeast mating pathway at the plasma membrane, 
indicating yet another way the MAPK scaffold protein helps shape the cellular 
response for suitable biological processes. 
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Figure I-1. General features of cell signaling.
A. An example of a signaling pathway activated by an extracellular signaling molecule.  A receptor 
binds to a ligand and triggers signaling mediated by intracellular signaling molecules.  These 
molecules interact with target proteins that alter cellular behaviors.  PM, plasma membrane.
B. Cellular responses to external stimuli.  1. a cell in resting state; 2. extracellular signaling 
molecules are presented; 3. activation of the receptors leads to a dynamic recruitment of 
intracellular signaling molecules to the plasma membrane; 4. signal is passed on to targets (e.g., 
nucleus). 
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Figure I-2. Pheromone response MAPK pathway in yeast.
A. MAPK cascade.
B. Mating reaction.  Haploid yeast cells (a or α) produce mating pheromone (a-factor or α-factor), 
which triggers cell cycle arrest, formation of mating projection, and cell fusion to produce diploid 
zygotes (a/α cell).
C. Mating pathway.  Mating pheromone binds to a G-protein coupled receptor (GPCR) and 
triggers the dissociation of Gβγ dimer from Gα.  Gβγ recruits scaffold protein Ste5 and associated 
MAPKs (Ste11, Ste7, and Fus3) to the plasma membrane (PM).  Ste11 activation by Ste20 
results in signaling through the MAPK cascade.
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PM
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Figure I-3. Plasma membrane localization of signaling proteins.
A. Mechanisms for plasma membrane recruitment of intracellular signaling proteins.  1. covalent 
attachment of lipid groups; 2. protein-protein interaction domain (e.g., SH2 domain); 3. lipid-
protein interaction domain (e.g., PH domain). 
B. Plasma mebrane localization of Ste5.  Collaboration of protein-protein (Gβγ and the RING-H2
domain) and lipid-protein interactions (membrane and PM / PH domains) recruites Ste5 to the 
plasma membrane in mating signaling.    
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Figure I-4. Cdc42 and downstream effectors.
Cdc42 plays essential roles in polarized cell growth in yeast.  Yeast Cdc42 interacts with a 
number of downstream effectors to control various cell processes.  PAK, p-21 activated kinase; 
MAPK, mitogen-activated kinase.
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Figure I-5. Ste20 participates in three MAPK pathways in yeast. 
Ste20, together with its upstream activator Cdc42, participates in three MAPK pathways in yeast 
(mating, invasive growth, HOG).  Note that in all three cases Ste20 activates the same substrate 
Ste11 (MAPKKK).  HOG, high osmolarity glycerol. 
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Figure I-6. Regulation of Ste20 localization and activity by Cdc42.
A.  Cdc42-dependent activation of Ste20 at the plasma membrane (PM).  Binding of the CRIB 
domain (shown in blue) to GTP-Cdc42 releases the autoinhibition.  Proline-rich (Pro) region of the 
kinase (shown in green) binds to the SH3 domain of a cortical protein Bem1 and this interaction 
also contributes to Ste20 activation.
B. Mutations in the CRIB domain used in this study.  SH mutation disrupts Cdc42 binding (inactive 
kinase).  ∆CRIB disrupts both Cdc42 binding and autoinhibition.  L369G disrupts autoinhibition 
without affecting Cdc42 binding.
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Figure I-7. Functions of scaffold proteins.
A. Scaffold proteins can bind multiple pathway components and serve as an organizing platform.
B. Scaffold proteins can modulate the activity of bound pathway components. 
C. Scaffold proteins can insulate pathways from each other and allow a single molecule (A) to 
have two distinct functions. 
D. Scaffold proteins themselves undergo multiple levels of regulation.  Their functions can be 
modified from both outside and inside the pathway in which they participate.
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Figure I-8. MAPK activity at the systems level.
A. Ultrasensitive response.  Response of a system can be definied as Michaelis-Menten 
sensitivity or ultrasensitivity.  In Michaelis-Menten sensitivity response, 81-fold change in input 
level is required to achieve 10% to 90% increase in response.  In ultrasensitive response, smaller 
than 81-fold change is required.  Hill coefficient (nH) is also used to describe these responses, 
where nH=1 (Michaelian) and nH>1 (ultrasensitive).
B. MAPK pathway that mediates Xenopus oocyte maturation.  Once MAPK is activated, it inhibits 
MAPKKK degradation.  
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Figure I-9. Negative regulators of the mating pathway.
Negative regulators of the mating pathway are shown.  1, MAPKs of the pathway downregulate 
their upstream components (exact target(s) is not known).  Only Fus3 is shown in this figure; 2. 
Bar1 degrades pheromone, and Sst2 promotes GTP hydrolysis of Gα subunit; 3. phosphatases 
Ptp2, Ptp3, and Msg5 dephosphorylate MAPK.
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 Abstract 
 
The Rho-type GTPase Cdc42 is a central regulator of eukaryotic cell 
polarity and signal transduction.  In budding yeast, Cdc42 regulates polarity and 
MAP kinase signaling in part through the PAK-family kinase Ste20.  Activation of 
Ste20 requires a Cdc42/Rac interactive binding (CRIB) domain, which mediates 
its recruitment to membrane-associated Cdc42.  Here, we identify a separate 
domain in Ste20 that interacts directly with membrane phospholipids and is 
critical for its function.  This short region, termed the basic-rich (BR) domain, can 
target GFP to the plasma membrane in vivo and binds PIP2-containing liposomes 
in vitro.  Mutation of basic or hydrophobic residues in the BR domain abolishes 
polarized localization of Ste20 and its function in both MAP kinase-dependent 
and independent pathways.  Thus, Cdc42 binding is required but is insufficient; 
instead, direct membrane binding by Ste20 is also required.  Nevertheless, 
phospholipid specificity is not essential in vivo, as the BR domain can be 
replaced with several heterologous lipid-binding domains of varying lipid 
preferences.  We also identify functionally important BR domains in two other 
yeast Cdc42 effectors, Gic1 and Gic2, suggesting that cooperation between 
protein-protein and protein-membrane interactions is a prevalent mechanism 
during Cdc42-regulated signaling, and perhaps for other dynamic localization 
events at the cell cortex. 
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 Introduction 
 
Control of cellular architecture and interaction with the extracellular 
environment rely on dynamic localization of proteins to the cell cortex.  For 
example, signal transduction is often initiated by the assembly of protein 
complexes at the plasma membrane, where external stimuli are detected by 
membrane receptors (Cho, 2006; Kholodenko et al., 2000).  Dynamic assembly 
can be ensured by reversible recruitment of cytoplasmic factors to the 
membrane-localized complex (Johnson and Cornell, 1999; Teruel and Meyer, 
2000).  Hence, signaling proteins commonly consist of multiple, modular 
interaction domains that dictate their localization and assembly behavior 
(Pawson and Nash, 2003).  Membrane recruitment is governed not only by 
protein-protein interactions but also by protein-membrane interactions, which can 
be mediated by lipid-binding motifs such as pleckstrin homology (PH) domains as 
well as PX, C1, C2, FYVE, ENTH, and FERM domains (Hurley, 2006; Lemmon, 
2003).  These domains have distinct structural folds and often recognize specific 
phospholipids.  Other proteins can interact with membranes via short polybasic 
motifs, which contain multiple positively charged residues that bind acidic 
phospholipids through electrostatic interactions, and which often act in concert 
with other interaction domains to promote efficient membrane targeting (Fivaz 
and Meyer, 2003; Heo et al., 2006).  Although there are several physiologically-
relevant examples, the short length and indefinite sequence of these polybasic 
41
 motifs hinders their identification and obscures estimates of their prevalence 
(Fivaz and Meyer, 2003).  This study reports the identification of short, basic-rich 
membrane-interaction domains in multiple Cdc42 effectors in the budding yeast 
Saccharomyces cerevisiae.  
 
Cdc42, a member of the Rho family of small GTPases, plays a central role 
in the regulation of cellular polarity in all eukaryotic cells (Etienne-Manneville, 
2004; Johnson, 1999).  In budding yeast, Cdc42 controls polarized cell growth by 
regulating cytoskeleton assembly and membrane trafficking, and also 
participates in several signal transduction pathways (Johnson, 1999; Park and Bi, 
2007).  To regulate these processes, Cdc42 interacts with a number of 
downstream effectors.  One class includes three members of the p21-activated 
kinase (PAK) family of serine/threonine protein kinases—Ste20, Cla4, and 
Skm1—which function in signal transduction, polarized growth, and cell cycle 
control (Cvrckova et al., 1995; Hofken and Schiebel, 2002; Holly and Blumer, 
1999; Leberer et al., 1992).  Another class includes two redundant cell polarity 
factors, Gic1 and Gic2, which function in actin polarization and septin assembly 
(Brown et al., 1997b; Chen et al., 1997).  Each of these effectors has a 
conserved Cdc42/Rac-interactive binding (CRIB) domain, which mediates Cdc42 
binding and regulates their function in vivo. 
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 Ste20 is perhaps the best understood Cdc42 effector in budding yeast.  It 
regulates multiple mitogen-activated protein kinase (MAPK) pathways that 
control mating, filamentous growth, and osmotic stress response, and it is also 
involved in cell polarity and cell cycle control (Cvrckova et al., 1995; Hofken and 
Schiebel, 2002; Holly and Blumer, 1999; Leberer et al., 1992; Liu et al., 1993; 
O'Rourke and Herskowitz, 1998; Raitt et al., 2000).  In the mating pathway, 
Ste20 activates MAPK cascade signaling when mating pheromones bind to 
membrane receptors (Dohlman and Thorner, 2001).  The receptor-activated G?? 
dimer binds Ste20 (Leeuw et al., 1998) and recruits the scaffold protein Ste5 to 
the plasma membrane (Pryciak and Huntress, 1998), allowing Ste20 to 
phosphorylate the first in a chain of Ste5-associated kinases that eventually 
trigger cell cycle arrest, transcription of mating genes, and polarized 
morphogenesis.  Ste20 is recruited to sites of polarized cell growth, such as the 
tips of buds and mating projections, via binding of its CRIB domain to Cdc42 
(Ash et al., 2003; Lamson et al., 2002; Leberer et al., 1997; Peter et al., 1996).  
Cdc42 binding also regulates Ste20 kinase activity by disrupting an autoinhibitory 
conformation formed by interactions between the CRIB and kinase domains 
(Lamson et al., 2002).  Point mutations in the CRIB domain can differentially 
affect Cdc42 binding and autoinhibition.  Those that disrupt Cdc42 binding 
without affecting autoinhibition (S338A H345G) produce a nonfunctional kinase, 
whereas those that disrupt autoinhibition (L369G) produce a constitutively active, 
Cdc42-independent kinase (Lamson et al., 2002).  Thus, localization and 
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 activation of Ste20 are normally coupled by their dependence on Cdc42 binding.  
Proper localization and function of Ste20 is also promoted by binding of a proline-
rich motif in Ste20 to an SH3 domain in the cortical protein Bem1 (Moskow et al., 
2000; Winters and Pryciak, 2005).  
 
Here, we show that the localization and function of Ste20 is critically 
dependent on a previously-unrecognized element.  We identify a short 
membrane-binding region in the Ste20 N-terminus that promotes the proper 
polarized localization of Ste20.  This membrane-binding domain is required for 
Cdc42-dependent regulation of Ste20 and for the in vivo function of the kinase in 
both MAPK-dependent and MAPK-independent pathways.  Furthermore, we 
identify similar membrane-binding motifs in two other Cdc42 targets, Gic1 and 
Gic2, and show that they are critical for the function of these proteins.  Our 
observations suggest a common theme for Cdc42 effectors in which a 
membrane-binding domain is required to help target the protein to its activator. 
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 Materials and Methods 
 
Strains and Plasmids 
Standard yeast media and genetic methods were used (Rose and Fink, 1990).  
Yeast strains and plasmids are listed in Tables II-1 and II-2, respectively. 
 
Table II-1.  Yeast strains used in Chapter II. 
 
strain 
bkgnd* 
strain name genotype source §  
    
(a) KBY211 MAT? ste20::ADE2 cla4::LEU2 + YCpTRP1-cla4-75ts (1) 
(a) PPY866 MAT? FUS1::FUS1-lacZ::LEU2 ste4::ura3FOA ste5::ADE2 ste20::TRP1 (2) 
(a) PPY913 MATa ste20-3?::TRP1 FUS1::FUS1-lacZ::LEU2 (3) 
(a) PPY1114 MATa ADE2  (4) 
(a) PPY1249 MATa ADE2 ste20-1::TRP1 (5) 
(a) PPY1368 MATa ADE2 FUS1::FUS1-lacZ::LEU2 (6) 
(b) PPY1209 MATa his3 leu2 trp1 ura3 ste20-1::TRP1 (3) 
(c) CCY1033-5D MATa ADE2 LYS2 gic1-?1::LEU2 gic2-1::HIS3 (7) 
(c) L40 MATa LYS2::(lexAop)4-HIS3 URA3::(lexAop)8-lacZ (8) 
(c) PPY1978 † MATa lte1?::kanMX6 ste20?::KlTRP1 + pDH166 (CEN HIS3 PGAL1-STE20) this study 
(d) PT2? MAT? hom3 ilv1 can1 (2) 
(d) SEY6210.1 MATa leu2-3,112 ura3-52 his3-?200 trp1-?901 lys2-801 suc2-?9 (9) 
(d) AAY102.1 MATa leu2-3,112 ura3-52 his3-?200 trp1-?901 lys2-801 suc2-?9 
stt4?::HIS3 + pRS415-stt4-4ts 
(10) 
(d) AAY104.1 MATa leu2-3,112 ura3-52 his3-?200 trp1-?901 lys2-801 suc2-?9 
pik1?::HIS3 + pRS314-pik1-83ts 
(10) 
(d) AAY202.1 MATa leu2-3,112 ura3-52 his3-?200 trp1-?901 lys2-801 suc2-?9 
mss4?::HIS3 + YCplac111-mss4-102ts 
(11) 
    
 
* Strain background:  (a) W303 (ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1 can1); (b) 
?1278b; (c) S288c (ade2 his3-?200 leu2 lys2-801 trp1 ura3-52); (d) other. 
 
§ Source:  (1) (Holly and Blumer, 1999); (2) (Pryciak and Huntress, 1998); (3) (Lamson 
et al., 2002); (4) (Harris et al., 2001); (5) (Winters and Pryciak, 2005); (6) (Winters et al., 
2005); (7) (Chen et al., 1997): (8) (Bartel and Fields, 1995): (9) (Robinson et al., 1988); 
(10) (Audhya et al., 2000); (11) (Stefan et al., 2002). 
 
† Strain PPY1978 was derived by transforming THY87 (lte1? ste20? + pLTE1) (Hofken 
and Schiebel, 2002) with the HIS3-marked PGAL1-STE20 plasmid pDH166 (Leberer et al., 
1997), propagating the transformants on galactose media, and then screening for loss of 
the URA3-marked LTE1 plasmid. 
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 Table II-2.  Plasmids used in Chapter II. 
 
Name Alias Description ** Source § 
    
pPP167 pBTM116 2?m TRP1 lexA-DBD 2-hybrid vector (1) 
pPP244 pGAD424 2?m LEU2 GAL4-AD 2-hybrid vector (1) 
pPP477 pH-GS5-CTM CEN HIS3 PGAL1-STE5-CTM (2) 
pPP538 pRL116 CEN URA3 GFP-STE20 (3) 
pPP681 pRS316 CEN URA3 vector (4) 
pPP1009 pRL116-S338A,H345G CEN URA3 GFP-STE20(S338A,H345G) (5) 
pPP1010 pRL116?334-369 CEN URA3 GFP-STE20(?334-369)  (5) 
pPP1027 pGAD-CDC42-V12, S188 2?m LEU2 GAL4-AD-CDC42-V12, S188 (5) 
pPP1053 pB20N2 2?m TRP1 lexA-DBD-STE20(1-499) (5) 
pPP1059 pB20N2-S338A 2?m TRP1 lexA-DBD-STE20(1-499)/S338A (5) 
pPP1061 pB20N2-S338A/H345G 2?m TRP1 lexA-DBD-STE20(1-499)/S338A,H345G (5) 
pPP1109 pRL116-S338A/H345G/L369G CEN URA3 GFP-STE20(S338A,H345G,L369G)  (5) 
pPP1117 pRL116-L369G CEN URA3 GFP-STE20(L369G)  (5) 
pPP1843 pUG-GST-GFP 2?m URA3 PGAL1-GST-GFP vector (6) 
pPP1877 pUG-GST-F20-A 2?m URA3 PGAL1-GST-GFP-ste20(1-333)  this study 
pPP1878 pUG-GST-F20-B 2?m URA3 PGAL1-GST-GFP-ste20(330-381)    this study 
pPP1880 pUG-GST-F20-D 2?m URA3 PGAL1-GST-GFP-ste20(434-499)    this study 
pPP1931 pGEX-PLC? PH GST-PLC?11-142 in pGEX-5X-1 (7) 
pPP1939 pUG-GST-F20-F 2?m URA3 PGAL1-GST-GFP-ste20(1-254)  this study 
pPP1940 pUG-GST-F20-G 2?m URA3 PGAL1-GST-GFP-ste20(254-333)   this study 
pPP1947 pGEX-6P-1 E. coli GST fusion vector (Amersham) (8) 
pPP1961 pUG-GST-F20-J 2?m URA3 PGAL1-GST-GFP-ste20(330-499)  this study 
pPP2204 pRL116 BR* CEN URA3 GFP-STE20-BR* this study 
pPP2238 pRL116 BR*/?CRIB CEN URA3 GFP-STE20(?334-369)/BR* this study 
pPP2239 pRL116 BR*/L369G CEN URA3 GFP-STE20(L369G/BR*) this study 
pPP2317 pRL116 PH CEN URA3 GFP-STE20[(?285-311) + Cla461-180] this study 
pPP2318 pRL116 ?BR CEN URA3 GFP-STE20(?285-311) this study 
pPP2325 pRL116 S338A,H345G/PH CEN URA3 GFP-STE20[(?285-311) /S338A, H345G + 
Cla4
61-180
] 
this study 
pPP2342 pRL116 SHL/PH CEN URA3 GFP-STE20[(?285-311) /S338A, H345G, 
L369G + Cla4
61-180
] 
this study 
pPP2407 pCUGTF-PH CEN URA3 PGAL1-GST-GFP-CLA4
61-180
 this study 
pPP2418 pCUGGFP-Opi1Q2 CEN URA3 PGAL1-GFP-OPI1(103-189)   this study 
pPP2419 pCUGTF-GIC2NS CEN URA3 PGAL1-GST-GFP-GIC2(1-128) this study 
pPP2426 pCUGGFP-Spo20 CEN URA3 PGAL1-GFP-SPO20(51-91) this study 
pPP2428 pUG-GST-F20-P 2?m URA3 PGAL1-GST-GFP-ste20(285-311) this study 
pPP2430 pRL116 BR-1 CEN URA3 GFP-STE20(K285N,K286AN,R287G, 
K288A) 
this study 
pPP2431 pRL116 BR-2 CEN URA3 GFP-STE20(R297A,K299A) this study 
pPP2433 pCUGTF-F20-P CEN URA3 PGAL1-GST-GFP-ste20(285-311)   this study 
pPP2436 pRL116-N2 CEN URA3 GFP-STE20(F302N,F305N) this study 
pPP2454 pRL116-WASP CEN URA3 GFP-STE20[(?285-311) + N-WASP175-205] this study 
pPP2455 pRL116-PLC CEN URA3 GFP-STE20[(?285-311) + PLC?11-140] this study 
pPP2456 pRL116-FAPP CEN URA3 GFP-STE20[(?285-311) + FAPP11-100] this study 
pPP2458 pRL116-Opi1 CEN URA3 GFP-STE20[(?285-311) + OPI1103-189] this study 
pPP2459 pRL116-Spo20 CEN URA3 GFP-STE20[(?285-311) + SPO2051-91] this study 
pPP2461 pRL116-N5 CEN URA3 GFP-
STE20(M298N,V301N,F302N,F305N,V306N) 
this study 
pPP2462 pRL116 BR-3 CEN URA3 GFP-STE20(K310N, R311G) this study 
pPP2469 pRL116 BR-1/2 CEN URA3 GFP-
STE20(K285N,K286AN,R287G,K288A,R297A,K299A) 
this study 
pPP2470 pRL116 BR-1/3 CEN URA3 GFP-
STE20(K285N,K286AN,R287G,K288AK310N,R311G) 
this study 
pPP2471 pRL116 BR-2/3 CEN URA3 GFP-STE20(R297A,K299A,K310N,R311G) this study 
pPP2472 pRL116 BR-1/2/3 CEN URA3 GFP-STE20(BR-1/2/3) this study 
pPP2477 pCUGTF-GIC2 96-128 CEN URA3 PGAL1-GST-GFP-GIC2(96-128)  this study 
pPP2480 pCUGTF-PLC CEN URA3 PGAL1-GST-GFP-PLC?(11-140) this study 
pPP2481 pCUGTF-GIC1 89-117 CEN URA3 PGAL1-GST-GFP-GIC1(89-117)  this study 
pPP2513 pRL116-Gic2 CEN URA3 GFP-STE20[(?285-311) + GIC296-128] this study 
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 pPP2514 pRL116-Gic1 CEN URA3 GFP-STE20[(?285-311) + GIC189-117] this study 
pPP2515 pGEX-S20P GST-STE20
285-311
 in pGEX-6P-1 this study 
pPP2528 pCUGTF-GIC1 1-117 CEN URA3 PGAL1-GST-GFP-GIC1(1-117)   this study 
pPP2529 pCUGTF20P-N5 CEN URA3 PGAL1-GST-GFP-ste20(285-311)/N5 this study 
pPP2531 pCUGTF20P BR-1/2/3 CEN URA3 PGAL1-GST-GFP-ste20(285-311)/BR-1/2/3 this study 
pPP2533 pCUGTF-GIC1 1-88 CEN URA3 PGAL1-GST-GFP-GIC1(1-88)  this study 
pPP2535 pCUGTF-GIC2 1-95 CEN URA3 PGAL1-GST-GFP-GIC2(1-95)  this study 
pPP2538 pRL116-FAPP/L369G CEN URA3 GFP-STE20[(?285-311)/L369G +  
FAPP1
1-100
] 
this study 
pPP2539 pRL116-FAPP/SH CEN URA3 GFP-STE20[(?285-311)/S338A,H345G + 
FAPP1
1-100
] 
this study 
pPP2540 pRL116-FAPP/SHL CEN URA3 GFP-STE20[(?285-311)/SHL + FAPP11-100] this study 
pPP2640 pGIC1-GFPx3 CEN URA3 GIC1-GFPx3  TCYC1   (GIC1 DNA seq.: -398 
to +942) 
this study 
pPP2641 pGIC2-GFPx3 CEN URA3 GIC2-GFPx3  TCYC1   (GIC2 DNA seq.: -525 
to +1149) 
this study 
pPP2642 pGIC1?BR-GFPx3 CEN URA3 GIC1(?89-117)-GFPx3  TCYC1    this study 
pPP2643 pGIC2?BR-GFPx3 CEN URA3 GIC1(?96-128)-GFPx3   TCYC1   this study 
pPP2671 pGIC1-PLC-GFPx3 CEN URA3 GIC1[(?89-117) + PLC?11-140]-GFPx3  TCYC1 this study 
pPP2672 pGIC1-C4-GFPx3 CEN URA3 GIC1[(?89-117) + CLA461-180]-GFPx3 TCYC1  this study 
pPP2673 pGIC2-PLC-GFPx3 CEN URA3 GIC2[(?96-128) + PLC?11-140]-GFPx3  TCYC1   this study 
pPP2674 pGIC2-C4-GFPx3 CEN URA3 GIC2[(?96-128) + CLA461-180]-GFPx3  TCYC1   this study 
pPP2913 pGIC1N4-GFPx3 CEN URA3 GIC1(N4)-GFPx3  TCYC1   this study 
pPP2914 pGIC1A6-GFPx3 CEN URA3 GIC1(A6)-GFPx3  TCYC1  this study 
pPP2915 pGIC2N4-GFPx3 CEN URA3 GIC2(N4)-GFPx3  TCYC1  this study 
pPP2916 pGIC2A6-GFPx3 CEN URA3 GIC2(A6)-GFPx3  TCYC1  this study 
pPP2927 pRL116 myc CEN URA3 myc13-STE20 this study 
pPP2928 pRL116 myc S338A,H345G CEN URA3 myc13-STE20(S338A,H345G) this study 
pPP2929 pRL116 myc ?BR CEN URA3 myc13-STE20(?285-311) this study 
pPP2930 pRL116 myc BR* CEN URA3 myc13-STE20(BR*) this study 
pPP2943 pCUGTF-FAPP1 CEN URA3 PGAL1-GST-GFP-FAPP1
1-100
 this study 
pPP2949 pB20N2 BR* 2?m TRP1 lexA-DBD-STE20(1-499)/BR* this study 
pPP2950 pB20N2 ?BR 2?m TRP1 lexA-DBD-STE20(1-499)/?285-311 this study 
    
 
§ Source:  (1) (Bartel and Fields, 1995); (2) (Pryciak and Huntress, 1998); (3) (Leberer et 
al., 1997); (4) (Sikorski and Hieter, 1989); (5) (Lamson et al., 2002); (6) (Winters et al., 
2005); (7) (Nakanishi et al., 2004); (8) Amersham, Inc. 
 
**STE20 BR* = K285N, K286N, R287G, K288A, R297A, M298G, K299A, K310N, R311G 
STE20 N5 = M298N, V301N, F302N, F305N, V306N 
STE20 BR-1/2/3 = K285N, K286N, R287G, K288A, R297A, K299A, K310N, R311G 
STE20 SHL = S338A, H345G, L369G 
 GIC1 N4 = F101N, M104N, F105N, L111N 
GIC1 A6 = K97A, K98A, K99A, K106A, K107A, K108A 
GIC2 N4 = V111N, L115N, L118N, L122N 
GIC2 A6 = K109A, K110A, K114G, K119A, K120A, K121A 
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 Mating, filamentation, two-hybrid, and ?-galactosidase assays 
Mating assays, halo assays of growth arrest, and FUS1-lacZ transcriptional 
induction assays in response to ? factor or galactose-inducible constructs, were 
performed as described previously (Lamson et al., 2002); all transcription and 
shmoo formation assays used 5 ?M ? factor for 2 hr.  Agar invasion assays used 
fresh transformants patched onto YPD plates, as described previously (Winters 
and Pryciak, 2005).  Quantitative two-hybrid and ?-galactosidase assays used 
methods described previously (Lamson et al., 2002). 
 
Microscopy 
To visualize GFP-Ste20, Gic1-GFPx3, and Gic2-GFPx3, plasmid-transformed 
cells were grown at 30ºC in –Ura media, and observed without fixation using a 
Nikon E600 epifluorescence microscope with a 50X Plan oil immersion objective.  
Images were captured using a Hamamatsu Orca-ER digital camera and IPLab 
Spectrum version 3.5.5 software (Scanalytics, Inc.).  To analyze galactose 
inducible GFP and GST-GFP fusions to isolated protein domains, cells were 
grown at 30ºC in selective raffinose medium and then induced with 2% galactose 
for 2hrs. 
 
Liposome Binding Assays 
GST fusion proteins were expressed from pGEX-6P-1 and purified as described 
previously (Nakanishi et al., 2004) from E. coli strain BL21-RIPL (Stratagene).  
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 Phospholipids in chloroform were purchased from Avanti Polar Lipids (Alabaster, 
AL).  To prepare sucrose-laden liposomes (Sciorra et al., 1999), phospholipid 
mixtures were dried in glass test tubes under a stream of nitrogen, then 
resuspended in 20 mM HEPES (pH7.5) with 20 mM NaCl and 0.2 M sucrose, 
vortexed (~1min), and sonicated in a water bath sonicator (4x1 min).  This 
suspension (200 ?l) was mixed with 700 ?l of Buffer A (20 mM NaPO4 pH7.5, 
200 mM NaCl), and centrifuged at 200,000xg for 15 min at 4ºC.  Pelleted 
liposomes (80 or 200 nmol total lipid) were resuspended in Buffer A containing 
10 ?g of bovine serum albumin, and then were incubated with 2 ?g of purified 
protein on ice for 30 min in a final volume of 200 ?l.  Centrifugation was repeated, 
and protein in the supernatant (precipitated with 4.5 % trichloroacetic acid) and 
pellet fractions was analyzed by SDS-PAGE and Coomassie Blue staining.  
 
Yeast cell lysates and protein analysis 
PPY913 cells carrying Myc-Ste20 plasmids were cultured in -Ura growth 
medium, and 2 x 107 cells in the log phase (OD660 ~0.7) were collected by 
centrifugation.  Whole-cell lysates were prepared by a post-alkaline extraction 
method (Kushnirov, 2000), and analyzed by SDS-PAGE and immunoblotting 
using rabbit anti-Myc antibody (1:200, Santa Cruz) and alkaline phosphatase-
conjugated secondary antibody (goat anti-rabbit, 1:3000, BioRad). 
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 Results 
 
The Ste20 regulatory region contains a membrane interaction domain 
Ste20 is a large protein (939 residues) with a C-terminal kinase domain 
and an N-terminal "regulatory" region, which comprises over half of the protein 
and contains the binding sites for both Cdc42 and Bem1 (Figure II-1A).  In order 
to test whether these binding sites could suffice as independent cortical-
localization domains, we made a series of GFP fusions to fragments from the 
Ste20 N-terminus (Figure II-1A); these GFP fusions also contained a 
homodimerizing GST moiety, which can help reveal weak localization 
determinants by increasing binding avidity (Winters et al., 2005).   Despite their 
role in localization of full-length Ste20, the isolated Cdc42-binding and Bem1-
binding domains, or fragments containing both domains, were unable to localize 
to the cell cortex (Figure II-1A, i-iii).  Surprisingly, however, a fragment that 
lacked any previously characterized domains, residues 1-333, localized to the 
cortex (Figure II-1A, iv).  (This fragment also affected cell morphology, as 
discussed in Apendix.)  Further dissection revealed that a short (27 a.a.) domain, 
residues 285-311, was sufficient for the cortical localization (Figure II-1A, v-vii).  
This short region contains many basic residues (Figure II-1A) and is conserved 
among fungal Ste20 orthologs (Figure II-2), and hence we named it the basic-rich 
(BR) domain.  
 
50
 The sequence features and localization pattern of the BR domain 
suggested that it might bind directly to the plasma membrane, with its positively 
charged residues interacting with negatively charged phospholipids, as we found 
recently with a domain from another mating pathway protein, Ste5 (Winters et al., 
2005).  To test this notion we performed in vitro liposome-binding assays using a 
bacterially-produced GST fusion to the Ste20 BR domain (residues 285-311).  
This GST-Ste20BR fusion protein bound detectably to liposomes containing 
phosphatidylinositol-4,5-bisphosphate (PIP2) but not to those containing other 
phospholipid species (Figure II-1B).  This binding was sensitive to PIP2 levels 
(Figure II-1C), though it appeared more dependent on the density of PIP2 than on 
its total concentration (e.g., greater binding for 80 nmol lipid with 10% PIP2 than 
for 200 nmol lipid with 5% PIP2), which is consistent with a multivalent mode of 
electrostatic interaction seen previously for polybasic domains and anionic 
membranes (Papayannopoulos et al., 2005; Wang et al., 2002).  When 
compared to the pleckstrin homology (PH) domain from mammalian PLC? 
(Figure II-1D), which is specific for PIP2 (Rebecchi et al., 1992), the binding 
observed with the GST-Ste20BR fusion was relatively weak, as it required a 
higher percentage of PIP2 and a smaller fraction of input protein was bound.  
However, this was not entirely surprising given similar recent observations with 
analogous domains from other yeast proteins (Nakanishi et al., 2004; Winters et 
al., 2005).  Because several different GST fusions containing the Ste20 BR 
domain were subject to unusually rapid proteolysis in E. coli cell extracts (data 
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 not shown), we did not perform further analysis using the in vitro system.  
Nevertheless, these results demonstrated that the Ste20 BR domain could bind 
directly to acidic phospholipid membranes, and thereby led us to probe the role 
of this domain in vivo. 
 
The BR domain is important for Ste20 localization and function 
To test the role of the BR domain in full-length Ste20, we initially made two 
mutations (Figure II-3A): one in which all the basic residues were replaced with 
non-charged residues (BR*), and one in which the entire BR domain was deleted 
(?BR).  These mutations were introduced into constructs expressing GFP-tagged 
Ste20 from its own promoter.  Ste20 normally localizes to small and medium 
buds, and to shmoo tips in cells exposed to mating pheromone.  We found that 
neither the BR* mutant nor the ?BR mutant localized to the bud tip (Figure II-3B).  
When exposed to mating pheromone, ste20? cells expressing the BR* mutant 
could not form mating projections, and GFP-Ste20 localization was diffuse 
(Figure II-3B).  To check localization in cells that could form projections, we 
repeated the experiment in STE20 cells and found that the BR* and ?BR mutants 
failed to localize to the shmoo tip (Figure 2-3B).  Therefore, membrane targeting 
by the BR domain is not a spurious feature of the isolated domain but is 
important for normal localization of full-length Ste20. 
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  To test if the BR domain is required for the signaling role of Ste20, we first 
measured pheromone response.  Both ?BR and BR* mutant forms of Ste20 
failed to induce the FUS1-lacZ reporter gene in response to ? factor (Figure II-
3C), yielding signaling defects comparable to that caused by S338A H345G 
mutations (“SH”) in the CRIB domain, which severely disrupt Cdc42 binding 
(Lamson et al., 2002).  Similar defects were observed in cell cycle arrest and 
mating assays (Figure II-3C).   Because the GFP-Ste20 fusions were difficult to 
detect by western blotting, we introduced the same mutations into a Myc-Ste20 
construct; these showed that the signaling defects were not due to reduced 
protein levels (Figure II-3C).  It is unlikely that the BR domain mutations disrupt 
signaling by perturbing a larger structural domain involving the entire N-terminus, 
because deletion of other regions more N-terminal to the BR domain (e.g., ?124-
270, ?2-119) did not cause any detectable defect (see Figure A-4A).  Since 
Ste20 participates in multiple MAPK pathways, we also tested if these BR 
mutants could function in the filamentous growth pathway by an agar invasion 
assay, and found that they were defective (Figure II-3D).  Ste20 also plays a role 
in pathways that are independent of MAPK signaling but are essential for cell 
viability; namely, deletion of STE20 is lethal in cells that lack either the related 
PAK-family kinase Cla4 or the mitotic exit network factor Lte1 (Cvrckova et al., 
1995; Hofken and Schiebel, 2002).  We found that the Ste20 BR domain mutants 
were unable to support growth under either of these conditions (Figure II-3E, F).  
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 Collectively, these results indicate that the BR domain is important for multiple 
functions of Ste20 in signaling and viability. 
  
The BR domain is required for Cdc42-dependent regulation of Ste20 
Because the BR domain is required for both localization and function of 
Ste20, which are normally controlled by Cdc42, we reasoned that membrane 
binding might allow Ste20 to be activated by membrane-localized Cdc42.  To test 
this notion, we combined the BR* mutation with mutations in the Ste20 CRIB 
domain, L369G and ?CRIB (?334-369), which disrupt autoinhibition and hence 
activate the Ste20 kinase independent of Cdc42 (Lamson et al., 2002).  Indeed, 
these additional mutations restored pheromone signaling to the Ste20 BR* 
mutant (Figure II-4A, left), suggesting that the BR* mutation prevents Cdc42 from 
activating Ste20.  Notably, signaling was less efficient for the BR* L369G double 
mutant than for L369G alone, implying that membrane binding plays an 
additional role once Ste20 is activated, such as enhancing its ability to 
phosphorylate cortical substrates.  In fact, this parallels previous findings that 
Cdc42 binding plays two separable roles in activation and localization of Ste20; 
for example, although both L369G and ?CRIB mutants are constitutively active, 
the L369G mutant, which still binds Cdc42, signals more efficiently than ?CRIB, 
which cannot bind Cdc42 and is delocalized ((Lamson et al., 2002); and Figure II-
4A, left).  To rule out the possibility that the BR mutant signaling defects were 
due to impaired binding between Ste20 and G?? (Leeuw et al., 1998), we 
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 activated the mating pathway in a G??-independent manner, using ste4? ste5? 
ste20? cells that express membrane-targeted Ste5 (Ste5-CTM) (Pryciak and 
Huntress, 1998).  The BR* mutant phenotypes matched those seen during 
pheromone response (Figure II-4A, right), implying that the BR domain serves 
primarily to promote Ste20 regulation by Cdc42, not G??.  Nevertheless, when 
using a two-hybrid assay to measure interaction between the Ste20 N-terminus 
and Cdc42 (Lamson et al., 2002; Leberer et al., 1997), neither of the BR domain 
mutations blocked Cdc42 binding (Figure II-4B).  Therefore, we conclude that 
separate BR-membrane and CRIB-Cdc42 interactions are jointly required for 
Cdc42 to regulate Ste20 at the plasma membrane (Figure II-4C), and that 
membrane binding allows Cdc42 to promote both activation of Ste20 and its 
subsequent signaling. 
 
The function of the BR domain requires both basic and hydrophobic 
residues 
Given the critical functional role of the Ste20 BR domain, we probed its 
sequence requirements in greater detail.  The basic residues in the BR domain 
are distributed in three small clusters of 2-4 basic residues each (Figure II-5A).  
In addition, the C-terminal half of the BR domain is enriched in hydrophobic 
residues and has the potential to form an amphipathic ?-helix (Figure II-5A), 
suggesting that the BR domain might insert into the inner leaflet of the plasma 
membrane (Hristova et al., 1999).  To compare the role of basic and hydrophobic 
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 residues, we made additional mutations (Figure II-5B): one set changed each 
cluster of basic residues, either individually (BR-1, BR-2, BR-3) or in 
combination; another set used polar Asn residues to replace hydrophobic 
residues at either two (N2) or five (N5) positions.  When introduced into the 
isolated BR domain (residues 285-311), the BR-1/2/3 and N5 mutations each 
eliminated membrane targeting (Figure II-5C), indicating that both basic and 
hydrophobic residues are required.  In full-length Ste20, mutations in 
hydrophobic residues (N2, N5) severely disrupted pheromone signaling (Figure 
II-5D).  Mutations in basic residues had a milder effect on a per-residue basis but 
they showed an additive effect in which signaling became gradually more 
disrupted as more residues were mutated (Figure II-5D).  Although they changed 
fewer basic residues, the BR-2 and BR-3 mutations had stronger effects on 
signaling than the BR-1 mutation, either alone or when combined in double 
mutants (e.g., compare BR-2/3 with BR-1/2  and BR-1/3).  This result correlates 
with the fact that the BR-2 and BR-3 clusters lie within the potential amphipathic 
?-helix and in the more conserved portion of the BR domain (see Figure II-2).  
Taken together, these findings show that in addition to basic residues, the 
hydrophobic residues in the BR domain are critical to both its membrane-
targeting ability and its functional role in Ste20 signaling. 
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 Substitution of the Ste20 BR domain with foreign membrane-binding 
domains 
To rigorously test whether Ste20 requires the BR domain for membrane 
binding rather than for binding to an unknown protein partner, we replaced the 
BR domain with heterologous membrane-binding motifs (Figure II-6A).  We used 
PH domains from mammalian PLC? (which binds PIP2), mammalian FAPP1 
(which binds PI4P and PIP2), and yeast Cla4 (which binds multiple 
phospholipids) (Kavran et al., 1998; Levine and Munro, 2002; Wild et al., 2004), 
as well as basic-rich motifs from yeast Spo20 (which prefers PA) and yeast Opi1 
(which binds PA and mediates both membrane and nuclear localization) (Loewen 
et al., 2004; Nakanishi et al., 2004).  When expressed as isolated domains 
tagged with GFP, each of these domains localized in a manner consistent with 
previous studies (Figure II-6B), although in several cases they showed polarized 
localization that was not reported previously (see Discussion).  
 
Chimeras containing these foreign domains in place of the Ste20 BR 
domain were expressed from the native Ste20 promoter and tested for 
localization and pheromone response.  Except for the FAPP1 domain, which 
caused strong localization to Golgi membranes, each of the foreign domains 
restored Ste20 localization to bud tips and to shmoo tips in pheromone treated 
cells (Figure II-6C).   In addition, the Opi1 chimera showed strong nuclear 
localization, consistent with the dual targeting activity of the isolated Opi1 domain 
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 (Loewen et al., 2004).  In pheromone response assays, signaling was restored to 
levels that agreed with the localization of each chimera (Figure II-6D).  Namely, 
the FAPP1 chimera signaled very poorly, whereas those that localized to the 
plasma membrane functioned at or near wild-type levels.  Thus, the BR domain 
of Ste20 is functionally replaceable by other membrane-binding motifs that can 
mediate plasma membrane localization.   
 
In principle, the foreign domains could rescue the signaling defect of the 
Ste20?BR mutant by disrupting the autoinhibitory conformation, rather than by 
restoring interaction with Cdc42.  To distinguish between these possibilities, we 
tested whether Cdc42 binding was still required in the Ste20Cla4 chimera, by 
introducing the CRIB domain mutations S338A H345G.  This new mutant 
(Cla4/SH) was defective at signaling (Figure II-6E), whereas this defect was 
reversed in a further mutant (Cla4/SHL) in which autoinhibition was disrupted by 
the additional mutation L369G (Lamson et al., 2002).  Therefore, as with wild-
type Ste20, the chimeras are still autoinhibited and are still activated by Cdc42 
binding.  A related approach suggests that Golgi mislocalization of the Ste20FAPP1 
chimera disrupts both activation by Cdc42 and post-activation signaling efficiency 
(Figure II-7).  Taken together, these results show that the role of the Ste20 BR 
domain is to provide a membrane-binding activity that promotes regulation of 
Ste20 by membrane-localized Cdc42.  They also indicate that the function of the 
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 BR domain does not require a specific protein structure or binding to a specific 
phospholipid, as long as it can localize the kinase to the plasma membrane. 
 
BR domains in the yeast Cdc42 effectors Gic1 and Gic2 
The finding that Ste20 function is critically dependent on a small, 
previously-unrecognized membrane-binding domain raised the possibility that 
similar domains might be required in other yeast Cdc42 binding partners or in 
other polarized proteins.  In S. cerevisiae, there are five Cdc42 effectors with 
recognizable CRIB domains (Figure II-8A).  Interestingly, Cla4 and Skm1 have 
PH domains at a position similar to that of the Ste20 BR domain, and the PH 
domain of Cla4 is essential for its function (Benton et al., 1997; Wild et al., 2004).  
Therefore, we wondered if the other two Cdc42 targets, Gic1 and Gic2, might 
also contain membrane-binding domains in an analogous position.  To test this 
idea, we expressed GST-GFP fusions to N-terminal fragments of Gic1 and Gic2, 
and examined their membrane-targeting activity in vivo (Figure II-8B).  Indeed, 
domains from both proteins conferred membrane localization, and in each case 
the responsible sequence mapped to a short (29-33 a.a.) motif adjacent to the 
CRIB domain.  As with Ste20, these Gic1 and Gic2 domains were found to be 
rich in basic and hydrophobic residues (Figure II-8C), and hence were named 
“BR” domains.  Notably, the Gic1 BR domain (but not the Gic2 BR domain) also 
showed nuclear-targeting activity, the strength of which was influenced by 
adjacent sequences (Figure II-8B).  Related dual targeting behavior has been 
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 found recently for similar domains in Opi1 and Ste5 (Loewen et al., 2004; Winters 
et al., 2005), and was also weakly apparent for the Ste20 BR domain (see Figure 
II-1A, panels vi-vii).  In addition to their targeting activity as isolated motifs, the 
BR domains from both Gic1 and Gic2 could potently substitute for the Ste20 BR 
domain in pheromone response assays (Figure II-9). 
 
To test their functional significance in full-length Gic1 and Gic2, we made 
deletions of these domains (?BR) and point mutations of basic or hydrophobic 
residues (Figure II-8C); these mutants were expressed from their native 
promoters and tagged with three tandem copies of GFP.  When assayed in gic1? 
gic2? strains (Figure II-8D), the ?BR mutations in both Gic1 and Gic2 disrupted 
their ability to support growth at the restrictive temperature (36ºC), showing that 
the BR domains are functionally important.  Mutation of basic or hydrophobic 
residues had distinct effects on the two proteins.  In Gic1, mutation of six basic 
residues (A6) had no evident effect, whereas mutation of four hydrophobic 
residues (N4) severely reduced function (Figure II-8D).  Conversely, in Gic2 it 
was the mutation of basic residues (A6) that had the stronger effect, whereas 
mutation of hydrophobic residues (N4) caused a weak but detectable defect 
(Figure II-8D).  Thus, the BR domains are important for both Gic1 and Gic2, but 
their dependence on basic versus hydrophobic residues is not identical; this may 
relate to differences in the competitive effect of nuclear targeting by the two 
domains (see Discussion).  As with Ste20, we found that replacing the BR 
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 domains in Gic1 and Gic2 with PH domains from yeast Cla4 or mammalian PLC? 
reversed the growth defect of the ?BR mutants (Figure II-8D), suggesting that it 
is the membrane-targeting activity of the BR domains that is functionally 
important. 
 
The effects of BR domain mutations on localization were notably different 
between Gic1 and Gic2.  The results with Gic2 clearly support a role for the BR 
domain in polarized localization, as localization to nascent bud sites was 
abolished by each of the BR domain mutations (?BR, N4, or A6), and was 
restored in the Gic2PLC? and Gic2Cla4 chimeras (Figure II-8D).  Notably, Gic2-
GFPx3 levels were actually increased by the BR domain mutations (data not 
shown), which is consistent with the fact that Cdc42 binding promotes 
degradation of Gic2 (Jaquenoud et al., 1998).  In contrast to these Gic2 
phenotypes, none of the Gic1 BR mutations disrupted polarized localization 
(Figure II-8D).  However, this result is consistent with previous findings that Gic1 
remains localized even when Cdc42 binding is disrupted by mutations in the 
CRIB domain (Chen et al., 1997); furthermore, as with the previous CRIB domain 
mutants, the Gic1?BR mutant showed enhanced localization to bud necks 
(Figure II-10).  Thus, while Gic1 clearly must contain other localization 
information, our results agree with expectations if the Gic1 BR domain serves 
primarily to facilitate interaction with Cdc42.  Interestingly, full-length Gic1 also 
shows faint nuclear localization (Chen et al., 1997; Iwase et al., 2006), and this 
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 was reduced in all mutant and chimeric forms except for the N4 mutant (Figure II-
8D).  This indicates that nuclear localization of full-length Gic1 depends on the 
basic residues of the BR domain, although the functional significance of this 
localization is unknown (see Discussion).  Despite the complex localization 
behavior of Gic1, our findings in total demonstrate that multiple yeast Cdc42 
effectors contain membrane-binding domains next to their CRIB domains, 
suggesting a common mechanism for their membrane-localized regulation by 
Cdc42.    
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 Discussion 
 
Prevalence of short membrane-binding domains 
In this study we identify short (~30 residue) membrane-binding motifs in 
the budding yeast Cdc42 effectors Ste20, Gic1, and Gic2.  These BR domains 
were previously undetected, and yet they are critical for the in vivo function of 
each protein.  Unlike larger (e.g., 100-120 residue) lipid-binding modules such as 
PH domains, which have a defined tertiary structure and signature sequence 
motifs, the short domains found here and in other recent studies (Heo et al., 
2006; Loewen et al., 2004; Nakanishi et al., 2004; Winters et al., 2005) are 
difficult to recognize from sequence alone.  Direct comparison of these domains 
does not yield a clear “consensus” at the primary sequence level, although most 
are significantly enriched in both basic and bulky hydrophobic groups (Table II-3).  
In some cases the basic residues may be clustered (Heo et al., 2006) and some 
may form an amphipathic ?-helix (this study and Nakanishi et al., 2004; Winters 
et al., 2005), though the BR domain sequences from Gic1 and Gic2 suggest no 
propensity for this structure.  Algorithms for predicting membrane-seeking 
peptides on the basis of hydrophobic moment (Phoenix and Harris, 2002) or 
comparative pattern recognition (Sapay et al., 2006) identify some of the 
experimentally characterized motifs, but they fail to identify others (S.T. and 
P.M.P., unpublished observations).  In comparison, we have found it relatively 
straightforward to identify these domains by overexpressing protein fragments as 
63
 dimerized GFP fusions.  Because BR-like domains exist in at least two mating 
pathway proteins and at least three Cdc42 effectors, we suspect that they may 
be relatively prevalent among cortical proteins but are underappreciated because 
of their short, cryptic nature. 
 
Our analysis reveals that all five CRIB-containing Cdc42 effectors in 
budding yeast possess membrane-binding domains (PH or BR) in the same 
position.  This feature may be widespread among Rho GTPase targets.  For 
example, of the two PAKs in the fission yeast S. pombe, Pak2/Shk2 has a PH 
domain (Sells et al., 1998) and Pak1/Shk1 has an uncharacterized basic-rich 
sequence adjacent to its CRIB domain.  Furthermore, uncharacterized 
sequences that are rich in basic and hydrophobic residues can be found adjacent 
to CRIB domains in mammalian PAKs 1-3 (Bokoch, 2003), mammalian Borg 
proteins (Joberty et al., 1999), and targets of the plant GTPase Rop1 (Wu et al., 
2001) (see Table II-3).  In addition to these GTPase effectors, a recent study 
shows that polybasic domains are common in small GTPases themselves (Heo 
et al., 2006). 
 
Synergistic protein-protein and protein-membrane interactions  
The overall behavior of the BR domains identified here is similar to a 
related domain from Ste5 (Winters et al., 2005), the mating pathway scaffold 
protein.  In each case, the membrane-binding domain normally does not function 
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 alone but rather in conjunction with binding to a membrane protein such as 
Cdc42 or G??.  Similarly, Cdc42 binding alone may be generally insufficient for 
localization, as fragments containing only the Cdc42-binding domains from Cla4 
(Wild et al., 2004) or Ste20 (this study) cannot localize to the cell cortex.  In this 
regard it is noteworthy that Gic2 “CRIB” fragments used as reporters for active 
Cdc42 during yeast cell polarization (Ozbudak et al., 2005) include both the CRIB 
domain and the BR domain identified here. 
 
The mammalian Cdc42 effector N-WASP, a regulator of actin assembly, 
provides a well-studied paradigm for synergism between protein and 
phospholipid binding (Prehoda et al., 2000; Rohatgi et al., 2000).  N-WASP 
activation requires Cdc42 to bind in concert with PIP2, which acts through a 
polybasic domain located similarly to the BR domains of yeast Ste20, Gic1, and 
Gic2.  However, there are notable differences between these domains.  First, the 
N-WASP domain consists almost entirely of basic residues, and its PIP2-binding 
properties can be mimicked by a run of ten consecutive lysines 
(Papayannopoulos et al., 2005), whereas the yeast BR domains require both 
basic and hydrophobic residues.  In fact, the N-WASP domain does not localize 
to the plasma membrane when expressed in yeast, and it cannot restore 
signaling when used to replace the Ste20 BR domain (Figure II-11).  Second, the 
polybasic domain of N-WASP has been proposed to interact transiently with 
acidic residues in Cdc42 and thereby accelerate CRIB-Cdc42 binding by 
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 "electrostatic steering" (Hemsath et al., 2005).  In contrast, it seems unlikely that 
the yeast BR domains need to directly contact Cdc42, given the ability of PH 
domains to substitute for their function.  Rather, our findings suggest a simpler 
general model in which the BR domain provides membrane affinity, and this 
promotes binding between the CRIB domain and membrane-localized Cdc42.   
 
Cooperative binding of proteins to both Cdc42 and a specific phospholipid 
offers the potential for “coincidence detection”, in which two separate signal 
inputs are integrated together (Prehoda et al., 2000; Wild et al., 2004).  While an 
attractive notion, there is little evidence that modulation of phospholipid levels is 
a significant regulator of Cdc42 targets in vivo, and our chimeric proteins suggest 
that lipid specificity is not critical for Ste20, Gic1, or Gic2 function.  Nevertheless, 
cooperative binding can still be advantageous even without lipid specificity by 
allowing the protein-protein interaction affinity to be weak, which may permit 
more dynamic sampling of the status of the protein partner (Fivaz and Meyer, 
2003).  Indeed, even during the slow protrusive growth of yeast cells, polarized 
Cdc42 targets can be extremely dynamic (Ozbudak et al., 2005). 
 
Roles for charge and hydrophobicity  
We found that multiple basic residues in the Ste20 BR domain contribute 
additively to its function.  A similar additive effect was seen in tests of PIP2 
binding by basic domains from mammalian MARCKS and N-WASP 
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 (Papayannopoulos et al., 2005; Wang et al., 2002).  These behaviors are 
consistent with multivalent electrostatic interaction between a polycationic protein 
domain and a polyanionic membrane surface (Papayannopoulos et al., 2005).  
However, different basic residues can make unequal contributions, as mutation 
of four basic residues in the first Ste20 cluster (BR-1) had a much weaker effect 
than mutation of four basic residues in the second and third clusters (BR-2/3), 
perhaps because the latter region is part of the predicted amphipathic helix.  In 
addition, BR-like domains can be remarkably tolerant of reduced positive charge, 
as loss of three, four, or even six basic residues in Ste20 or Gic1 (this study), or 
in Ste5 (Winters et al., 2005), can yield a protein with largely intact function in 
vivo. 
 
Furthermore, positive charge is often not sufficient.  Instead, hydrophobic 
residues can also play a critical role in membrane binding, most likely by 
partitioning into the hydrophobic core of the lipid bilayer (Hristova et al., 1999; 
Wang et al., 2002).  They may also help counteract alternative targeting effects 
of basic regions, such as nuclear targeting.  Indeed, mutations that add or 
remove hydrophobic residues from mixed basic/hydrophobic domains can 
dramatically alter the partitioning between nucleus and plasma membrane (Heo 
et al., 2006; Winters et al., 2005). Thus, hydrophobic residues may be especially 
important when the basic residues confer affinity for other intracellular 
destinations.  This could explain why Ste20 and Gic1 are less tolerant of losing 
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 hydrophobic residues compared to Gic2, because both the Ste20 and Gic1 BR 
domains show nuclear affinity whereas the Gic2 BR domain does not.  It may 
also help explain why the strong contribution of hydrophobicity to membrane 
localization in vivo is often poorly reflected during liposome binding assays in 
vitro (Loewen et al., 2004; Nakanishi et al., 2004; Winters et al., 2005). 
 
The nuclear targeting activity of several membrane-binding domains 
reported here and in other recent studies (Heo et al., 2006; Loewen et al., 2004; 
Winters et al., 2005) is curious, but in most cases the functional significance is 
unknown.  For Ste20, nuclear translocation has been proposed to allow it to 
phosphorylate histone H2B and promote apoptosis in response to oxidative 
stress (Ahn et al., 2005), but preliminary tests suggest that neither the BR 
domain nor the CRIB domain is required for this process (S-H. Ahn and C.D. 
Allis, personal communication).  Gic1 shows some nuclear affinity, but chimeras 
that lack this localization still function normally (see Figure II-8D).  Thus, it 
remains unclear whether nuclear targeting by BR-like domains is mostly a 
gratuitous consequence of their basic content, or if it provides a mechanism for 
sampling multiple compartments that is commonly exploited for functional 
purposes. 
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 Plasma membrane targeting   
The short membrane-binding domains identified here and elsewhere 
(Nakanishi et al., 2004; Winters et al., 2005) preferentially target the plasma 
membrane.  As discussed previously (Johnson and Cornell, 1999; Lemmon, 
2003), this localization need not imply selectivity for a particular lipid because the 
plasma membrane is the most acidic due to its enrichment in lipids such as PIP2, 
PA, and PS (Schneiter et al., 1999; Sprong et al., 2001; Okeley and Gelb, 2004).  
In vitro, the Ste20 BR domain favors liposomes containing PIP2, which is highly 
acidic and hence offers a strong electrostatic attraction.  Yet when lipid kinase 
mutants are used to deplete lipid pools in vivo, the Ste20 BR domain is 
detectably displaced from the plasma membrane only after depletion of both PIP2 
and PI(4)P (Figure II-12), reminiscent of results with other polybasic domains 
(Heo et al., 2006; Winters et al., 2005).  Although our chimeric proteins suggest 
that interaction with a specific lipid species is not required for Ste20 function in 
vivo, the poor signaling by the Golgi-localized Ste20FAPP1 chimera underscores 
the utility of preferential affinity for the plasma membrane.  The degree to which 
this is important for any given protein may depend on the other interactions that 
synergistically control its localization.  Indeed, when the same FAPP1 PH domain 
was used to replace a membrane-binding domain in Ste5, the chimera could be 
diverted to the plasma membrane in response to G?? activation (Winters et al., 
2005); this difference could be due to a stronger protein-protein interaction or to 
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 the presence of a second membrane-binding domain in Ste5 (Garrenton et al., 
2006). 
 
Interestingly, many of the isolated membrane-targeting domains localized 
asymmetrically to the membrane of growing buds.  A similar pattern was seen 
with a domain from Ste5 (Winters et al., 2005), and the new examples show that 
it is not uncommon; in fact, we often observed this behavior even for domains 
(e.g., PLC?, Cla4, Spo20) that showed uniform localization in previous studies 
(Nakanishi et al., 2004; Stefan et al., 2002; Wild et al., 2004).  The asymmetry 
may be more apparent in our studies because we assayed newly-synthesized 
proteins shortly after induced expression, which might help prevent saturation of 
preferred binding sites and/or minimize the effects of diffusion (Valdez-Taubas 
and Pelham, 2003).  It is possible that the asymmetry reflects a polarized 
distribution of specific lipids such as PIP2, PA, or PS.  Alternatively, these 
domains might tend to bind membranes in the secretory pathway and thereby 
become transported to sites of polarized growth.  In principle, either explanation 
could contribute to proper cell polarity control, which has been proposed to use a 
positive-feedback mechanism in which polarity regulators such as Cdc42 are 
delivered to sites of polarization by directional secretion (Wedlich-Soldner et al., 
2004).    
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 In conclusion, this study uncovers several new examples of an emerging 
group of short membrane-binding motifs that play essential roles in signaling and 
polarized localization, and suggests a common mechanism in which general 
membrane-targeting motifs work in conjunction with specific protein-protein 
interactions in order to regulate the function of Cdc42 targets and other cortical 
factors. 
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Figure II-1. The Ste20 regulatory region contains a membrane-binding domain.
A. Left, fragments used to map a membrane targeting domain in the Ste20 N-terminus. Fragment 
330-381 spans the minimal Cdc42-binding motif predicted from prior studies (Kim et al., 2000; 
Morreale et al., 2000; Gladfelter et al., 2001), although it is part of a larger conserved region that 
also includes the autoinhibitory domain (see Figure II-2).  Right, Ste20 fragments were expressed 
as GST-GFP fusions (pPP1843, pPP1878, pPP1880, pPP1961, pPP1877, pPP1939, pPP1940, 
or pPP2428) from a galactose-inducible promoter in wild-type cells (PPY1368).  A minimum 
region for membrane localization maps to residues 285-311, denoted the basic-rich (BR) domain.
B. The Ste20 BR domain binds liposomes containing PIP2.  A purified GST-BR fusion (Ste20 
residues 285-311) was mixed with 80 nmol of sucrose-laden liposomes containing 
phosphatidylcholine (PC) alone or 80% PC plus 20% (mol/mol) of PS, PA, PE, PI, PI(4)P, or PIP2.  
Liposomes were pelleted, and protein in bound (pellet) and unbound (sup) fractions is shown.  
“Input” shows 25% of input protein (= 0.5 µg).  GST was loaded on each gel as a size marker.
C. Dependence of GST-BR binding on concentration and density of PIP2.  Binding assays (in 
200 µl volume) used 80 or 200 nmol of PC liposomes with varying molar percentage of PIP2 (0-
20%).  “Input” shows 10% of input protein (= 0.2 µg).
D. Comparison of liposome binding by GST alone, GST-BR, and GST-PLCδPH, using 80 nmol of 
PC-based liposomes with 0-20% PIP2.  Only pellet fractions are shown. “Input” shows 12.5% of 
input protein (= 0.25 µg).
72
BR
domain
CRIB &
auto-
inhibitory
domain
kinase
domain
affects
cell 
morph.
Bem1
binding
domain
?
?
590
285 311
939
12072 87
254
333
434 499
1
381
S. cerevisiae
S. bayanus
S. kudriavzevii
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Figure II-2.   Ste20 orthologs from 11 fungi were aligned using Multalign ver. 5.4.1 (Blosum 62-12-2 matrix).  (F. Corpet, 1988, 
Nucl. Acids Res. 16: 10881-10890; http://bioinfo.genopole-toulouse.prd.fr/multalin/multalin.html). Invariant and nearly-invariant 
residues are colored red; other strongly-conserved residues are colored green.  Blocks of high sequence conservation 
correspond to functional motifs identified previously (brown) or in this study (blue).
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Figure II-3. The BR domain is important for Ste20 localization and function.
A. Basic residues (+) and mutations in the BR domain (BR* and ∆BR) are shown.
B. Localization of the indicated GFP-Ste20 alleles (pPP538, pPP2204, and pPP2318) was 
examined in PPY1249 (ste20∆) and in PPY1114 (STE20) with or without αF (5µM, 2hrs).  The 
∆BR and BR* mutations abolish bud tip and shmoo tip localization.
C. Mating pathway phenotypes of ∆BR and BR* mutants.  PPY913 (ste20∆) cells carrying a 
vector (pRS316) or GFP-Ste20 alleles (pPP538, pPP2318, pPP2204, pPP1009) or Myc-Ste20 
alleles (pPP2927, pPP2929, pPP2930, pPP2928) were compared for induction of the 
transcriptional reporter FUS1-lacZ by α-factor.  Bars, mean ± SD (n = 4).  Below, GFP-Ste20 
alleles were used for growth arrest and patch mating assays, and Myc-Ste20 alleles were used to 
check protein expression by anti-myc immunoblot.  WT, wild type; SH, S338A H345G.
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D. Agar invasion.  PPY1209 (Σ1278b ste20∆) cells carrying the indicated GFP-Ste20 alleles were 
assayed for invasive growth.  Plates are shown before and after non-adherent cells were rinsed 
off with water.
E. BR domain mutations disrupt the Cla4-redundant essential function of Ste20.  Five-fold serial 
dilutions of KBY211 (ste20∆ cla4∆ YCp-TRP1-cla4-75ts) cells carrying the indicated GFP-Ste20 
alleles were spotted onto –Ura plates and incubated for 2 days at 25 or 37ºC.
F. ∆BR and BR* mutants cannot support growth of ste20∆ lte1∆ cells.  Five-fold serial dilutions of 
PPY1978 (ste20∆ lte1∆ PGAL1-STE20) cells carrying GFP-Ste20 alleles (as in panel E) were 
spotted onto –Ura –His plates containing either glucose or both raffinose and galactose, and 
incubated at 30ºC for 5 days (galactose) or 2 days (glucose).
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Figure II-4. The BR domain is required for Cdc42-dependent regulation of Ste20.
A. Mutations that disrupt the autoinhibitory conformation of Ste20 suppress the requirement for 
the BR domain.  At left, response to pheromone was tested in ste20∆ cells (PPY913) harboring 
the indicated GFP-Ste20 alleles (pRS316, pPP538, pPP1117, pPP1010, pPP1009, pPP1109, 
pPP2204, pPP2239, or pPP2238).  Results (mean ± SD; n = 14) were normalized to WT Ste20 
(100% = 56 β-galactosidase units).  At right, the ability of the same GFP-Ste20 alleles to mediate 
pheromone- and Gβγ-independent signaling was tested by expression of PGAL1-STE5-CTM 
(pPP477) in ste4∆ ste5∆ ste20∆ cells (PPY866).  Results (mean ± SD; n = 4) were normalized to 
WT Ste20 (100% = 127 β-galactosidase units).  The L369G and ∆CRIB mutations disrupt Ste20 
autoinhibition (Lamson et al., 2002); as controls, the SH (S338A H345G) and SHL (S338A H345G 
L369G) mutations were also tested to compare the ability of L369G to suppress either CRIB or 
BR domain mutations.  
B. BR domain mutations do not affect Cdc42 binding.  An activation domain fusion to 
Cdc42G12V C188S  (pPP1027), or vector (pPP244), was co-expressed with DNA binding domain 
fusions to the Ste20 N-terminus (DBD-Ste201-499; from top to bottom, pPP167, pPP1053, 
pPP1059, pPP1061, pPP2950 and pPP2949) in the two-hybrid reporter strain PPY760.  
Interaction was measured by quantitative β-galactosidase assay (mean ± SD; n=4).  As controls, 
mutations in the Ste20 CRIB domain that disrupt Cdc42 binding either moderately (S338A) or 
severely (SH = S338A H345G) (Lamson et al., 2002) were assayed in parallel.
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C. Schematic model for the Cdc42-dependent regulation of Ste20 at the plasma membrane.  In 
mutants lacking a functional BR domain (∆BR) or a functional CRIB domain (SH), membrane-
localized activation of Ste20 is impaired.  Only when both domains are intact (WT) is Ste20 
efficiently localized to the plasma membrane, allowing kinase activation and efficient access to 
cortical substrates.
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Figure II-5. BR domain function requires both basic and hydrophobic residues.
A. At top, basic and hydrophobic residues in the Ste20 BR domain are indicated with + and º, 
respectively.  At bottom, a helical wheel projection of the underlined sequence shows the potential 
for forming an amphipathic α-helix. 
B. BR-1, BR-2, and BR-3 mutants contain changes at individual clusters of 2-4 basic residues 
each.  N2 and N5 mutants contain Asn replacements of 2 or 5 hydrophobic residues, respectively.  
Additional derivatives that combine mutations at multiple basic clusters are denoted by slashes 
(BR-1/2, BR-1/3, BR-2/3, and BR-1/2/3) in panels C-D.
C. Effects of the most extreme mutations (BR-1/2/3 and N5) on localization of the isolated Ste20 
BR domain (expressed as a GST-GFP fusion).  Plasmids pPP2433, pPP2531, and pPP2529 were 
analyzed in WT cells (PPY1368). 
D. Mating pathway phenotypes.  Pheromone response was tested using ste20∆ cells (PPY913) 
harboring GFP-Ste20 derivatives (pRS316, pPP538, pPP2430, pPP2431, pPP2462, pPP2469, 
pPP2470, pPP2471, pPP2472, pPP2204, pPP2436, pPP2461, pPP1009).  Results (mean ± SD; 
n = 4-12) were normalized to WT (100% = 46.4 β-galactosidase units).  Below, patch mating tests 
of the same transformants are shown.
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Figure II-6. Functional replacement of the Ste20 BR domain with heterologous 
membrane-binding domains.
A. Schematic diagram of chimeras in which the BR domain of Ste20 was replaced by PH 
domains from Cla4, PLCδ, and FAPP1, or by basic domains from Spo20 and Opi1.
B. Localization of the isolated membrane-binding domains expressed as galactose-inducible 
GST-GFP fusions (Cla4, PLCδ, FAPP1) or GFP fusions (Spo20, Opi1).  PPY1368 cells harbored 
pPP2407, pPP2480, pPP2943, pPP2426, or pPP2418.
C. Localization of GFP-Ste20 chimeras (pPP538, pPP2318, pPP2317, pPP2455, pPP2456, 
pPP2459, and pPP2458) in ste20∆ cells (PPY1249) during vegetative growth (-αF), and in wild-
type cells (PPY1114) treated with α factor (+αF).
D. Pheromone response of ste20∆ cells (PPY913) carrying GFP-Ste20 chimeras (pRS316, 
pPP538, pPP2318, pPP2317, pPP2455, pPP2456, pPP2459, and pPP2458).  Results (mean ± 
SD, n = 8) were normalized to WT (100% = 60.8 β-galactosidase units).  
E. Signaling by the Ste20Cla4 chimera still requires Cdc42 binding.  The effects of mutations in 
the CRIB domain (SH, SHL) were compared when the native BR domain was either intact or 
replaced with the Cla4 PH domain.  Pheromone response was tested in ste20∆ cells (PPY913) 
harboring the indicated GFP-Ste20 derivatives (pRS316, pPP538, pPP1009, pPP1109, pPP2318, 
pPP2317, pPP2325, or pPP2342).  Results (mean ± SD; n = 6) were normalized to WT (100% = 
64.3 β-galactosidase units).
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Figure II-7. The mislocalilzed Ste20FAPP1 chimera is compromised both for 
activation by Cdc42 and for post-activation signaling events.
   
Pheromone response is assayed in ste20∆ cells (PPY913) carrying GFP-Ste20 chimeras 
(pPP538, pPP2456, pPP1117, pPP2538, pPP1109, pPP2540, pPP1009, or pPP2539).  Results 
(mean ± SD, n = 4) are normalized to WT (100% = 68.3 β-galactosidase units).
Note that signaling by the Ste20FAPP1 chimera is improved by mutations that disrupt autoinhibition 
(i.e., L369G; compare FAPP1 with L369G FAPP1, and SH FAPP1 with SHL FAPP1).  However, 
for all forms, signaling is always weaker when Ste20 harbors the Golgi-targeting FAPP1 domain 
(black bars) than when it harbors the native plasma membrane-targeting BR domain (white bars). 
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Figure II-8. BR domains in the yeast Cdc42 effectors Gic1 and Gic2.
A. Domain organization of CRIB domain-containing Cdc42 effectors in budding yeast.  Data in 
panels B-D reveal the presence of functional BR domains in Gic1 and Gic2.
B. Identification of membrane-targeting domains in Gic1 and Gic2.  GST-GFP fusions to N-
terminal fragments of Gic1 and Gic2 were expressed in wild-type cells (PPY1368).  Plasmids 
used were pPP2528, pPP2533, pPP2481, pPP2419, pPP2535, and pPP2477.  
C. Mutations in the BR domains of Gic1 and Gic2.  Basic and hydrophobic residues are indicated 
with + and º, respectively.
D. The BR domains of Gic1 and Gic2 are essential for their functions.  The left panels show five-
fold serial dilutions of PPY1835 (gic1∆ gic2∆) carrying various Gic1-GFPx3 and Gic2-GFPx3 alleles, 
after incubation for 2 days at 30ºC or 36ºC on selective media.  The right panels show localization 
of the same derivatives expressed in wild-type cells (PPY1368).  “∆BR” denotes Gic1∆89-117 or 
Gic2∆96-128.  “PLCδ” and “Cla4” denote chimeras with PH domains replacing the Gic1 or Gic2 
BR domains.  Gic1 plasmids were pPP2640, pPP2642, pPP2913, pPP2914, pPP2671, and 
pPP2672.  Gic2 plasmids were pPP2641, pPP2643, pPP2915, pPP2916, pPP2673, and 
pPP2674.  
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Figure II-9. The BR domains from Gic1 and Gic2 can functionally replace the 
Ste20 BR domain.  
Pheromone response of ste20∆ cells (PPY913) carrying GFP-Ste20 chimeras (pRS316, pPP538, 
pPP2318, pPP2514, and pPP2513) are shown.  Results (mean ± SD, n = 4) are normalized to 
WT (100% = 76.0 β-galactosidase units).  Ste20Gic1 and Ste20Gic2 chimeras, in which the BR 
domain of Ste20 is replaced with the BR domains of Gic1 and Gic2 respectively, rescue the 
signaling defect of the ∆BR mutant.   
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Figure II-10. Subcellular localization of Gic1∆BR mutant.  
A. Gic1-GFPx3 and Gic1∆BR-GFPx3 constructs (pPP2640 and pPP2642, respectively) were
expressed in wild-type (PPY1368) cells and observed under microscope.  GFP positive cells were
rondomly chosen and scored for bud tip, nuclear, and bud neck localization.  (n = 251 for Gic1-
GFPx3, and n = 195 for GIC1∆BR-GFPx3, from two seperate experiments.)  Changes in cell 
morphology are also scored.         
B. An example of Gic1∆BR-GFPx3 at bud neck.
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Figure II-11. The polybasic domain from N-WASP does not functionally replace 
the Ste20 BR domain.  
A. Pheromone response of ste20∆ cells (PPY913) carrying GFP-Ste20 chimeras (pRS316, 
pPP538, pPP2318, and pPP2454) are shown.  Results (mean ± SD, n = 4) are normalized to WT 
(100% = 45.67 β-galactosidase units).  The N-WASP chimera, in which the BR domain of Ste20 
is replaced with the polybasic domain of mammalian N-WASP, does not rescue the signaling 
defect of the ∆BR mutant.   
B. The N-WASP chimera does not localize to the plasma membrane.  Localization of the N-
WASP chimera (pPP2454) in ste20∆ cells (PPY1249) (-αF, top) and in wild-type cells (PPY1114) 
treated with 5µM αF (+αF, bottom) are shown.
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Figure II-12. Localization of membrane-binding domains in mutants of lipid 
kinases.  
The PH domain of mammalian PLCδ, Ste20 BR domain, Gic1 BR domain, and Gic2 BR domain 
were expressed as GST-GFP fusions from the GPD1 promoter in wild-type (SEY6210.1) and 
temperature-sensitive mutants of lipid kinases Stt4 (PI4 kinase), Pik1 (PI4 kinase), and Mss4 
(PI4P kinase) (AAY102.1, AAY104.1, and AAY202.1, respectively).  In PI4 kinase mutants, PI(4)P
level is decreased to about 50% of wild-type, and in Mss4 mutants, PI(4,5)P2 level is reduced to 
~10% of wild-type (Desrivieres et al., 1998).  Cultures were grown at 23ºC, and observed under 
the microscope at 30~45 minutes after incubation at non-permissive temperature (38ºC).  As 
expected, PLCδPH delocalized in mss4 cells at non-permissive temerature (38ºC).  Plasma 
membrane localization of the Ste20 BR domain is not significantly affected in these mutants. (a 
slight change in plasma membrane localization in mss4 mutant at 38ºC was observed.) 
BR domains from Gic1 and Gic2 did not show any delocalization from the plasma membrane in 
any of the lipid kinase mutants at the non-permissive temperature.
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Name ¶ Residues Sequence †
11-37
51-77
101-127
161-187
221-241
285-311
341-367
401-427
Ste20
461-487
Gic1 89-117
Gic2 96-128
Ste5 42-70
Spo20 61-80
Opi1 109-138
Rit 195-219
Rin 198-218
N-WASP 186-200
PAK1 41-73
PAK2 40-72
PAK3 35-68
Shk1 89-118
Borg1 1-29
Borg2 1-30
Borg3 1-22
Borg4 1-26
Borg5 1-25
Ric1 1-26
Ric2 31-60
Ric3 1-25
Ric4 61-90
Ric5 1-26
Ric6 1-22
Ric7 1-29
Ric8 1-27
Ric9 1-27
Ric10 1-27
Ric11 1-39
RopGAP1 85-114
RopGAP2 40-69
RopGAP3 70-99
RopGAP4 51-80
RopGAP5 30-59
(BR domain)
(BR domain)
(BR domain)
amino acid composition (%) ‡
Length Basic Nonpolar Acidic Polar Source §
27 7.4 14.8 25.9 22.2
27 11.1 7.4 11.1 29.6
27 3.7 25.9 11.1 40.7
27 7.4 22.2 11.1 44.4
27 11.1 3.7 33.3
27 3.7 33.3 this study
27 11.1 18.5 18.5 22.2
27 7.4 18.5 7.4 33.3
27 11.1 7.4 3.7 37.0
30 3.3 26.7 this study
33 3.0 36.4 this study
29 3.4 24.1 (1)
20 5.0 16.7 (2)
30 10.0 23.3 (3)
25 4.0 24.0 (4)
25 8.0 16.0 (4)
16 6.3 6.3 12.5 (5)
33 12.1 18.2 15.2 (6)
33 18.2 15.2 15.2 (7)
34 14.7 14.7 11.8 (8)
30 13.3 36.7 (9)
29 10.3 20.7 (10)
30 6.7 16.7 (10)
22 4.5 13.6 (10)
26 19.2 7.7 30.8 (10)
25 16.0 4.0 28.0 (10)
26 15.4 22.7 23.1 (11)
30 13.3 20.0 30.0 (11)
25 20.0 16.0 (11)
30 20.0 16.7 (11)
26 19.2 22.7 11.5 (11)
22 18.2 22.7 22.7 (11)
29 17.2 17.2 24.1 (11)
27 18.5 14.8 29.6 (11)
27 14.8 25.9 22.2 (11)
27 14.8 18.5 (11)
39 15.4 5.1 20.5 (11)
30 16.7 10.0 30.0 (12)
30 13.3 10.0 26.7 (12)
30 10.0 16.7 16.7 (12)
30 23.3 16.7 (12)
30 10.0 16.7 (12)
Table II-3.  Sequence comparison of characterized and putative membrane-
interaction domains.
¶ Sequences of characterized membrane-binding motifs (from Ste20, Gic1, Gic2, Opi1, Rit, Rin, and N-WASP) are 
directly compared with sequences that lie immediately N-terminal to CRIB motifs in PAKs, Borgs, RICs, and RopGAPs.  
In the top section, the Ste20 BR domain is compared with randomly chosen sequences of the same length within the N-
terminal regions that lack membrane-targeting activity (see figure II-1A).  S.c. = Saccharomyces cerevisiae; H.s. = Homo 
sapiens; S.p. = Schizosaccharomyces pombe; M.m. = Mus musculus; A.t. = Arabidopsis thaliana. 
† Basic residues are shown in red, and bulky hydrophobic residues are shown in blue.
‡ Basic = K, R; Nonpolar (bulky) = V, L, I, M, F, W; Acidic = E, D; Polar = S, T, N, Q, Y, C.  Cases
where basic or nonpolar content exceeds 20% are highlighted in red.
§ Source: (1) (Winters et al., 2005); (2) (Nakanishi et al., 2004); (3) (Loewen et al., 2004); (4) (Heo et. al., 2005); (5)
(Hemsath et al., 2005); (6) NP_002567; (7) NP_002568; (8) NP_002569; (9) SPBC1604.14c; (10) (Joberty et al., 1999);
(11) (Wu et al., 2001); (12) (Wu et al., 2000).
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Chapter III 
 
Membrane localization of scaffold proteins promotes graded 
input-output signaling behavior in the yeast MAP kinase 
cascade 
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 Abstract 
 
Signaling through mitogen-activated protein kinase (MAPK) cascade 
pathways can show various input-output behaviors, including either switch-like or 
graded responses to increasing levels of stimulus.  Prior studies suggest that 
switch-like behavior is promoted by positive feedback loops and nonprocessive 
phosphorylation reactions, but it is unclear whether graded signaling is a default 
behavior or if it must be enforced by separate mechanisms.  Here, we 
experimentally probe the determinants of graded signaling in the yeast mating 
MAPK pathway.  We find that graded behavior is robust, as it resists perturbation 
by loss of several negative feedback regulators.  However, the pathway becomes 
switch-like when activated by a crosstalk stimulus that bypasses multiple 
upstream components.  To dissect contributing factors, we developed a method 
for gradually varying the signal input at different pathway steps in vivo.  Input at 
the beginning of the kinase cascade produced a sharp, threshold-like response.  
Surprisingly, the scaffold protein Ste5 increased this threshold behavior when 
limited to the cytosol.  However, if Ste5 was allowed to function at the plasma 
membrane, signaling was graded.  The results suggest that the MAPK cascade 
is inherently switch-like, but is converted to a graded system by the pathway-
specific activation mechanism.  Scaffold-mediated assembly of signaling 
complexes at the plasma membrane simultaneously enhances signal 
propagation and reduces pathway ultrasensitivity.  This helps shape the input-
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 output properties of the system to fit the physiological context. 
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 Introduction 
 
Mitogen-activated protein kinase (MAPK) cascades are used ubiquitously 
by eukaryotic cells to respond to a variety of stimuli (Qi and Elion, 2005).  Due to 
this diversity, the core MAPK cascade module may need to adopt different input-
output signaling behaviors that can be tailored to the physiological context.  For 
example, some metazoan MAPK pathways react to increasing levels of stimulus 
in an all-or-none, or "switch-like", manner, such that individual cells in the 
population are either "on" or "off", with no intermediate response (Ferrell and 
Machleder, 1998) (Figure III-1A).  By converting the analog input into a binary 
output, this type of signaling behavior can facilitate all-or-none cellular decisions; 
indeed, it has been observed in pathways that control irreversible changes in 
biological states such as cell cycle progression (Ferrell and Machleder, 1998; 
Huang and Ferrell, 1996) as well as in some stress-responsive pathways 
(Bagowski and Ferrell, 2001).   
 
In contrast, the S. cerevisiae mating MAPK pathway responds to 
increasing levels of pheromone in a graded manner, such that all cells in the 
population uniformly increase their signal output in proportion to the level of 
stimulus (Colman-Lerner et al., 2005; Poritz et al., 2001) (Figure III-1A).  This is 
true despite that fact that the mating pathway involves a cascade of four kinases, 
which might be expected to be even more switch-like than the usual three-kinase 
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 cascade (Ferrell, 1997).  Nevertheless, graded signaling is well suited to the 
physiological characteristics of the mating response, including its reversibility 
(i.e., growth resumes when pheromone is removed) and the fact that distinct 
responses (e.g., cell-cell adhesion, cell cycle arrest, transcriptional induction, 
morphological changes, cell-cell fusion) are triggered at different threshold doses 
over a wide (100x) range in correlation with their temporal order during mating 
(Dorer et al., 1995; Moore, 1983).  Similarly, mammalian growth factors such as 
EGF and PDGF also trigger graded MAPK signaling (Mackeigan et al., 2005; 
Whitehurst et al., 2004), and the intermediate responses permitted by graded 
signaling may allow a single MAPK pathway to trigger different cell fates in the 
developing Drosophila eye (Yang and Baker, 2003).  While graded signaling may 
appear superficially simpler than switch-like signaling, it is not necessarily the 
default behavior of MAPK pathways.  In fact, unique challenges may be posed by 
the need for accurate signal transmission over a wide range of amplitudes.  
 
Theoretical and biochemical approaches have revealed molecular 
mechanisms that contribute to switch-like signaling.  One contributor is the 
presence of positive feedback loops in which pathway output amplifies signaling 
input earlier in the pathway (Ferrell and Machleder, 1998; Kholodenko, 2006).   
Switch-like behavior can also be promoted by non-processive phosphorylation: 
because individual kinases in the cascade can require multiple independent 
phosphorylation events (separated by dissociation events), they show a 
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 nonlinear dependence on the concentration of their upstream activators (Ferrell 
and Machleder, 1998; Huang and Ferrell, 1996; Patwardhan and Miller, 2007).  
Either mechanism can contribute to a sigmoidal dose-response relationship 
termed “ultrasensitivity”, in which a small change in the level of input stimulus 
near a threshold value produces a dramatic change in signaling output.  In 
principle, therefore, graded signaling could result from the simple absence of 
these mechanisms, or from the presence of separate mechanisms that 
counteract a default tendency toward switch-like behavior. 
 
Many MAPK pathways incorporate “scaffold” proteins that bind multiple 
kinases in the cascade (Dard and Peter, 2006; Kolch, 2005).  It has been 
hypothesized that scaffold proteins might counteract the switch-like tendencies of 
MAPK cascades, because assembly of a multi-kinase complex could allow 
multiple phosphorylations to proceed processively, without intervening steps of 
dissociation (Burack and Shaw, 2000; Ferrell, 2000; Kolch, 2005; Levchenko et 
al., 2000).  In the budding yeast mating pathway (Figure III-1B), Ste5 is a 
prototypical scaffold protein that is essential for MAPK pathway signaling (Dard 
and Peter, 2006; Dohlman and Thorner, 2001; Elion, 2001).  In addition to 
providing binding sites for multiple pathway kinases, Ste5 co-recruits these 
kinases to the plasma membrane in response to a pheromone-activated receptor 
and heterotrimeric G protein (Maeder et al., 2007; Pryciak and Huntress, 1998; 
van Drogen et al., 2001).  Of special relevance to the present study, membrane 
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 translocation of Ste5 promotes both the initial activation of kinases at the top of 
the pathway as well as the propagation of signal through the remainder of the 
kinase cascade (Lamson et al., 2006).  However, there is no experimental 
information regarding whether Ste5, or any MAPK scaffold, plays a major role in 
promoting a graded mode of signaling.  Furthermore, it has been hypothesized 
that scaffold proteins could equally likely make signaling more switch-like, rather 
than less so (Ferrell, 2000). 
 
In this study we sought to experimentally probe the molecular 
mechanisms that influence whether signaling is graded or switch-like in the 
budding yeast mating pathway.  To do so we analyzed signal output at the 
single-cell level and exploited a rich foundation of tools available in this well-
studied system that allowed us to activate signaling in diverse ways, at multiple 
different points in the pathway, and in the presence or absence of various 
regulators.  We found that eliminating negative feedback loops did not alter the 
graded response, but signaling became switch-like when the pathway was 
activated using an artificial crosstalk stimulus that bypasses multiple upstream 
factors, including Ste5.  Contrary to expectation, the mere presence of the Ste5 
scaffold protein in the cytoplasm increased, rather than decreased, pathway 
ultrasensitivity.  However, the opposite effect was observed when Ste5 
functioned at the membrane, which promoted graded signaling.  The results 
suggest that scaffold-mediated assembly of signaling complexes at the plasma 
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 membrane reduces the inherent ultrasensitivity of the MAPK cascade, and that 
this may be a consequence of enhanced signal propagation that converts low 
levels of input into a proportional level of output.  These properties help shape 
the input-output behavior of the system in a physiologically appropriate manner. 
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 Materials and Methods 
 
Strains and Plasmids 
Standard yeast media and genetic methods were used (Rose and Fink, 1990).  
Yeast strains and plasmids are listed in Tables III-1 and III-2, respectively.  The 
PFUS1-GFP reporter constructs contain FUS1 promoter sequences from -833 to -1 
placed upstream of an enhanced GFP (S65A V68L S72A; Cormack et al., 1996); 
they were targeted to the URA3 or TRP1 locus by cleavage with StuI or XbaI, 
respectively.  Constructs encoding PGAL1-dependent activators of the mating 
pathway were described previously (Drogen et al., 2000; Harris et al., 2001; 
Pryciak and Huntress, 1998; Winters et al., 2005), but here they were integrated 
into the genome by transferring them to the integrating vector pRS303 (Sikorski 
and Hieter, 1989) and then targeting them to the HIS3 locus by cleavage with 
NheI or with BsiWI for pIH-GS4.  To create strains in which PGAL1-dependent 
transcription was controlled by exogenous ?-estradiol, the construct pIT-ADGEV 
was targeted to the TRP1 locus by cleavage with SnaBI; pIT-ADGEV encodes 
the hybrid transcription factor Gal4DBD-hER-VP16 on a NotI-EcoRI fragment from 
pHCA/GAL4(1-93).ER.VP16 (Louvion et al., 1993) transferred into pRS304 
(Sikorski and Hieter, 1989).  The phosphatase mutant strains (PPY1406, 1407, 
1408, 1418, 1420) are PFUS1-GFP derivatives of strains from (Zhan et al., 1997), 
which were a gift from Robert Deschenes; the msg5?::kanR derivatives were 
created by PCR-mediated deletion (Longtine et al., 1998).  Ste5 mutations that 
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 disrupt binding to Ste11 (I504T) or Ste7 (V763A S861P) were transferred from 
previously-described plasmids (Inouye et al., 1997) into the Ste5-myc13 plasmid 
pPP1969 (Winters et al., 2005).   
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 Table III-1.  Yeast strains used in Chapter III. 
 
bkgd* name genotype‡ source §  
    
(a) PPY1167 MATa ste11::ADE2 ste5::ADE2 FUS1::FUS1-lacZ::LEU2 (1) 
(a) PPY1370 MATa ADE2 FUS1::FUS1-lacZ::LEU2 URA3::PFUS1-GFP (1) 
(a) PPY1372 MATa ste5::ADE2 hog1::hisG FUS1::FUS1-lacZ::LEU2 URA3::PFUS1-GFP this study 
(a) PPY1374 MATa ADE2 FUS1::FUS1-lacZ::LEU2 TRP1::PFUS1-GFP this study 
(a) PPY1386 MATa ADE2 FUS1::FUS1-lacZ::LEU2 URA3::PFUS1-GFP fus3::LEU2 this study 
(a) PPY1387 MATa ADE2 FUS1::FUS1-lacZ::LEU2 URA3::PFUS1-GFP kss1::ura3
FOA
 this study 
(a) PPY1397 MATa ADE2 FUS1::FUS1-lacZ::LEU2 URA3::PFUS1-GFP TRP1::ADGEV 
HIS3::PGAL1-STE4 
this study 
(a) PPY1398 MATa ste5::ADE2 FUS1::FUS1-lacZ::LEU2 URA3::PFUS1-GFP 
TRP1::ADGEV HIS3::PGAL1-STE5-CTM 
this study 
(a) PPY1399 MATa ste5::ADE2 FUS1::FUS1-lacZ::LEU2 URA3::PFUS1-GFP 
TRP1::ADGEV HIS3::PGAL1-STE5?N-CTM 
this study 
(a) PPY1400 MATa ste5::ADE2 FUS1::FUS1-lacZ::LEU2 URA3::PFUS1-GFP 
TRP1::ADGEV HIS3::PGAL1-STE11-4 
this study 
(a) PPY1402 MATa ste5::ADE2 FUS1::FUS1-lacZ::LEU2 URA3::PFUS1-GFP 
TRP1::ADGEV HIS3::PGAL1-STE11-4-STE7 
this study 
(a) PPY1409 MATa ADE2 FUS1::FUS1-lacZ::LEU2 TRP1::PFUS1-GFP sst2?::URA3 this study 
(a) PPY1410 MATa ADE2 FUS1::FUS1-lacZ::LEU2 TRP1::PFUS1-GFP 
STE11::URA3::STE11-4  
this study 
(a) PPY1451 MATa ADE2 TRP1::PFUS1-GFP bar1? this study 
(a) PPY1591 MATa ste5::ADE2 FUS1::FUS1-lacZ::LEU2 URA3::PFUS1-GFP 
TRP1::ADGEV HIS3::PGAL1-STE11-Asp3 
this study 
(a) PPY1593 MATa ADE2 TRP1::ADGEV HIS3:: PGAL1-GFP this study 
(a) PPY1631 MATa ADE2 FUS1::FUS1-lacZ::LEU2 URA3::PFUS1-GFP TRP1::ADGEV 
HIS3::PGAL1-STE11-4 
this study 
(a) PPY1632 MATa ADE2 FUS1::FUS1-lacZ::LEU2 URA3::PFUS1-GFP TRP1::ADGEV 
HIS3::PGAL1-STE11-Asp3 
this study 
(a) PPY1634 MATa ADE2 FUS1::FUS1-lacZ::LEU2 URA3::PFUS1-GFP TRP1::ADGEV 
HIS3::PGAL1-STE5-CTM 
this study 
(a) PPY1812 MATa ADE2 FUS1::FUS1-lacZ::LEU2 URA3::PFUS1-GFP ste20-1::TRP1 
HIS3::STE11-Asp3 
(1) 
(a) PPY1817 MATa ADE2 FUS1::FUS1-lacZ::LEU2 URA3::PFUS1-GFP TRP1::ADGEV 
HIS3::PGAL1-STE11-Cpr 
this study 
(a) PPY1825 MATa ADE2 FUS1::FUS1-lacZ::LEU2 URA3::PFUS1-GFP hog1::hisG this study 
(a) PPY2035 MATa ste5::ADE2 FUS1::FUS1-lacZ::LEU2 TRP1::ADGEV HIS3::PGAL1-
STE11-4 
this study 
(a) PPY2036 MATa ste5::ADE2 FUS1::FUS1-lacZ::LEU2 TRP1::ADGEV HIS3::PGAL1-
STE11-Asp3 
this study 
(a) PPY2038 MATa ste5::ADE2 FUS1::FUS1-lacZ::LEU2 URA3::PFUS1-GFP 
TRP1::ADGEV HIS3::PGAL1-STE11-Asp3  hog1?::kanR 
this study 
    
(b) PPY1406 MATa his3 leu2 ura3 lys1 met4 ptp2?::LEU2 ptp3?::URA3 TRP1::PFUS1-GFP  this study 
(b) PPY1407 MATa his3 leu2 ura3 TRP1::PFUS1-GFP this study 
(b) PPY1408 MATa his3 leu2 ura3 ptp3?::URA3 TRP1::PFUS1-GFP his2 this study 
(b) PPY1418 MATa his3 leu2 ura3 TRP1::PFUS1-GFP msg5?::kanR this study 
(b) PPY1420 MATa his3 leu2 ura3 lys1 met4 TRP1::PFUS1-GFP ptp2?::LEU2 ptp3?::URA3 
msg5?::kanR 
this study 
    
 
* Strain background:  (a) W303 (ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1 can1) (b) 
unknown 
 
‡ “ADGEV” denotes a construct encoding the hybrid transcription factor “GEV” (Gal4DBD-
hER-VP16 fusion protein) under control of the ADH1 promoter (Louvion et al., 1993). 
 
§ Source:  (1) (Lamson et al., 2006) 
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 Table III-2.  Plasmids used in Chapter III. 
 
name alias description source § 
    
pPP681 pRS316 CEN URA3 vector (1) 
pPP1268 pIH-GS5?N-CTM Integrating HIS3 PGAL1-ste5?N-CTM (2) 
pPP1532 pH-G11-Cpr CEN HIS3 PGAL1-STE11-Cpr (3) 
pPP1549 p304-FUS1-GFP integrating TRP1 PFUS1-GFP this study 
pPP1551 p306-FUS1-GFP integrating URA3 PFUS1-GFP (4) 
pPP1557 pIT-ADGEV integrating TRP1 PADH1-[GAL4DBD-hER-VP16] this study 
pPP1609 pIH-G11-4.S7 integrating HIS3 PGAL1-STE11-4-STE7 this study 
pPP1610 pIH-GS4 integrating HIS3 PGAL1-STE4 this study 
pPP1611 pIH-GS5-CTM integrating HIS3 PGAL1-STE5-CTM this study 
pPP1613 pIH-G11-4 integrating HIS3 PGAL1-STE11-4 this study 
pPP1744 pIH-GGFP integrating HIS3 PGAL1-GFP this study 
pPP1745 pIH-G11-Asp3 integrating HIS3 PGAL1-STE11-Asp3 this study 
pPP1926 pH-FD11-Asp3 CEN HIS3 STE11-Asp3 (4) 
pPP1950 pIH-STE11-Asp3 integrating HIS3 STE11-Asp3 (4) 
pPP1969 pS5k-myc CEN URA3 STE5-myc13 Tcyc1  (3) 
pPP2169 pH-FD11-WT CEN HIS3 STE11-WT (4) 
pPP2520 pIH-G11-Cpr integrating HIS3 PGAL1-STE11-Cpr this study 
pPP2544 pS5kmyc-?RING CEN URA3 ste5(?177-229)-myc13 Tcyc1 this study 
pPP2861 pS5kmyc-VASP CEN URA3 ste5(V763A, S861P)-myc13 Tcyc1 this study 
pPP2862 pS5kmyc-I504T CEN URA3 ste5(I504T)-myc13 Tcyc1 this study 
pPP3030 pS5kmyc-?239-335 CEN URA3 ste5(?239-335)-myc13 Tcyc1 this study 
pPP3044 pS5kmyc-ND CEN URA3 ste5(Q292A, I294A, Y295A, L307A, P310A, 
N315A)-myc13 Tcyc1 
this study 
    
 
§ Source: (1) (Sikorski and Hieter, 1989); (2) (Strickfaden and Pryciak, 2008); (3) 
(Winters et al., 2005); (4) (Lamson et al., 2006). 
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 FACS Analysis 
Cultures were grown in YPD to log phase and GFP expression was induced by 
mixing the culture with equal volume of YPD containing ? factor, sorbitol, or ?-
estradiol at a 2x concentration in order to achieve the desired final (1x) 
concentration, and incubated at 30ºC for 2 hrs.  (Control experiments using 1, 2, 
and 4 hr induction times suggested that 2 hr provided an optimized dynamic 
range of GFP expression between low and high stimulus doses without any 
evident saturation of GFP accumulation.)   The cells were then harvested by 
centrifugation, resuspended in phosphate buffered saline, and separated by 
sonication using a Branson Sonifier S-450A with a microtip probe for 10 seconds.  
Cells were kept on ice without fixation until analyzed with a Becton-Dickinson 
FACScan flow cytometer (fixed cells gave similar results but with reduced signals 
and dynamic range).  For each condition the GFP fluorescent intensity of 10,000 
cells were measured.  Representative experiments are shown.  To plot dose-
response profiles that combined results from multiple experiments, and to obtain 
the Hill coefficient, the modal fluorescence from each stimulus dose was first 
normalized to that observed at the maximum (saturating) dose.  The data were 
then analyzed by non-linear least-squares fitting to a modified Hill equation 
(Huang and Ferrell, 1996); 
 Y = Bottom + (Top-Bottom)*Xn/Kn+Xn 
where Bottom = minimum fluorescence, Top = maximum fluorescence, X = 
stimulus concentration, K = stimulus concentration giving half-maximal response, 
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 and n = Hill coefficient (nH).  The fitted response curves were overlaid onto the 
observed data points (mean ± SD) using Prism 4 software (GraphPad Software, 
Inc.). 
 
?-Galactosidase assay 
To monitor induction of the FUS1-lacZ reporter, cells were grown in YPD or 
selective media, and induced with ? factor, sorbitol, or ?-estradiol as described 
above for FACS experiments, or by adding galactose (2% final concentration) to 
cells growing in 2% raffinose medium.  One ml of culture was collected by 
centrifugation, and ?-galactosidase assays were performed on cell lysates as 
described previously (Pryciak and Hartwell, 1996). 
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 Results 
 
Single cell analysis of pheromone response pathway signaling 
Switch-like and graded signaling can be indistinguishable at the population 
level (Ferrell and Machleder, 1998), and so the ability to analyze signaling at the 
single-cell level is essential.  As in earlier studies (Colman-Lerner et al., 2005; 
Ingolia and Murray, 2007; Paliwal et al., 2007; Poritz et al., 2001), we used a 
reporter gene in which GFP is expressed from the promoter of a pheromone-
induced gene, FUS1 (Figure III-1C).  Pheromone signaling could then be 
measured in single cells by either fluorescence microscopy or FACS analysis.  In 
wild-type cells carrying the PFUS1-GFP reporter, GFP fluorescence increased in 
response to pheromone in a gradual, uniform manner (Figure III-1D).  That is, 
although there was a range of fluorescence at any given concentration, which 
was the subject of a prior study (Colman-Lerner et al., 2005), it was clear that 
increased pheromone levels caused the majority of cells to gradually shift to 
greater intermediate levels of signaling.  This behavior confirms that the mating 
pathway response is indeed graded, as originally described by Poritz et al. 
(Poritz et al., 2001) and subsequent studies (Colman-Lerner et al., 2005; Ingolia 
and Murray, 2007).  The contrast between this graded signaling behavior and the 
switch-like behavior seen in some other MAPK pathways (Bagowski and Ferrell, 
2001; Ferrell and Machleder, 1998) was the subject of our further 
experimentation. 
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Graded signaling is retained in mutants that lack negative regulators 
Because previous studies indicate that positive feedback loops promote 
switch-like signaling (Ferrell and Machleder, 1998), it was conceivable that 
negative feedback might have the opposite effect, and hence promote graded 
signaling.  Therefore, we tested three classes of negative regulators for their role 
in graded signaling.  First, we tested two proteins that act at the top of the 
pathway.  Bar1 is a protease that degrades ? factor, and hence decreases the 
level of stimulus.  Sst2, a member of the RGS family of GTPase activating 
proteins, inactivates the G? subunit of the pheromone-coupled heterotrimeric G 
protein.  Because expression of each gene is increased in response to 
pheromone (Dohlman and Thorner, 2001), they can be considered to be part of a 
negative feedback loop.  Nevertheless, despite clear shifts in the dose of 
pheromone required to trigger signaling, graded signaling was still observed in 
both bar1? and sst2? cells, and hence neither protein is required for this 
behavior (Figure III-2A).  
 
The MAP kinases Fus3 and Kss1 are positive components of the mating 
pathway, but they also participate in a negative feedback loop in which they 
attenuate signaling at an upstream step in the pathway and thereby limit their 
own phosphorylation (Gartner et al., 1992; Zhou et al., 1993).  Although there 
were some effects on basal signaling and the dynamic range, signaling in both 
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 fus3? and kss1? cells remained graded (Figure III-2B).  These results are 
generally consistent with those obtained in previous studies using microscopy-
based assays (Colman-Lerner et al., 2005; Paliwal et al., 2007). 
 
Finally, the tyrosine phosphatases Ptp2 and Ptp3, as well as the dual-
specificity phosphatase Msg5, negatively regulate mating pathway signaling by 
dephosphorylating kinases in the MAPK cascade (Doi et al., 1994; Zhan et al., 
1997).  Yet mutants lacking one, two, or all three phosphatases still showed 
graded signaling, suggesting that these phosphatases are not required for this 
behavior (Figure III-2C).  Collectively, these results indicate that no single 
negative regulator of the pathway is solely responsible for the graded mode of 
signaling, and therefore the graded behavior is robust to genetic perturbation. 
 
Crosstalk signaling is switch-like 
Previous studies have theorized that scaffold proteins may promote 
graded signaling behavior by increasing the processivity of phosphorylation 
events in the kinase cascade (see Introduction).  Although the scaffold protein 
Ste5 is ordinarily critical for mating pathway signaling, this requirement can be 
bypassed via the phenomenon of “crosstalk” between the mating and the high 
osmolarity glycerol (HOG) MAPK pathways (Figure III-3A).  The HOG pathway 
stimulates glycerol synthesis in response to high osmolarity, and it shares some 
components with the mating pathway.  These two pathways are normally 
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 insulated from each other, but hog1? mutant cells will activate the mating 
pathway in response to high osmolarity treatment, and this crosstalk requires the 
mating pathway kinases but not Ste5 or the upstream receptor-G??? module 
(O'Rourke and Herskowitz, 1998) (Figure III-3A).  When we treated hog1? ste5? 
mutants carrying the PFUS1-GFP reporter gene with increasing amounts of 
sorbitol, the response was heterogeneous: at intermediate concentrations the cell 
population bifurcated into responding and non-responding groups, visible as two 
peaks in the FACS profile (e.g., at 0.25-0.5 M sorbitol; Figure III-3B).  This 
indicated that crosstalk signaling is switch-like.  Importantly, in hog1? STE5 cells, 
which can respond to either stimulus, signaling was graded in response to 
pheromone but not in response to sorbitol (Figure III-3C).  Thus, the response 
behavior is dictated by the stimulus, not by the mere absence of Hog1.   
 
Although the graded signaling behavior correlates with the involvement of 
the Ste5 scaffold, from these data it is equally possible that the pheromone 
receptor or heterotrimeric G protein plays a critical role.  Furthermore, because 
the precise mechanism by which cells measure high osmolarity remains unclear 
(Hohmann et al., 2007), we cannot rule out that the switch-like behavior is 
generated at the level of the initial stimulus sensor.  That is, if cells do not sense 
the magnitude of osmolarity change but only whether it exceeds a certain 
setpoint (e.g., like a thermostat), then the osmotic stimulus itself may be 
inherently switch-like.  Indeed, the population-averaged response to the osmotic 
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 stimulus rises very suddenly over a narrow dose range, unlike pheromone 
response (Figure III-3C, bottom).  A similar caveat may apply to previous 
examples in which mammalian cells showed switch-like responses to osmotic 
shock or protein synthesis inhibitors (Bagowski and Ferrell, 2001).  Nevertheless, 
our results emphasize two important points.  First, our ability to observe switch-
like signaling shows that the normal graded behavior does not simply reflect a 
technical limitation of the transcription-based assay system.  Second, a single 
MAP kinase cascade can mediate either graded or switch-like responses, 
depending on the nature and mechanism of pathway input. 
 
Signaling via graded expression of active pathway components 
To further probe the critical determinants of graded signaling behavior, we 
developed a method for varying the level of input at different steps in the mating 
pathway by using a dose-dependent expression system (Figure III-4A).  Here, 
active pathway components were expressed from the GAL1 promoter, and 
expression levels were controlled by a hybrid transcription factor (Gal4DBD-hER-
VP16) whose activity can be varied over a wide range by adding the exogenous 
hormone ?-estradiol (Louvion et al., 1993).  We first established that increasing 
doses of ?-estradiol gave proportional and uniform increases in gene 
transcription from the GAL1 promoter, as evidenced by graded expression of a 
PGAL1-GFP reporter (Figure III-4B).  Subsequently, we used the GAL1 promoter 
to express various activators of the mating pathway (Figure III-4C), and then 
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 used the PFUS1-GFP reporter to measure pathway signaling as a function of ?-
estradiol dose.  This method could trigger maximum signaling levels comparable 
to those induced by galactose (Figure III-4D).  
 
When signaling was triggered near the top of the pathway by graded 
expression of the G? subunit (Ste4) or a membrane-targeted form of Ste5 (Ste5-
CTM), we observed a graded response (Figure III-5A), similar to the normal 
behavior induced by pheromone.  In contrast, when signaling was triggered by 
expression of pre-activated versions of the MAPKKK Ste11 (Ste11-4 or Ste11-
Asp3), we observed a threshold-like response in which there was a sudden 
transition from very weak to very strong signaling output (Figure III-5B), indicative 
of ultrasensitivity (Huang and Ferrell, 1996).  Curve-fitting analysis of multiple 
trials showed that the Ste11-4 and Ste11-Asp3 experiments follow a sigmoidal 
dose-response profile with a Hill coefficient (nH) of ~4, which is close to the nH ~ 5 
behavior observed for the Xenopus MAP kinase cascade in vitro (Huang and 
Ferrell, 1996) (or in vivo under conditions where positive feedback was blocked 
(Ferrell and Machleder, 1998)).  This stands in stark contrast to the nH ~ 1 
behavior observed during pheromone treatment or graded expression of Ste4 
and Ste5-CTM.  Thus, the mating MAPK pathway can show either ultrasensitive 
or graded behavior, depending on the position in the pathway where input is 
modulated.  
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 We performed several additional experiments to distinguish between 
possible explanations for these results.  First, because overexpression of 
constitutively-active forms of Ste11 can bypass the requirement for Ste5 (Cairns 
et al., 1992), it seemed possible that the ultrasensitive response to active Ste11 
is a consequence of scaffold-independent signaling, as hypothesized previously 
(Burack and Shaw, 2000; Ferrell, 2000; Levchenko et al., 2000).  We found that 
although Ste5 was not required for signaling at the highest levels of Ste11-4 or 
Ste11-Asp3 expression, Ste5 increased signaling efficiency at lower expression 
levels (e.g., at 3-10 nM ?-estradiol; Figure III-5C).  Contrary to expectations, 
however, the presence of Ste5 made signaling by the active Ste11 alleles more 
threshold-like rather than less so (nH ~ 4 vs. nH ~ 2).  Thus, in these experiments 
Ste5 clearly affects the propagation of signal from active Ste11, but its effect on 
ultrasensitivity is opposite to prior theoretical predictions.  Note that these effects 
of Ste5 were likely mediated in the cytoplasm because no stimulus (e.g., 
pheromone) was added to recruit Ste5 to the plasma membrane.  The ability of 
cytoplasmic Ste5 to enhance signaling at mild levels of Ste11-4 expression (e.g., 
3 nM ?-estradiol) required intact MAPKKK and MAPKK binding domains but not 
MAPK or G?? binding domains (Figure III-5D); this may imply that signaling is 
limited by the efficiency of the Ste11 ? Ste7 phosphorylation step(s), which 
could explain why Ste5 is dispensable when activated Ste11 is expressed at very 
high levels.  Indeed, binding sites for Ste11 and Ste7, but not for Fus3, were 
required to amplify signaling from activated Ste11 (Ste11-Asp3), indicating that 
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 Ste5 promotes the rate limiting Ste11 ? Ste7 step (Figure III-6).   
 
Next, we considered the possibility that regulation of the very first 
phosphorylation step (Ste20 ? Ste11) might be required for graded signaling, 
and hence that constitutively activating mutations in Ste11 may prohibit a graded 
response.  However, this possibility was ruled out by the observation that ste20? 
cells expressing Ste11-Asp3 at native levels (which still require pheromone for 
efficient signal propagation; Lamson et al., 2006) still showed a graded response 
to pheromone treatment (Figure III-7A).  Finally, we wondered if the threshold-
like behavior might be due to changes in kinase-substrate stoichiometry as the 
expression level of Ste11 increased.  However, when we used graded 
expression of a different form of Ste11, a membrane-targeted derivative (Ste11-
Cpr) whose signaling requires membrane-localized Ste5 (Winters et al., 2005), 
we observed a graded response (nH ~ 1, Figure III-7B).  Further controls showed 
that the graded signaling by Ste5-CTM was independent of both endogenous 
Ste5 and the N-terminal region of Ste5 involved in G??-binding and dimerization 
(Figure III-7C).  In addition, we found that the ability of Ste11-4 and Ste11-Asp3 
to activate the HOG pathway (Drogen et al., 2000; Harris et al., 2001; Posas and 
Saito, 1997), which can antagonize the mating pathway (Harris et al., 2001; 
McClean et al., 2007), contributed to the heterogeneity of their signaling 
responses in ste5? cells (i.e., broad FACS histograms in Figure III-5B) but did 
not otherwise contribute to their threshold behavior (Figure III-7D). 
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Analysis of the collective results revealed that the involvement of 
membrane-localized Ste5 (rather than simply the presence of Ste5) was common 
to all experiments that yielded graded signaling behavior.  Namely, membrane-
localized Ste5 mediates signaling by pheromone (both in wild-type cells and in 
ste20? STE11-Asp3 cells) as well as by graded expression of Ste4, Ste5-CTM, 
and Ste11-Cpr.  In contrast, membrane-localized Ste5 does not participate in the 
settings that yield switch-like or ultrasensitive signaling, such as hyperosmotic 
crosstalk or graded expression of Ste11-4 and Ste11-Asp3.  We previously found 
that active forms of Ste11 are relatively inefficient activators of the mating 
pathway on their own, but their signaling efficiency is substantially enhanced 
when Ste5 is recruited to the membrane (Lamson et al., 2006).  Therefore, this 
enhancement effect of membrane-localized Ste5 may simultaneously promote a 
graded response by allowing signaling output to increase in linear proportion to 
the amount of active Ste11, rather than requiring a threshold level of Ste11 
activity to be surpassed (see Discussion).  
 
Lastly, because of the role of non-processive phosphorylation reactions in 
ultrasensitive signaling (Ferrell and Bhatt, 1997; Huang and Ferrell, 1996), we 
also analyzed the signaling behavior when Ste11-4 was directly fused to its 
downstream substrate, the MAPKK Ste7 (Harris et al., 2001).  In principle, this 
could increase processivity of the Ste11 ? Ste7 phosphorylation reactions by 
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 preventing their dissociation.  Interestingly, the ultrasensitivity of the signaling 
response was mildly reduced (from nH =1.9 to nH = 1.6), but even more striking 
was the acquisition of relatively uniform intermediate responses at intermediate 
expression levels (Figure III-7E).  (For technical reasons involving the extremely 
hyperactive signaling of this fusion protein, reliable results could be obtained only 
in ste5? strains and not in STE5 strains.)  This result is consistent with the 
prediction that increasing processivity can reduce ultrasensitivity, though we 
have no way of directly verifying that processivity has been increased.  
Nevertheless, the contrast between this behavior and the increased 
ultrasensitivity effect of cytoplasmic Ste5 may suggest that cytoplasmic Ste5 is 
incapable of promoting processive phosphorylation in the manner that had been 
predicted (see Discussion).  
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 Discussion 
 
In summary, although graded signaling may appear simpler than switch-
like signaling, our results along with those from previous studies (Ferrell and 
Machleder, 1998; Huang and Ferrell, 1996) suggest that the MAP kinase 
cascade module is inherently ultrasensitive, and hence that specific mechanisms 
can either enhance or counteract this default tendency in order to generate 
switch-like or graded responses, respectively (Figure III-8A).  A general model 
that can explain the graded input-output behavior of the yeast mating pathway 
relates to the effect of Ste5 membrane recruitment on signal propagation through 
the MAP kinase cascade (Lamson et al., 2006).  Specifically, because the active 
form of the MAPKKK Ste11 on its own is relatively inefficient at signaling, it must 
accumulate to a high threshold level before any significant output occurs.  But 
membrane recruitment of Ste5 enhances propagation of signal from active Ste11 
through the kinase cascade, thus allowing low levels of Ste11 activity to produce 
some output signal.  This broadens the range of input levels that can yield a 
measurable output, and thereby makes signaling less ultrasensitive and more 
graded (Figure III-8B).   
 
The surprising finding that Ste5 molecules in the cytoplasm cannot reduce 
ultrasensitivity may indicate that cytoplasmic Ste5 is incapable of promoting 
processive phosphorylation, contrary to most prior expectations (Burack and 
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 Shaw, 2000; Ferrell, 2000; Kolch, 2005; Levchenko et al., 2000).  Why would this 
be so?  Perhaps the simplest explanation would be that the common view of 
scaffolds—in which they are fully occupied with kinases that efficiently interact 
with each other while bound to a single scaffold molecule—is incorrect.  Instead, 
it may be the case that most Ste5 molecules in the cytoplasm are incompletely 
occupied with kinases (Figure III-9A, left).  This view was postulated previously in 
order to explain both experimental and theoretical considerations (Flatauer et al., 
2005; Lamson et al., 2006; Pincet, 2007), and is supported by recent evidence 
using fluorescence cross-correlation spectroscopy (Maeder et al., 2007; 
Slaughter et al., 2007).  Hence, cytoplasmic scaffolds may largely influence 
kinases only one at a time, such as by directly modulating their specific activity 
(Bhattacharyya et al., 2006a), which would negate a role in fostering processivity. 
 
Two classes of molecular model could explain how the assembly of 
scaffolded signaling complexes at the membrane might reduce ultrasensitivity.  In 
the first class, membrane localization may promote processive phosphorylation.  
For example, membrane recruitment could increase occupancy of the scaffold 
(Figure III-9A, middle), as suggested by recent quantitative microscopy (Maeder 
et al., 2007; Slaughter et al., 2007), or it could promote signaling in trans 
between kinases bound to different scaffold molecules (Figure III-9A, right), 
which has been detected indirectly (Inouye et al., 1997; Yablonski et al., 1996).  
Either mechanism could now permit the scaffold to promote processive 
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 phosphorylation reactions largely as had been previously assumed to occur on 
single, cytoplasmic molecules.  Alternatively, by analogy to serial binding models 
for receptor-ligand interactions (Andrews, 2005; Chan et al., 2001), it is 
conceivable that membrane-recruited scaffolds create a high surface density of 
kinase binding sites that inhibits escape of initially-captured molecules (by rapid 
rebinding after dissociation).  This could favor the conversion of singly-
phosphorylated substrates to multiply-phosphorylated forms despite an excess of 
unphosphorylated molecules in the cytoplasm (Figure III-9B).  In the second 
class of model, ultrasensitivity could be reduced without affecting processivity.  
Namely, for the pool of kinases that are recruited to the membrane, their local 
concentration may be sufficiently high to activate them to completion by non-
processive phosphorylation.  Here, increasing stimulus levels would simply 
increase the fraction of the total cellular pool of kinases that move into this zone 
(Figure III-9C).  Although our results do not distinguish among these scenarios, 
they highlight the notion that the relevant molecular context in which scaffold-
mediated signaling occurs is likely to be fundamentally different from the simplest 
models involving fully-occupied scaffolds in the cytoplasm. 
 
It is worth emphasizing that a variety of theoretical modeling studies have 
discussed the possible effects of scaffolding on the input-output behavior of MAP 
kinase cascades (Burack and Shaw, 2000; Ferrell, 2000; Kofahl and Klipp, 2004; 
Kolch, 2005; Levchenko et al., 2000; Pincet, 2007), but to our knowledge none of 
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 these models has predicted the experimentally-observed behavior in which 
pathway ultrasensitivity can be either increased or decreased depending on 
whether the scaffold is cytoplasmic or membrane-associated, respectively.  
Curiously, a recent study in a mammalian system also suggests a critical role for 
membrane-localized signaling complexes in promoting graded signaling through 
the Raf-MEK-ERK cascade in response to growth factor-activated Ras (Tian et 
al., 2007), though there are two notable differences.  First, that study asserted 
that graded signaling depends critically on confining plasma membrane Ras 
molecules into “nanoclusters”, whereas there is no evidence at present to 
suggest an analogous clustering structure in the yeast system.  Second, the role 
of nanoclusters in ensuring graded signaling derives from mathematical 
simulations, whereas our study uses experimental manipulations that change 
input-output behavior.  Nevertheless, the broader impact of each set of findings is 
that assembly of signaling complexes at the plasma membrane can have 
profound effects on the input-output behavior of a pathway, as compared to when 
signaling is completely cytoplasmic.  Modulation of these effects can allow cells 
to tune the systems-level properties of the signaling pathway in a manner that 
optimally suits the biological phenomenon being controlled. 
114
AC
graded
response
switch-like
response
st
im
ul
us
stimulus
MAPK
pathway
response
PFUS1 GFP
α factor
ce
ll 
nu
m
be
r
fluorescence (A.U.)
D
103102101100
[αF] (µM)
0
0.3
1
3
10
0.1
B
PM
Fus3
Ste7
Ste11
β γ
MAPKKK
MAPKK
MAPK
GTP
Ste20
Cdc42
pheromone (e.g., α factor)
mating
• transcriptional induction
• cell cycle arrest
• morphological changes
S
te
5
α
Figure III-1.  Graded MAP kinase cascade signaling.
A. Graded vs. switch-like responses.  At intermediate doses of stimulus, the population of cells 
may respond homogeneously (graded) or heterogeneously (switch-like).  Although these different 
response behaviors can look similar when averaged over multiple cells in a population, they are 
highly distinct when signaling is analyzed in individual cells.
B. Pheromone response pathway in S. cerevisiae.  PM, plasma membrane. 
C. Schematic drawing of the reporter gene PFUS1-GFP, which allows measurement of pheromone 
response in single cells.
D.  Wild type cells show a graded response to increasing amounts of pheromone.  FACS profiles 
show wild type (PPY1370) cells treated with 0-10 µM α factor for 2 hrs.  Each histogram 
represents 10,000 cells.  Fluorescence is plotted in arbitrary units (A.U.).
115
WT
103102101100
A
ce
ll 
nu
m
be
r
fluorescence (A.U.)
0.3
10
0.1
0
3
1
103102101100
sst2∆
103102101100
1
30
0.3
0
10
3
[αF]
(nM)
[αF]
(nM)
3
100
1
0
30
10
[αF]
(µM) bar1∆
B
0.3
10
0.1
0
3
1
[αF] (µM)
103102101100
fus3∆
ce
ll 
nu
m
be
r
fluorescence (A.U.)
C
0.3 100.10 31
[αF] (µM)
ce
ll 
nu
m
be
r
103102101100
WT
103102101100
ptp3∆
103102101100
msg5∆
103102101100
ptp2∆ ptp3∆
103102101100
ptp2∆ ptp3∆
msg5∆ *
*
*
fluorescence (A.U.)
Figure III-2.  Graded signaling in mutants of negative regulators.
A. Graded pheromone responses of wild-type (PPY1374), bar1∆ (PPY1451), and sst2∆ (PPY
1409) strains.  Pheromone concentrations differ in each experiment because Bar1 and Sst2 affect 
pheromone sensitivity, but each strain was analyzed over a 100-fold range centered on its half-
maximal response point.
B. Graded responses of fus3∆ (PPY1386) and kss1∆ (PPY1387) strains.
 
C. Graded responses of phosphatase mutants (PPY1407, PPY1408, PPY1418, PPY1406, and 
PPY1420).  The appearance of split peaks (*) in some strains correlated with the presence of 
sonication-resistant cell aggregates, as judged by microscopy (unpublished observations).
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Figure III-3.  Crosstalk signaling is switch-like.
A. Crosstalk between the mating and the high osmolarity glycerol (HOG) pathway.  Although 
these pathways are normally separate, high osmolarity stimuli will trigger activation of mating 
pathway kinases (and induction of mating specific genes) when HOG pathway output is disrupted 
(e.g., in hog1∆ cells).  Pathway components necessary for this phenomenon are shown in red.  
Only the Sho1 branch of the HOG pathway is shown.
B. Crosstalk signaling is switch-like.  PPY1372 (hog1∆ ste5∆) cells were treated with 0-1 M 
sorbitol for 2 hrs, and PFUS1-GFP expression was analyzed by FACS. 
C. Stimulus identity influences the signaling behavior.  Top: PFUS1-GFP FACS profiles of hog1∆ 
STE5 cells (PPY1825) treated with either α factor or sorbitol. Bottom: responses in the same 
strains were averaged over the entire cell population, using a FUS1-lacZ reporter gene and β-
galactosidase assays (mean ± SD; n=3).
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Figure III-4.  Dose-dependent expression of mating pathway activators.
A. Expression of genes under control of the GAL1 promoter can be regulated by β-estradiol in cells that 
contain the hybrid transcription factor “GEV” (Louvion, 1993), which contains the Gal4 DNA binding domain 
(DBD), the human estrogen receptor, and the VP16 activation domain (AD).
B. β-Estradiol-induced expression from the GAL1 promoter is uniform and graded.  Top: representative 
FACS profiles showing expression of a PGAL1-GFP reporter.  Bottom: FACS results from multiple trials were 
plotted against β-estradiol concentration (mean ± SD; n=4).
C. Inducible pathway activators.  Constitutively-active components expressed from the GAL1 promoter are 
shown in red.  In each cartoon, other pathway components that are still required for signaling are shown in 
white, whereas those that are bypassed are omitted.  Specifically: overexpression of Ste4 (Gβ) bypasses the 
requirement for pheromone and the receptor (Whiteway, 1990); membrane-targeted Ste5 (Ste5-CTM) 
bypasses the receptor and Gβγ (Pryciak, 1998); mutationally-activated Ste11 derivatives (Ste11-4, Ste11-
Asp3) additionally bypass the Cdc42-Ste20 module and show partial dependence on the Ste5 scaffold (as 
indicated by the dashed outline) (Cairns, 1992; Stevenson, 1992; van Drogen, 2000); membrane-targeted 
Ste11 (Ste11-Cpr) bypasses the receptor and Gβγ but still requires Cdc42-Ste20 and Ste5 (Winters, 2005).
D. Signaling output using β-estradiol is comparable to that of galactose-induced signaling.  Cells carrying the 
indicated PGAL1-inducible pathway activators (PPY1397, PPY1634, PPY1631, PPY1632, and PPY1591) 
were treated with either 2% galactose (GAL) in raffinose medium (RAFF) or 100nM β-estradiol in glucose 
medium (YPD).  Pathway signaling was measured using a FUS1-lacZ assay (mean ± SD; n=4).
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Figure III-5.  Signaling behavior during graded expression of active pathway 
components.
PGAL1-driven pathway activators were expressed using variable doses of β-estradiol.  Panels A-C 
show representative FACS results (PFUS1-GFP fluorescence) for each experiment, dose-response 
curves fitted to the average results (mean ± SD) from multiple trials, and the calculated Hill 
coefficients (nH) as a measure of sensitivity to changes in stimulus levels.
A. Graded signaling resulting from expression of Ste4 (PPY1397; n = 6) or Ste5-CTM (PPY1634; 
n = 3).
B. Ultrasensitive signaling resulting from expression of constitutively-active Ste11 derivatives, 
Ste11-4 (PPY1631; n = 6) or Ste11-Asp3 (PPY1632; n = 6).
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C. Dependence on Ste5 scaffolding is not sufficient to ensure graded signaling.  Constitutively-
active Ste11-4 and Ste11-Asp3 alleles were expressed in ste5∆ cells (PPY1400 [n = 5] and PPY
1591 [n = 3], respectively).  For comparison, the red dashed lines show the response curves for 
the same Ste11 derivatives expressed in STE5+ cells (from panel B).  Note that the mere 
presence of Ste5 enhances both the efficiency and ultrasensitivity of signaling.
D. The ability of cytoplasmic Ste5 to enhance signaling by active Ste11 requires binding sites for 
Ste11 (MAPKKK) and Ste7 (MAPKK), but not those for Fus3 (MAPK) or Gβγ.  A ste5∆ PGAL1-
STE11-4 strain (PPY2035) was transformed with the indicated Ste5 plasmids (pPP681, pPP1969, 
pPP2544, pPP3030, pPP2862, and pPP2861), and FUS1-lacZ induction (mean ± SD; n = 3-4) 
was measured 2 hr after β-estradiol treatment.  At right, Ste5 domain organization and mutated 
regions (see Inouye, 1997 and references therein)
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Figure III-6.  Domain requirements for Ste5 to promote signaling from different 
alleles of Ste11.  
PPY1167 (ste5∆ ste11∆) cells were co-transformed with the indicated Ste5 plasmids (pPP681, 
pPP2104, pPP2544, pPP3044, pPP2862, and pPP2863) and Ste11 plasmids (pPP2169, 
pPP1926, and pPP1532).  FUS1-lacZ induction (mean ± SD) was measured 2hr after α factor 
treatment (Ste11 and Ste11-Asp3, n = 4 each) or 3hr after galactose induction (Ste11-Cpr, n = 6).  
Left: for normal pheromone signaling, Fus3 binding is not required; Middle: active Ste11 (Ste11-
Asp3) signaling is enhanced by the addition of pheromone (amplification) (Lamson et al., 2006).  
Fus3 binding is not required; Right: membrane-localized Ste11 (Ste11-Cpr) signaling requires the 
PM domain as well as the binding sites for Ste11 and Ste7, but not for Gβγ and Fus3; Bottom: 
domain organization of Ste5 is shown at the bottom.  ND = Q292A, I294A, Y295A, L307A, 
P310A, N315A (see Table III-2).    
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Figure III-7. Factors contributing to graded signaling versus ultrasensitivity.
A. Graded response to pheromone is independent of the Ste20 to Ste11 phosphorylation step. 
Wild type (PPY1370) and ste20∆ STE11-Asp3 cells (PPY1812) were treated in parallel with 
varying concentrations of α-factor.  Fitted dose-response curves are shown for both strains (n=3), 
and representative FACS results are shown for PPY1812 (see Figure III-1 for examples of WT 
strains).
B. Expression of a membrane-targeted form of Ste11 results in graded signaling.  Ste11-Cpr was 
expressed in STE5+ cells (PPY1817) using β-estradiol (n = 4).  For comparison, the red dashed 
line shows the ultrasensitive response curve obtained when Ste11-4 was expressed in STE5+ 
cells (from Figure III-5B).
C. Graded signaling by membrane-targeted Ste5 is independent of both its N-terminus and 
endogenous Ste5.  Ste5-CTM and Ste5∆N-CTM were expressed using β-estradiol in cells where 
the native STE5 locus was deleted (ste5∆; PPY1398 [n = 6] and PPY1399 [n = 5], respectively).  
For comparison, the red dashed line shows the response curve for Ste5-CTM expressed in 
STE5+ cells (from Figure 4A).  Note that because Ste5∆N (= ∆1-214) lacks the Ste5 RING-H2 
domain implicated in Gβγ binding and homodimerization (Inouye, 1997), these functions cannot 
be required for graded signaling.
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D. Activation of the HOG pathway alters homogeneity of Ste11-induced signaling but not 
threshold effects.  PGAL1-STE11-Asp3, which can activate both mating and HOG pathways (van 
Drogen, 2000), was expressed using β-estradiol in ste5∆ HOG1 or ste5∆ hog1∆ cells (PPY1591, 
PPY2038) and assayed in parallel (n = 3).  Note that Hog1 clearly contributes to the population 
heterogeneity seen in ste5∆ strains (c.f., Figure III-5B-C), but a similar threshold behavior is 
evident both with and without Hog1. 
E. Fusion of Ste7 to constitutively active Ste11-4 attenuates ultrasensitivity.  A Ste11-4-Ste7 
fusion protein (Harris, 2001) was expressed in ste5∆ cells (PPY1402) using β-estradiol (n=5).  
For comparison, the red dashed line shows the response curve obtained when unfused Ste11-4 
was expressed in ste5∆ cells (from Figure III-5B).  Note from the FACS profiles how, in contrast to 
unfused Ste11-4 (c.f., Figure III-5B), the Ste11-4-Ste7 fusion protein allows signaling to transition 
gradually and uniformly through several intermediate levels of signaling (e.g., from 0.3 to 10 nM 
β-estradiol).
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Figure III-8. Interpretive framework and specific models for how membrane 
localization of scaffold proteins affects signaling efficiency, processivity, and 
ultrasensitivity.
A. The MAP kinase cascade is inherently ultrasensitive (middle).  Additional molecular 
mechanisms may either enhance or counteract this default tendency to generate switch-like 
(right) or graded responses (left).
B. The effect of Ste5 membrane recruitment on signal propagation through the MAP kinase 
cascade.  Top: previous results (Lamson, 2006) indicate that in the yeast mating pathway, the 
active form of the MAPKKK (Ste11) on its own results in only weak signaling, but signal output is 
strengthened when the scaffold protein (Ste5) is recruited to the plasma membrane (PM).  
Bottom: In the cytoplasm, active MAPKKK must accumulate to a high threshold level before any 
significant output occurs, resulting in ultrasensitive behavior.  At the PM, the scaffold protein 
enhances propagation of signal from MAPKKK through the kinase cascade, thus allowing low 
levels of MAPKKK activity to produce some output signal (denoted by arrows from the red dashed 
line to the black solid line), resulting in graded behavior.
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Figure III-9. Interpretive framework and specific models for how membrane 
localization of scaffold proteins affects signaling efficiency, processivity, and 
ultrasensitivity (continued).
A. Membrane recruitment may increase the occupancy of the scaffold protein (middle), or it may 
allow phosphorylation in trans between kinases bound to different scaffold molecules (right).  
Either mechanism would allow the presence of multiple kinase binding sites in the scaffold 
molecule to fulfill its predicted role in increasing processivity within the phosphorylation cascade.
B. Localized scaffold proteins may create a high density of kinase binding sites at the PM, 
promoting rapid rebinding of kinases after dissociation.  This serial rebinding could enhance the 
conversion of singly-phosphorylated substrates into multiply-phosphorylated substrates despite 
an excess of unphosphorylated substrates in the cytoplasm.  The net effect here would also be 
increased processivity, and hence decreased ultrasensitivity.
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C. At the PM, the local concentration of membrane-recruited kinases may be above that required 
to activate them to completion even by non-processive phosphorylation.  By promoting 
membrane recruitment of the scaffold protein, the input stimulus would increase the fraction of 
the total cellular pool of kinases that distribute to the region of high local concentration ([kinase]PM 
/ [kinase]total).  Thus, the signaling output would increase in relatively direct proportion to the input 
stimulus.
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 Chapter IV 
 
General Discussion 
 
 In my doctoral research, I have focused on the plasma membrane 
localization of yeast signaling proteins and how this affects the overall signaling 
behavior of the mating pathway.  In Chapter II, I have identified short membrane-
binding motifs (the BR domains) in yeast Cdc42 effectors Ste20, Gic1, and Gic2.  
I demonstrated that the BR domains are important for their normal localization 
and functions.  This result suggests a common mechanism for Cdc42 effectors to 
achieve proper localization and functions by using both general membrane 
interaction (BR or PH domains) and specific protein interaction (CRIB domain).  
In Chapter III, I examined the signaling behavior of the yeast mating pathway at 
the single cell level.  I found that mating pathway signaling is graded when the 
scaffold protein Ste5 functions at the plasma membrane.  Implications of these 
findings are already discussed in previous chapters.  In this chapter, I will discuss 
some of the remaining issues regarding these findings.  
 
Weak binding domains in signal transduction 
In Chapter II, I have identified weak membrane-binding domains that are 
essential for the localization and function of yeast proteins Ste20, Gic1, and Gic2.  
Though it was found to directly bind PIP2 in vitro, the BR domain of Ste20 had 
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 much weaker binding compared to the PH domain of mammalian PLC? (see 
Figure II-1).  Intuitively, strong and specific binding domains may sound more 
advantageous for signaling proteins to mediate specific functions.  However, the 
appropriate affinity for a given domain and its binding target depends largely on 
their biological context, such as their expression levels, compartmentalization 
and so on.  In signal transduction, the use of weak binding domains is not 
uncommon.  For example, recent genome-wide analysis in yeast showed that 
most PH domains in yeast have low affinity and/or nonspecific binding to 
phosphoinositides, and only a small minority have the target-specific high affinity 
binding seen in well-characterized examples of PH domains (such as PLC?) (Yu 
et al., 2004).  Therefore, weak binding domains may be advantageous in 
dynamic assembly and disassembly of signaling complexes, which need to be 
regulated in response to subtle changes in input.  
 
Plasticity of weak membrane binding domains  
The observations using chimeric proteins indicated remarkable flexibility of 
the Ste20 BR domain, in which lipid specificity or particular structure was not 
important for the function of the domain (see Figure II-6).  In the case of Ste20, 
the BR domain directs the protein to the general membrane vicinity so that other 
domains such as the CRIB domain and the proline-rich region can efficiently 
interact with their cortical targets.  For this purpose, membrane interaction 
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 domains with a broad range of affinity and specificity can be used, and having a 
low-affinity binding domain may not be necessary.   
Several observations support this idea.  First, additional Ste20 chimeras in 
which the BR domains are replaced with tandem copies of PH domains from 
mammalian PLC? were tested for mating pathway signaling (PLCx2 and PLCx3, 
see Figure IV-1B).  These Ste20 alleles can support signaling in the mating 
pathway.  Constitutively active, deregulated Ste20 is toxic to the cell (Leberer et 
al., 1997); however, the same set of Ste20 alleles does not cause any growth 
defect (Figure IV-1B and C).  Thus, increased membrane-binding affinity is well 
tolerated in the context of Ste20.  Additional constructs in which N-terminal 
myristoylation sequence from Gpa1 (G? subunit of the mating pathway 
heterotrimeric G protein) was added to Ste20 also functioned regardless of the 
presence and absence of the mutations that disrupts myristoylation (G2A), 
indicating that stable membrane association does not interfere with normal Ste20 
function (Myr and Myr2A, Figure IV-1B) (Song et al., 1996).  Thus, while the BR 
domain is a weak binding domain, it does not seem to be an essential feature for 
Ste20 function.   
Alternatively, these results may reflect the fact that PIP2 concentration in 
yeast plasma membrane is relatively low, and high-affinity PIP2 binding by the 
PH domain from PLC? may not be so potent in this context.  One can also argue 
that the signaling by these Ste20 alleles are slightly impaired compared to wild 
type Ste20 (60~70% of wild type), thus weak binding by the BR domain is more 
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 ideal in the context of Ste20.  In either case, the weak binding property of the 
Ste20 BR domains is appropriate, but not absolutely critical, for the signaling 
function of Ste20. 
One reason for this flexibility is the activity of Ste20 is mainly regulated by 
its upstream activator Cdc42.  Ste20 needs to interact with Cdc42 to become 
activated, thus constitutive localization of inactive Ste20 by a strong membrane 
interaction domain is not detrimental to the cell.  In addition, Ste20 activity in 
mating and HOG MAPK pathways in yeast is controlled at steps downstream of 
the MAPKKK Ste11.  Although in the mating pathway the Ste20 to Ste11 step is 
regulated by pheromone to some degree through the G?? and Ste20 interaction, 
efficient signaling from the activated Ste11 depends on the scaffold protein Ste5 
(Lamson et al., 2006; Leeuw et al., 1998).  Similarly in the HOG pathway, 
signaling through the cascade is ensured by the scaffold Pbs2 and the MAPK 
Hog1 (Posas and Saito, 1997).  Thus, the activity of Ste20 is further regulated 
downstream, thereby filtering out any undesired basal activity at the level of 
Ste20 (Lamson et al., 2006).  
In contrast, for proteins that are already functional at the membrane 
without additional activation step(s), plasma membrane localization itself needs 
to be tightly regulated.  For example, the scaffold protein Ste5 PM domain is kept 
weak by sub-optimal amphipathicity, and increasing membrane affinity results in 
aberrant signaling (Winters et al., 2005).  Although some degree of flexibility is 
also observed in the Ste5 PM domain, the replacement of the Ste5 PM domain 
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 by the PH domain from PLC? resulted in a significant decrease in signaling 
efficiency (~40% of wild type).  Therefore, in this case, Ste5 having a weak 
domain is clearly desirable.  Interestingly, the PH domain of Golgi specific FAPP1 
was functional in the context of Ste5 but not in Ste20 (see Figure II-6).  
Therefore, the balance between two domains that work together (PM-membrane, 
RING-G?? for Ste5, BR-membrane, CRIB-Cdc42 for Ste20) seems to be critical 
for the given function of the protein.   
The plasticity of the short membrane-binding domain is revealed by the 
chimera experiments in Ste5 and Ste20; however, it is unknown whether the 
globular membrane-binding domains such as PH domains or FYVE domains are 
also functionally replaceable by other membrane-binding domains.  One study 
showed that N-terminal regions of the yeast PAKs Ste20 and Cla4 were 
interchangeable; a Cla4 chimera with Ste20 N-terminus (including both the BR 
and the CRIB domains) behaves qualitatively the same as wild type Cla4 (and 
vice versa) (Keniry and Sprague, 2003).  Although intriguing, it is hard to 
generalize from this study that PH domains can also be functionally flexible, as 
Ste20 and Cla4 are homologous to each other and have partially overlapping 
functions, and the study used a large portion of Ste20 (residues 1-565) to fuse to 
the Cla4 kinase domain.  It is conceivable that the short membrane-binding 
motifs are rather primitive, or even accidental domains, which happened to have 
clusters of basic residues that confer some affinity to membrane lipids whereas 
structured domains such as PH domains may have acquired additional functions.  
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 In fact, some PH domains can bind protein targets in addition to phospholipids, 
thereby targeting to the specific membrane by cooperation between sites for two 
different targets by the single domain (Godi et al., 2004; Roy and Levine, 2004).  
In addition, domains that specifically bind lipids whose levels increase 
dramatically in response to signal input (such as PH domains that specifically 
bind PIP2) need to have specific binding in order to mediate their proteins’ 
functions, and may not be replaced by more general membrane-binding 
domains.  It would be interesting to test how precise these domains have to be in 
order to carry out their functions.  
 
Collaboration among weak binding domains 
As mentioned earlier, many phospholipid binding domains such as the 
majority of PH domains or the BR domains are too weak to direct membrane 
localization on their own.  Therefore, as seen in the BR and the CRIB domains of 
Ste20, efficient localization to the membrane is achieved by the collaboration 
among weak membrane binding domains and other interaction domains.  In 
yeast Cdc42 effectors, it is curious that the general membrane binding domains 
are all situated N-terminal to the CRIB domains (see Figure II-8A).  Although it is 
hard to predict from the primary sequences how close these domains would be in 
their folded forms, close proximity may be important for the two domains to 
function together.  For example, if the presence of membrane binding domains 
simply increases the chance of interaction by co-localization, it is better to have 
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 the two domains close to each other so that the CRIB domain can also be close 
to the membrane to interact with membrane-associated Cdc42.  However, if the 
membrane association induces allosteric change and increases the binding of 
the CRIB domain to Cdc42 (cooperative binding), the two domains may not have 
to be close to each other.  In either way, the similarity of the domain 
organizations among Cdc42 effectors may simply reflect the fact that the 
arrangement works, and further experimentation would be required to answer 
whether the close proximity of the two domains is necessary.  
Cooperation of weak interaction domains can also occur between the 
same domains.  Dimerization (or oligomerization) of the weak membrane binding 
domains can increase binding affinity by the avidity effect, in which the interaction 
between two binding partners occur on multiple binding sites.  For example, the 
PH domain from dynamin, a GTPase involved in vesicle scission, needs to be 
oligomerized to have high-affinity phospholipid binding (Klein et al., 1998).  An 
analogous example is found in the bacterial ATPase MinD, which contains a 
short membrane-binding domain (called MTS) similar to the BR domain (Szeto et 
al., 2003).  A single MTS motif is too weak to localize to the membrane but 
tandem copies of MTS can stably associate with the membrane, indicating that 
the membrane localization of MinD is regulated by oligomerization.  In the case 
of Ste20, the original identification of the BR domain was easily detected by the 
dimerization of the Ste20 N-terminal fragments by GST moiety (Figure I-1A).  
There is no evidence that Ste20 localization or function requires dimerization; 
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 however, the inhibitory interaction between the CRIB domain and the kinase 
domain may occur in trans (Parrini et al., 2002).  It is possible that Ste20 is 
dimerized when inactive, and this increases the membrane binding affinity of the 
BR domain prior to the activation of the kinase by Cdc42.   
  
In conclusion, the identification of the BR domain in yeast Cdc42 effectors 
offers further examples of short membrane-binding domains that are essential for 
protein localization and function.  These weak binding domains cooperate with 
other interaction domains to provide means to regulate dynamic and reversible 
interactions among signaling proteins.  In the future, it will be important to 
understand how multiple domains within a same protein function together, the 
requirements for the individual domains to collaborate with other domains in 
terms of affinity and specificity, and how these domains are used in combination 
to achieve appropriate cellular functions.   
 
How do scaffold proteins promote signaling? 
 In Chapter III, the mating pathway scaffold Ste5 is shown to promote 
graded signaling at the plasma membrane, but not in the cytoplasm.  The models 
that can explain these results suggest that Ste5 may not function in the 
conventional manner, which involves simultaneous binding of all binding partners 
to the same scaffold protein.  In this conventional view, the balance between the 
concentrations of scaffold proteins and binding partners is important; at high 
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 concentration of scaffold proteins, signaling becomes inhibited because the 
binding partners are sequestered into incompletely occupied scaffold proteins 
(Figure IV-2A).  This effect is called the prozone effect or combinational inhibition 
(Bray and Lay, 1997; Levchenko et al., 2000).  Observations from mammalian 
scaffold proteins KSR1 and JIP1 support this view, as overexpression of these 
scaffold proteins decrease signaling through the MAPK pathways in which they 
participate (Dickens et al., 1997; Yasuda et al., 1999).   
In contrast, yeast mating scaffold Ste5 does not inhibit signaling when 
overexpressed.  Rather, expression of Ste5 results in the activation of mating 
pathway signaling (Akada et al., 1996).  This lack of sensitivity to the relative 
concentration among the scaffold and the binding partners lead to the hypothesis 
that the binding of kinases to Ste5 may be cooperative, in which the binding of 
the MAPKKK Ste11 enhances binding of the other two downstream kinases Ste7 
and Fus3 (Dard and Peter, 2006).  If this is the case, the ultrasensitive signaling 
in the presence of cytoplasmic Ste5 can be explained as cooperativity leading to 
an increase in ultrasensitivity (Figure III-5B).  However, recent studies using live 
imaging such as fluorescent cross-correlation spectroscopy (FCCS) showed that 
the majority of Ste5 is present as a monomer and not associated with the kinases 
in the cytoplasm (Maeder et al., 2007; Slaughter et al., 2007).  Therefore, it is 
unlikely that such cooperative binding occurs in the cytoplasm. 
Is Ste5 fully occupied at the plasma membrane in response to 
pheromone?  Although it has been well established that Ste5 and all three 
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 kinases in the MAPK cascade are found at the shmoo tip in response to 
pheromone, it is still not clear how exactly the signaling through the cascade 
occurs.  Classic complementation experiments showed that the co-expression of 
two Ste5 alleles which are separately defective in signaling can support diploid 
zygote formation, indicating that Ste5 functions as a dimer or at a higher-order 
state (Yablonski et al., 1996; Inouye et al., 1997).  Since the latter study used two 
Ste5 alleles that cannot bind the MAPKKK Ste11 and the MAPKK Ste7, 
respectively, they concluded that Ste5 dimerization allows signaling to occur in 
trans.  The regions required for the self-association of Ste5 are mapped to the 
RING-H2 domain (binds G??) and a region overlapping the Ste11 binding site 
(Inouye et al., 1997; Yablonski et al., 1996).  These observations and others led 
to the hypothesis that the plasma membrane recruitment of Ste5 by G?? triggers 
dimerization and/or a conformational change that allows signaling to occur in 
trans (Elion, 2001; Inouye et al., 1997; Sette et al., 2000).  While it has been 
shown that artificial dimerization of Ste5 by GST moieties can activate signaling, 
there is no direct evidence that dimerization of Ste5 occurs in vivo at the plasma 
membrane.  Further studies such as isolation of mutations that separate the G??-
binding and self-association functions of the RING-H2 domain would be 
informative to resolve this issue. 
Instead of direct physical interaction among Ste5 molecules to form 
higher-order complexes, it is equally valid that the plasma membrane localization 
of Ste5 may simply concentrate pathway components in close proximity to 
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 promote efficient signaling through the cascade (Figure IV-2B, also see Figure 
III-9) (Lamson et al., 2006).  In this case, Ste5 does not have to be fully occupied 
by the kinases to promote signaling; instead, the plasma membrane localization 
of the scaffold proteins creates a functionally confined signaling domain close to 
the inner membrane surface.  Since the chance of protein-protein interaction 
depends largely on their effective concentrations, co-localization of pathway 
components at the plasma membrane by the scaffold protein have a profound 
effect on the efficiency of signaling through the cascade.  
In addition, this model allows for possible signal amplification through the 
scaffolded cascades; in the classic view where the reaction between bound 
pathway components occurs on the same scaffold molecule, one MAPKKK 
activates one MAPKK, and so on, there would be no signal amplification.  In fact, 
it has been observed that in the Drosophila photoactivation pathway with the 
scaffold protein INAD, signal amplification is severely limited (Scott and Zuker, 
1998).  However, if the pathway components are not confined on the same 
scaffold molecule, it is possible that one MAPKKK can activate more than one 
MAPKK, and so on to amplify signal within the area of high local concentration of 
pathway components before it becomes inactivated by phosphatases.  This is 
consistent with quantitative measurement of the mating pathway components, in 
which Fus3 is more abundant than Ste11 and Ste7, and its expression increases 
by 2.5-fold in response to pheromone (Ghaemmaghami et al., 2003; Slaughter et 
al., 2007).   
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It is interesting to note that scaffold proteins in yeast and in mammalian 
cells are not related at the sequence level, indicating a separate origin.  Yet they 
share basic functions, such as to bind multiple pathway components to direct 
information flow, promote signaling efficiency, and to localize the signaling 
complex to a particular subcellular location (Bhattacharyya et al., 2006b).  This 
underscores the necessity of the signaling pathways to be regulated, and 
scaffold proteins can provide multiple levels of regulation by influencing multiple 
pathway components.  Ste5 has been the archetypal scaffold protein since its 
discovery and many important roles for scaffold proteins have been identified 
from studies of Ste5.  This thesis describes a new role for Ste5 in promoting 
graded signaling at the plasma membrane, which is suitable for the biology of 
mating.  In the future, it will be interesting to see if separately evolved scaffold 
proteins in other systems also exhibit a similar function. 
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Figure IV-1. Functional replacement of the Ste20 BR domain with tandem copies 
of PLCδ PH domains.
A. Schematic diagram of Ste20 alleles.  Left: Ste20 chimeras in which the BR domain of Ste20 
was replaced by varying numbers of the PH domain from PLCδ.  Right: Ste20 alleles tagged with
the wild-type and mutant (G to A) myristoylation sequence from Gpa1 (Gα subunit).   
B. Pheromone response of ste20∆ cells (PPY913) carrying indicated GFP-Ste20 alleles (pRS
316, pPP538, pPP2318, pPP2455, pPP2536, pPP2537, pPP2229, and pPP2230) are shown.  
Results (mean ± SD, n = 4) are normalized to WT (100% = 72.3 β-galactosidase units).  
C. Growth curve of ste20∆ cells carrying plasmids used in B.  Cell numbers are estimated from 
the culture density (OD660, mean ± SD, n = 2). 
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Figure IV-2. A model for how scaffold proteins may promote signaling efficiency 
at the plasma membrane.
A. Prozone effect (or combinational inhibition).  When the concentration of scaffold is too low, the
signaling is low (left).  Signaling is high at the optimal concentration of scaffold (center).  At high 
concentration of scaffold, signaling becomes inhibited (right)
B. Plasma membrane localization of a scaffolded MAPK pathway may promote signaling by
increasing local concentrations of the kinases in the cortical domain.  If the signaling through
the cascade does not have to occur on single scaffold molecules, combinational inhibition does
not occur and may also result in signal amplification.
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 Appendix 
 
A motif in the Ste20 N-terminus affects cell morphology 
 
This body of work explores the potential role for the motif in the N-terminal 
region of Ste20 that induces morphological abnormality upon overexpression in 
yeast cells.  Though intriguing, the normal function of this Ste20 domain remains 
unclear.  For this reason, these results were not included in the previous 
chapters but assembled separately in this section. 
 
 
Background 
In budding yeast, Cdc42 plays an essential role in polarized growth (see 
Figure I-4).  The establishment of cellular polarity depends on Cdc42 and its 
downstream effectors, which organize actin cytoskeleton to direct secretory 
pathways to the site of growth (Pruyne and Bretscher, 2000).  Among these 
Cdc42 effectors are the p21-activated kinases (PAKs) Ste20 and Cla4.  Each 
kinase has separate functions; Ste20 activates MAPK pathways while Cla4 
regulates septins, a highly conserved group of GTP-binding proteins that function 
as a membrane-associated scaffold (Dobbelaere et al., 2003; Schmidt et al., 
2003).  At the same time Ste20 and Cla4 share an essential function, as the cell 
lacking both are inviable (Cvrckova et al., 1995).  Loss of Ste20 and Cla4 
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 function results in actin cytoskeleton defects, indicating that the PAKs can 
mediate Cdc42 signal to the actin cytoskeleton (Eby et al., 1998; Leberer et al., 
1997).  Ste20 has been shown to phosphorylate type I myosins Myo3 and Myo5, 
which participate in actin polymerization and endocytosis (Tanaka and Matsui, 
2001).  However, a constitutively active phosphomimetic mutant of Myo3 cannot 
rescue lethality of ste20? cla4? cells, indicating that Ste20 may have other 
targets (Wu et al., 1997).  Several studies have tried to identify downstream 
target(s) of Ste20 involved in polarized growth; Ste20 is found to genetically 
interact with polarisomes, a group of proteins that are important for apical actin 
organization (Pruyne and Bretscher, 2000).  Polarisome proteins include the 
yeast formin Bni1, which polymerizes actin (Evangelista et al., 2002; Sagot et al., 
2002).  Bni1 undergoes Ste20-dependent phosphorylation, indicating that Ste20 
may regulate polarisomes via Bni1 activation (Goehring et al., 2003).  More 
recently, proteins involved in sterol biosynthesis have been found to interact with 
Ste20, suggesting that Ste20 promotes cell polarity by regulating the composition 
of cellular membrane (Tiedje et al., 2007). 
In Chapter II of this study, the N-terminal fragment of Ste20 (1-333, see 
Figure A-1) induced morphological defects upon overexpression (Figure II-1A).  
This observation was particularly interesting because of the role of Ste20 in 
apical growth.  To better understand the function of Ste20 in polarized cell 
growth, I investigated the function of this motif by looking for the potential 
interacting targets. 
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 Results and discussion 
The original overexpressed Ste20 fragment that led to the identification of 
the BR domain (1-333) also induced elongated bud morphology (see Figure II-
1A, iv).  Upon further dissection, we found that this effect requires residues 72 to 
120 (Figure A-1A, ii, iii), which overlaps a region of strong local sequence 
conservation among fungal Ste20 orthologs (Figure II-2).  Interestingly, the 
morphological phenotype required the Ste20 N-terminus to be targeted to the 
plasma membrane (Figure A-1A, i, ii, vi), either by the native BR domain or by 
heterologous membrane-targeting motifs such as a carboxyl-terminal prenylation 
and palmitoylation motif (Cpr) from yeast Ras2 (Pryciak and Huntress, 1998); 
mutations in either targeting motif (BR* or Cpr-SS) eliminated the morphological 
effect (Figure A-1A, iv, vii).   
To gain further insights into the effect of Ste20 N-terminal overexpression, 
growth assays on cells expressing various fragments were carried out (Figure A-
2).  We found that overexpression of the entire Ste20 N-terminus is toxic to the 
cells, and the level of toxicity depends on the interaction domains contained in 
the expressed fragments.  In particular, overexpression of Ste20 N-terminal 
fragments containing both the CRIB domain and the BR domain, or the proline-
rich region and the BR domain, causes cells to become large and round after 
2~3hrs of galactose induction, and results in severe growth defect on galactose 
media (Figure A-2, 1-499, 1-439, 1-499 ?CRIB, 120-499, and 120-499 ?CRIB).  
This is consistent with the idea that the functions of important polarity control 
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 proteins such as Cdc42 and Bem1 are blocked by the overexpression of 
fragments containing interaction domains for these proteins, thereby resulting in 
severe growth defects.  The toxicity also correlates with the degree of 
morphological defects caused by the overexpression of the fragments.  
Specifically, fragments that block proper bud emergence (large and round cells) 
or bud-neck structure (pear-shaped cells) are more detrimental to the cells than 
the ones that cause bud elongation.  Finally, and most relevant to the topic of this 
section, the N-terminal region (a.a. 72-120) that causes bud elongation 
phenotype upon membrane targeting does not cause growth defects (54-333, 72-
333).  
A simple explanation for these observations is that a Ste20 domain 
involving residues 72-120 interacts with an unknown factor at the cell cortex that 
is not essential for the viability of the cell but is important for normal bud 
morphogenesis.  In mammalian Cdc42 targets of the WASP family, sequences in 
the analogous position provide binding sites for auxiliary regulatory factors (Zettl 
and Way, 2002).  In order to identify proteins that interact with the Ste20 N-
terminal morphological domain, we performed a two-hybrid library screen using 
the Ste20 N-terminal fragments containing residues 1-333 and 1-254 (see Figure 
II-1A) as the bait, as well as two-hybrid interaction assays with available 
constructs to see if proteins previously known to interact with Ste20 do so 
through the N-terminal domain. 
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 For the two-hybrid screen, we used both Gal4-based and LexA-based 
systems (Bartel and Fields, 1995).  Since these two systems have different 
properties and thus some interactions might be detected differently, using both 
systems would increase the chance of success.  We also used two sets of yeast 
libraries that were available to us (Chien et al., 1991; James et al., 1996).  
However, we were unable to identify any binding partner for the Ste20 N-terminal 
domain by this screen.  
Several explanations to this result include: 1) the screen was not 
saturated.  The initial transformation was less than ideal for some of the libraries, 
(need to be ~106, but some had only 20,000), so the potential target of this motif 
might have been missed; 2) vectors used (pGAD424 and pGBT9, see Table A-2) 
were reported to have lower sensitivity than the original two-hybrid vectors 
(Legrain et al., 1994).  Since the overexpression of Ste20 (1-333) fragments 
result in slow growth (Figure A-2), it is suitable to use these vectors since they 
are also shown to reduce toxic effects of protein overexpression.  However, the 
detection of weak interactions might have been missed; 3) it is possible that there 
was a problem with the bait.  The fusion protein may not have been correctly 
folded, or did not localize to the nucleus.  Since the fragment 1-333 contains the 
membrane-targeting BR domain, it is conceivable that the expression of this 
fragment did not result in a successful nuclear translocation. 
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 Ste20 is reported to physically interact with 30 proteins, and global 
analysis of phosphorylation in yeast has led to a list of 76 proteins that are 
potential Ste20 substrates (Ptacek et al., 2005).  Of these, we tested interactions 
between Ste20 N-terminal constructs used in the library screen and Hsl7, Boi1, 
Boi2, Bem4, and Bud8 by two-hybrid assay.  Hsl7 is a protein arginine N-
methyltransferase that regulates Swe1 degradation (Ma et al., 1996; Shulewitz et 
al., 1999).  Together with Hsl1 kinase, Hsl7 recruits Swe1 to the bud neck and 
promotes Swe1 phosphorylation and degradation, resulting in G2/M progression 
(Cid et al., 2001; McMillan et al., 1999).  Therefore, cells lacking Hsl7 exhibit 
elongated morphology (McMillan et al., 1999)  It is also reported to interact with 
Ste20 and Cdc42 (Fujita et al., 1999).  Boi1 and Boi2 are related proteins that 
interact with Rho-type GTPases and promote bud emergence (Bender et al., 
1996).  They have recently been implicated in the NoCut pathway, which inhibits 
abscission before the completion of cytokinesis (Norden et al., 2006).  Bem4 also 
interacts with Cdc42 and functions in bud emergence (Mack et al., 1996).  Bud8 
is involved in bud site selection (Harkins et al., 2001; Krappmann et al., 2007).  A 
Ste20 N-terminus interaction with any of these proteins would shed some light as 
to what process Ste20 might be involved; however, we could not detect any 
interactions. 
 
To test the requirement for the bud elongation phenotype observed in 
Ste20 N-terminal overexpression, additional epistasis analysis was carried out.  
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 In this set of experiments, the expression of the Ste20 (1-333) fragment was 
induced in several strain backgrounds carrying deletion mutations of genes with 
potential genetic interaction.  We found that the bud elongation phenotype did not 
depend on Kss1, indicating that the filamentous growth pathway is not involved in 
this phenotype.  Also, neither the G1 cyclin (cln1? cln2?) nor the B type cyclins 
(clb1? clb3? clb4?) involved in G2/M transition inhibited the bud elongation 
phenotype.  The bud elongation phenotype is attenuated in polarisome mutants 
(bni1?, spa2?, pea2?, and bud6?), suggesting the involvement of these proteins 
in producing bud elongation.  This result is not surprising given the normal 
function of polarisomes in apical growth (Pruyne and Bretscher, 2000).  It is also 
dependent on the cyclin-dependent kinase inhibitor Swe1 that inhibits G2/M 
transition, as with other morphogenesis defects caused by other factors (Lew, 
2003).  These results are summarized in Table A-3.   
During the cell cycle, yeast cells undergo several different states of 
polarized growth, and each state is regulated by a different distribution of Cdc42 
(Figure A-3A).  In apical growth, Cdc42 is clustered to direct bud emergence and 
bud growth to the tip.  In isotropic growth, Cdc42 is redistributed to allow 
expansion of the cell.  This apical to isotropic switch is regulated by cyclin-
dependent kinase (CDK) activity (Ahn et al., 2001; Pruyne and Bretscher, 2000; 
Sheu et al., 2000).  Ste20 is essential for prolonged apical growth in both shmoo 
formation and filamentous growth, and is regulated by G1 cyclins (Oda et al., 
1999; Wu et al., 1998).  The results collectively suggest that the bud elongation 
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 phenotype is the result of prolonged apical growth and delayed G2/M transition.  
In support of this idea, the septin localization in these elongated cells was 
normal, indicating that the bud neck structure is intact (Figure A-3B). 
 Interestingly, the expression of Ste20 (1-333) fragments is toxic to cells 
lacking Gin4, Nap1, and Elm1.  These proteins function in septin organization as 
well as Swe1 regulation (Barral et al., 1999).  Since the overexpression of the 
Ste20 (1-333) fragment was lethal in the gin4? background, a suppressor screen 
was performed to identify high copy suppressors of this lethality.  In this screen, 
gin4? cells were transformed with the Ste20 (1-333) fragment along with the 
YEp24 2?m library, and selected for viable colonies (Carlson and Botstein, 
1982).  However, we failed to isolate any candidate genes out of this screen.   
 
In parallel to the experiments using Ste20 1-333 fragments, mutations in 
the morphological domain (residues 72-120) were introduced into full-length 
Ste20 and tested in both MAPK signaling and MAPK-independent functions.  
These mutations include ?2-72, ?2-119, ?87-119 and 87-91 Ala5, which mutates 
conserved residues within the morphological domain (see Figure II-2). These 
mutants had no effect on the activity of full-length Ste20 in pheromone response 
(Figure A-4A).  In an attempt to reveal subtle defects (if any) in these mutants, 
the S338A mutation in the CRIB domain that reduces the Cdc42 binding was 
combined with the N-terminal deletion mutants (Lamson et al., 2002) (Figure A-
4B).  Again, no defect was detected in these mutants, although the signaling 
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 levels of ?2-119 mutants were slightly higher compared to the wild type.  It is 
tempting to speculate that this N-terminal region may have an inhibitory effect on 
Ste20 activity; however, the difference in the signaling level is not likely to be 
statistically significant and was not pursued further.  The N-terminal deletion 
mutants were also assayed in agar invasion or growth in the absence of Cla4 
(Figure A-5).  Again, these mutants behaved the same as the wild type, 
indicating that they are fully functional.  Therefore, the normal function of this 
Ste20 domain remains unclear at this point. 
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 Table A-1. Yeast strains used in Appendix. 
 
Name Alias Genotype Source § 
    
PPY424 L40 MATa ade2 his3-?200 leu2 lys2-801 trp1 ura3-52 LYS2::(lexAop)4-HIS3 
URA3::(lexAop)8-lacZ 
(1) 
PPY717  MATa his4 leu2 lys2 trp1 ura3 FUS1::FUS1-lacZ::LYS2 cla4?::TRP1 this study 
PPY913  MATa ste20-3?::TRP1 FUS1::FUS1-lacZ::LEU2 (2) 
PPY921 PJ69-4A MATa trp1-901 leu2-3,112 ura3-52 his3-200 gal4? gal80? LYS2::GAL1-HIS3 
GAL2-ADE2 met2::GAL7-lacZ (3) 
PPY1191 KBY211 MAT? ste20::ADE2 cla4::LEU2 + YCpTRP1-cla4-75ts (4) 
PPY1209  MATa his3 leu2 trp1 ura3 ste20-1::TRP1 (2) 
PPY1368  MATa ADE2 FUS1::FUS1-lacZ::LEU2 (5) 
PPY1383  MATa ADE2 his3 leu2 trp1 ura3 can1 ADE2 FUS1::FUS1-lacZ::LEU2 
kss1?::ura3FOA 
this study 
PPY1476  MATa his3?1 leu2?0 ura3?0 met15?0 spa2?::KanR this study 
PPY1478  MATa his3?1 leu2?0 ura3?0 met15?0 pea2?::KanR this study 
PPY1481  MATa his3?1 leu2?0 ura3?0 met15?0 bud6?::KanR this study 
PPY1508  MATa his3?1 leu2?0 ura3?0 met15?0 bni1?::KanR this study 
PPY1710 ELY86 MATa ade2 his3 leu2 trp1 ura3 cla4?::LEU2 (6) 
PPY1712 ELY93 MATa ade2 his3 leu2 ura3 cla4?::LEU2 ste20?::kanMX swe1?::his5MX6 + 
YCplac33-cla4-as3 (TRP1) 
(6) 
PPY1713 ELY95 MATa ade2 his3 leu2 ura3 cla4?::LEU2 ste20?::kanMX swe1?::his5MX6 
URA3::CDC3-GFP + YCplac33-cla4-as3 (TRP1 
(6) 
PPY1717 KA61 MATa bar1? ade2 his3 leu2 trp1 ura3 can1 cln1?::TRP1 cln2?::LEU2 (7) 
PPY1718 DK212 MATa bar1? ade2 his3 leu2 trp1 ura3 can1 clb1? clb3?::TRP1 clb4?::HIS3 (7) 
PPY1719 RA19 MATa bar1? ade2 his3 leu2 trp1 ura3 can1 gin4?::LEU2 (7) 
PPY1720 AS20 MATa bar1? ade2 his3 leu2 trp1 ura3 can1 elm1?::URA3 (7) 
PPY1721 SH24 MATa bar1? ade2 his3 leu2 trp1 ura3 can1 swe1?::URA3 (7) 
PPY1722 DK244 MATa bar1? ade2 his3 leu2 trp1 ura3 can1 nap1?::URA3 (7) 
PPY1792  MATa ade2 his3 leu2 trp1 ura3 can1 FUS1::FUS1-lacZ::LEU2 cla4?::TRP1 this study 
    
 
§ Source:  (1) (Bartel and Fields, 1995); (2) (Lamson et al., 2002); (3) (James et al., 1996); (4) 
(Holly and Blumer, 1999);  (5) (Winters et al., 2005); (6) (Weiss et al., 2000); (7) Kellogg Lab 
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 Table A-2. Plasmids used in Appendix. 
 
Name Alias Description Source § 
    
pPP167 pBTM116 2?m TRP1 lexA-DBD 2-hybrid vector (1) 
pPP244 pGAD424 2?m LEU2 GAL4-AD 2-hybrid vector (1) 
pPP311 pGBT9 2?m TRP1 PADH1-GAL4-DBD 2-hybrid vector (1) 
pPP538 pRL116 CEN URA3 GFP-STE20 (2) 
pPP681 pRS316 CEN URA3 vector (3) 
pPP964 pRL116-S338A CEN URA3 GFP-STE20(S338A) (4) 
pPP636 pGADXP 2?m LEU2 PADH1-GAL4-AD 2-hybrid vector (5) 
pPP1009 pRL116-S338A,H345G CEN URA3 GFP-STE20(S338A,H345G) (4) 
pPP1010 pRL116?334-369 CEN URA3 GFP-STE20(?334-369)  (4) 
pPP1211 pRL116-PP/GA CEN URA3 GFP-STE20(P475G, P477A) (6) 
pPP1212 pRL116-S338A, PP/GA CEN URA3 GFP-STE20(S338A, P475G, P477A) (6) 
pPP1651 pXP-BOI1 2?m LEU2 PADH1-GAL4-AD-BOI1 this study 
pPP1652 pXP-BOI2 2?m LEU2 PADH1-GAL4-AD-BOI2 this study 
pPP1843 pUG-GST-GFP 2?m URA3 PGAL1-GST-GFP vector (7) 
pPP1877 pUG-GST-F20-A 2?m URA3 PGAL1-GST-GFP-ste20(1-333)  this study 
pPP1878 pUG-GST-F20-B 2?m URA3 PGAL1-GST-GFP-ste20(330-381)    this study 
pPP1880 pUG-GST-F20-D 2?m URA3 PGAL1-GST-GFP-ste20(434-499)    this study 
pPP1939 pUG-GST-F20-F 2?m URA3 PGAL1-GST-GFP-ste20(1-254)  this study 
pPP1958 pUG-GST-F20-H 2?m URA3 PGAL1-GST-GFP-ste20(1-499) this study 
pPP1959 pUG-GST-F20-I 2?m URA3 PGAL1-GST-GFP-ste20(1-439) this study 
pPP1960 pUG-GST-F20-H/?CRIB 2?m URA3 PGAL1-GST-GFP-ste20(1-499)/?334-369 this study 
pPP1961 pUG-GST-F20-J 2?m URA3 PGAL1-GST-GFP-ste20(330-499)  this study 
pPP1962 pUG-GST-F20-H/BR* 2?m URA3 PGAL1-GST-GFP-ste20(1-499)/BR* this study 
pPP2008 pB20A 2?m TRP1 lexA-DBD-Ste20(1-333) this study 
pPP2009 pB20F 2?m TRP1 lexA-DBD-Ste20(1-254) this study 
pPP2010 pGBT20A 2?m TRP1 PADH1-GAL4-DBD-Ste20(1-333) this study 
pPP2011 pGBT20F 2?m TRP1 PADH1-GAL4-DBD-Ste20(1-254)  this study 
pPP2026 pUG-GST-F20-A/BR* 2?m URA3 PGAL1-GST-GFP-ste20(1-333)/BR*  this study 
pPP2035 pUG-GST-F20-K 2?m URA3 PGAL1-GST-GFP-ste20(54-333)  this study 
pPP2036 pUG-GST-F20-L 2?m URA3 PGAL1-GST-GFP-ste20(72-333) this study 
pPP2037 pUG-GST-F20-M 2?m URA3 PGAL1-GST-GFP-ste20(120-333) this study 
pPP2038 pUG-GST-F20-FM+ 2?m URA3 PGAL1-GST-GFP-ste20(1-254 w/MluI site at 
a.a.254) 
this study 
pPP2040 pUG-GST-F20-AM+ 2?m URA3 PGAL1-GST-GFP-ste20(1-333 w/MluI site at 
a.a.333) 
this study 
pPP2041 pUG-GST-F20-A/BR*M+ 2?m URA3 PGAL1-GST-GFP-ste20(1-333 w/MluI site at 
a.a.333)/BR* 
this study 
pPP2069 pUG-GST-F20F-Cpr 2?m URA3 PGAL1-GST-GFP-ste20(1-254)-Cpr this study 
pPP2070 pUG-GST-F20F-Cpr-SS 2?m URA3 PGAL1-GST-GFP-ste20(1-254)-Cpr-SS this study 
pPP2177 pEHG-GST  2?m HIS31 PGAL1-GST vector this study 
pPP2180 pEHG-GST-F20A 2?m HIS31 PGAL1-GST-Ste20(1-333) this study 
pPP2202 pRL116 ?2-72 CEN URA3 GFP-STE20(?2-72) this study 
pPP2203 pRL116 ?2-119 CEN URA3 GFP-STE20(?2-119) this study 
pPP2204 pRL116 BR* CEN URA3 GFP-STE20-BR* this study 
pPP2205 pRL116 ?87-119 CEN URA3 GFP-STE20(?87-119) this study 
pPP2212 pUG-GST-F20-N 2?m URA31 PGAL1-GST-GFP-Ste20(120-499) this study 
pPP2213 pUG-GST-F20-N/BR* 2?m URA31 PGAL1-GST-GFP-Ste20(120-499)/BR* this study 
pPP2214 pUG-GST-F20N/?CRIB 2?m URA31 PGAL1-GST-GFP-Ste20(120-499)/?334-369 this study 
pPP2318 pRL116 ?BR CEN URA3 GFP-STE20(?285-311) this study 
pPP2343 pRL116 ?2-72/S338A CEN URA3 GFP-STE20(?2-72)/S338A this study 
pPP2344 pRL116 ?2-72/S338A,H345G CEN URA3 GFP-STE20(?2-72)/S338A,H345G this study 
pPP2345 pRL116 ?2-119/S338A CEN URA3 GFP-STE20(?2-119)/S338A this study 
pPP2346 pRL116 ?2-119/S338A,H345G CEN URA3 GFP-STE20(?2-119)/S338A,H345G this study 
pPP2347 pRL116 ?87-119/S338A CEN URA3 GFP-STE20(?87-119)/S338A this study 
pPP2348 pRL116 ?87-119/ S338A, 
H345G 
CEN URA3 GFP-STE20(?87-119)/S338A,H345G this study 
pPP2356 pRL116-5A CEN URA3 GFP-STE20(S87A,L88A,D89A,D90A,P91A) this study 
pPP2429 pT-CDC12-GFP CEN TRP1 CDC12(-241-1224)-GFP TCYC1 this study 
pPP2575 pRL116 ?124-270 CEN URA3 GFP-STE20(?124-270) this study 
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 pPP2860 pGADXP-Bem4 2?m LEU2 PADH1-GAL4-AD-Bem4 this study 
pPP2869 pGADXP-Bud8 2?m LEU2 PADH1-GAL4-AD-Bud8 this study 
pPP2945 pGADXP-Bud8CD 2?m LEU2 PADH1-GAL4-AD-Bud8(533-579) this study 
 pGAD-Hsl7 2?m LEU2 GAL4-AD-Hsl7 this study 
 pGADXP-Hsl7 2?m LEU2 PADH1-GAL4-AD-Hsl7 this study 
 YL-1, YL-2, YL-3 2?m LEU2 GAL4-AD yeast genomic library S. Fields 
 YL2H-C1, YL2H-C2, YL2H-C3 2?m LEU2 GAL4-AD yeast genomic library P. James  
 112,113,378,379,380 YEp24 high copy number library  
    
 
§ Source:  (1) (Bartel et al., 1993); (2) (Leberer et al., 1997); (3) (Sikorski and Hieter, 1989); (4) 
(Lamson et al., 2002); (5) (Butty et al., 1998); (6) (Winters and Pryciak, 2005); (7) (Winters et al., 
2005). 
 
STE20 BR* = K285N, K286N, R287G, K288A, R297A, M298G, K299A, K310N, R311G 
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Table A-3. The effect of GST-GFP-Ste20(1-333) overexpression in various strain 
background. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Strain background: (a) W303 (ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1 can1); (b) 381G (cry1 
ade2-1
oc
 ade3 his4-580
am
 leu2-3,112 lys2
oc 
trp1am tyr1oc ura3-52 SUP4-3
ts
); (c) S288C (ade2 
his3-?200 leu2 lys2-801 trp1 ura3-52). 
 
**see Table III-1 for complete genotype. 
 
† Bud elongation phenotypes are observed at 3-5hrs (liquid culture) or after 12-24hrs (on 
galactose plates) after induction.  ND, not determined. 
 
‡ These strains have morphological defects.  KA61 (cln1? cln2?) cells are large and irregular 
shapes; AS20 (elm1?) cells are really elongated; RA19 (gin4?) and DK244 (nap1?) cells have 
slightly elongated phenotypes. 
 
§ Elongated buds with bumps. 
 
# Cells have already elongated (or irregular shape in cln1? cln2? – hard to tell if the bud 
elongation is even worse with the induction of the Ste20 N-terminal fragments. 
 
? Cells are slightly slow growing on galactose plate compared to wild type controls, so the growth 
defect is not caused by the induction of Ste20 N-terminal fragments.  
 
  
bud elongation 
phenotype †  
strain 
bkgd* strain name 
relevant 
genotype** 3-5h 12-24h 
growth 
on gal 
      
(a) PPY1368 wild type +++ +++ +++ 
(a) PPY1249 ste20?   +++§ +++    ++? 
(a) ELY95 ste20? (cla4-as) ND ND + 
(b) PPY717 cla4?    +++# +++    +? 
(a) ELY86 cla4?    +++# +++ + 
(a) PPY1792 cla4? ND ND    ++? 
(a) PPY1383 kss1? ND +++ +++ 
(a) KA61 ‡ cln1? cln2? +++   +++# + 
(a) DK212 clb1? clb3? clb4? +++ +++ +++ 
(a) RA19 ‡ gin4? ND   +++# +/- 
(a) AS20 ‡ elm1? ND   +++# + 
(a) DK244 nap1? ND +++ + 
(a) SH24 swe1? ND - +++ 
(a) ELY93 swe1? - ND ND 
(c) PPY1481 bud6? ++ ++ +++ 
(c) PPY1478 pea2? ++ ++ +++ 
(c) PPY1508 bni1? + + +++ 
(c) PPY1476 spa2? + + +++ 
      
153
(i) 1-333 (iii) 120-333(ii) 72-333
(v) 1-254 (vi) 1-254 + Cpr (vii) 1-254
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Figure A-1. A motif in the Ste20 N-terminus affects cell morphology.
The indicated fragments were expressed as GST-GFP fusions from the GAL1 promoter 
(pPP1843, pPP2040, pPP2036, pPP2037, pPP2041, pPP2038, pPP2069, pPP2070) in WT cells 
(PPY1368).  The bud elongation phenotype requires residues 72-120 as well as membrane 
localization via either the native BR domain or a heterologous membrane-targeting sequence 
(Cpr vs. control sequence Cpr-SS; Pryciak and Huntress, 1998).
154
+ +
Ste20
???????
1
CRIB ProBR
499333 439381120 25472
M
Vector
1-499
1-439
1-499 BR*
1-333
1-499 ∆CRIB
1-333 BR*
1-254
Vector
1-499
1-499 BR*
120-333
1-499 ∆CRIB
120-499 BR*
120-499
120-499 ∆CRIB
Vector
1-499
330-499
434-499
54-333
330-381
72-333
120-333
glucose galactose
++++
++++
-
-
+/-
++++
+++
++(+)
++++
++++
-
+++
++++
++++
++++
+++
++++
+
-
+/-
++
+/-
-
++++
morph. BR CRIB Pro
+ + + +
+ + +
+ + +
+ +
+
+
+ + + +
+
+ +
+
+
+ +
+ + + +
+ + +
+ + +
+ +
+ + +
+ +
+ +
Figure A-2. Toxicity of overexpressed Ste20 N-terminal fragments.
A. Domain organization of Ste20 N-terminus (a.a. 1-499).  Numbers indicate amino acid residues.
M, morphological domain; BR, BR domain; CRIB, CRIB domain; Pro, proline-rich region.
B. Overexpression of various Ste20 N-terminal fragments.  5-fold serial dilutions of wild-type cells 
(PPY1368) carrying indicated GST-GFP-Ste20 plasmids (see Table A-2 for details) were grown 
on selelctive glucose and galactose media at 30ºC.  + indicates the presence of each domain in 
the N-terminal fragments.  Images are taken after 2 days (glucose) and 3 days (galactose).  Dark 
patches indicate growth, which is scored on the right (-, no growth; +/-, poor growth; +, growth).  
Subcellular localization of each fragment is also indicated (PM, plasma membrane; cyto, 
cytoplasm, PM/c, predominant cytoplasmic sigals with plasma membrane localization).  
Morphological changes caused by these fragments are also indicated (large, large and round 
cells; elongated, elongated buds; pear, pear-shaped cells; irr, irregular shapes).    
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Figure A-3. Polarized cell growth in yeast.
A. Polarized cell growth in yeast.  In G1, Cdc42 is dispersed and cells grow isotropically.  Once
the cell becomes large enough, Cdc42 is clustered to the nascent bud site and induces bud 
emergence.  Cell undergo apical growth, and at the G2/M transition, Cdc42 is dispersed again
and the bud grows isotropically to produce an ovoid cell.  At the end of cytokinesis, Cdc42 orients
the actin cytoskeleton to the bud neck to promote cytokinesis.  Cyclin-dependent kinase (CDK) 
Cdc28 and PAK activities regulate this Cdc42 distribution as indicated.  In cells overexpressing 
the Ste20 (1-333) fragment, the G2/M apical to isotropic switch may be delayed and thus result in 
bud elongation. (adapted from: Pruyne and Bretscher, Journal of Cell Science 113:365-75 (2000))
B. Normal septin localization in cells expressing Ste20 (1-333) fragments.  WT cells (PPY1368)
carrying Cdc12-GFP (pPP2429) and either GST vector (pPP2177) or GST-Ste20 (1-333) (pPP
2180) were induced with 2% gal for 3hrs.  Merged DIC and GFP (Cdc12) imges are shown.
B
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Figure A-4. Mutations in the morphology-altering domain do not affect the 
function of full-length Ste20 in mating pathway signaling.   
 
A. PPY913 (ste20∆) cells harboring the indicated GFP-Ste20 derivatives (pRS316, pPP538, 
pPP2202, pPP2203, pPP2205, pPP2575, pPP2318, pPP1010, or pPP2356) were tested for 
induction of FUS1-lacZ by α-factor.  Results (mean ± SD, n = 4-8) were normalized to WT (100% 
= 53 β-galactosidase units).  “87-91 Ala5” denotes a mutant with Ala replacements at residues 
87-91 (SLDDP), which form part of a conserved sequence block (see Figure II-2). 
B.  PPY913  (ste20∆) cells harboring the indicated GFP-Ste20 derivatives (pRS316, pPP538, 
pPP2202, pPP2203, pPP2205, pPP2356, pPP964, pPP2343, pPP2345, pPP2347, pPP1009,
pPP2344, pPP2346, or pPP2348) were tested for induction of FUS1-lacZ by α-factor.  Results 
(mean ± SD, n=6) were normalized to WT (100% = 56.2 β-galactosidase units). 
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Figure A-5. Mutations in the morphology-altering domain do not affect the 
functions of full-length Ste20 in invasive growth pathway signaling or cell viability.   
 
A.  PPY1209 (Σ1278b ste20∆) cells darrying the indicated GFP-Ste20 alleles (1. pPP681, 
2. pPP538, 3. pPP2202, 4. pPP2203, 5. pPP2205, 6. pPP2204, 7. pPP964, 8. pPP1211, 
9. pPP1212) were assayed for invasive growth.  Plates are shown before and after non-adherent 
cells were rinsed off with water after incubation for 24 hrs (top) and 30 hrs (bottom) at 30ºC.
B.  5-fold serial dilution of KBY211 cell cultures (ste20∆ cla4∆ cla4-75ts) carrying the indicated 
GFP-Ste20 alleles (from top to bottom, pPP681, pPP538, pPP2202, pPP2203, pPP2205, 
pPP2204,pPP964) were spotted on YPD plates and incubated at 23ºC or 37ºC for 2 days.
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